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THESIS ABSTRACT 
 
Background.  Haematopoietic stem cell transplantation (HSCT) is an intensive 
procedure associated with psychological distress particularly during the first 
weeks (acute phase).  Based on the self-regulatory model of adjustment to 
illness, a preparatory group intervention was developed aiming at alleviating 
distress by reducing negative perceptions of HSCT and fostering helpful coping. 
Aims.  The present study aimed to evaluate the feasibility of delivering the 
intervention and of conducting a trial to assess its efficacy.  It also aimed to 
explore the applicability of the self-regulatory model in HSCT. 
Methods.  Participants were adults from consecutive referrals at two transplant 
centres.  Half were randomised to the intervention and half to treatment as 
usual at each site.  Psychological distress, HSCT perceptions, and coping were 
assessed at baseline (following consent), on transplant day, two weeks, and 
four weeks after transplantation. 
Results.  Of 99 eligible patients, 45 consented.  Main barriers included inability 
to consent prior to transplantation, competing priorities, being unwell, and long 
travel distance.  Of 21 participants randomised to intervention, five attended.  
Main barriers included being unable to attend prior to transplantation and having 
competing priorities.  Groups could not be held sufficiently frequently to enable 
attendance prior to transplantation, as randomising participants to the control 
group prevented sufficient accrual at each site.  Anxiety peaked two weeks 
following transplantation but depression increased throughout the acute phase.  
Intervention effects were small but sample sizes for a full trial appeared 
feasible.  Negative perceptions of HSCT and use of a range of coping styles 
(including styles considered helpful) predicted higher distress throughout the 
period. 
Conclusions.  The findings revealed considerable barriers to delivering a 
group-based intervention and conducting a trial to assess its effectiveness.  
This highlighted a need for better integration with routine care and alternative 
trial procedures.  However, the findings illustrated complex psychological needs 
during the acute phase of HSCT and the role of negative HSCT perceptions and 
unhelpful coping in underpinning distress.   
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Abstract 
Objectives 
To investigate the characteristics, methodology, quality, and efficacy of psychological 
interventions for distress in adult patients undergoing haematopoietic stem cell 
transplantation (HSCT).  
 
Methods 
A systematic review of relevant studies was conducted using six databases with 
supplementary hand searching.  Included studies employed an experimental or quasi-
experimental design, interventions included at least one psychological component, and 
outcomes involved psychological distress in affective terms.  Data were abstracted and study 
quality was assessed using Cochrane Foundation criteria amended to include confounder and 
common factors control.  Data were examined and synthesised using a narrative approach and 
meta-analysis. 
 
Results 
Eleven articles for nine interventions met the inclusion criteria out of 11070 abstracts.  
The studies varied in quality, general, intervention, and methodological characteristics while 
findings were mixed.  Interventions tended to show better efficacy when incorporating a 
major psychological component involving cognitive behavioural or emotional processing 
methods with substantial interventionist input.  However, this was also associated with 
methodological limitations and threats to internal validity such as poor confounder and 
common factors control.  A meta-analysis yielded a small but significant pooled effect size 
estimate in favour of interventions with inconsequential heterogeneity.  Risk of bias remained 
a concern.   
 
Conclusions 
Psychological interventions may provide some benefit in alleviating distress in HSCT 
but conclusions remain tentative in light of methodological limitations and risk of bias.  
Further research is needed to evidence the individual contribution of intervention components 
and mechanism of change together with improving intervention efficiency and 
methodological quality.  
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Background 
Haematopoietic stem cell transplantation (HSCT) is a complex procedure aimed at a 
range of haematological and autoimmune illnesses and involves transfer of haematopoietic 
stem cells harvested either from the patient (autologous) or a matched donor (allogeneic) [1].  
Over 45,000 individuals worldwide undergo the procedure annually often resulting in 
substantial benefits but the procedure remains very costly (up to £100,000 per transplant) and 
is very intensive [1].  The initial stages often involve administration of high doses of 
chemotherapy sometimes with radiation aiming at severe depletion of bone marrow cells 
including cancer cells and suppression of the immune system in preparation for engraftment 
[1].  This is followed by stem cell infusion to restore haematological and immune systems.  
The process can last several weeks involving very high levels of toxicity often in addition to 
previous chemotherapy, prolonged periods of isolation due to immunosuppression, and a 
range of debilitating side effects [1-3].  Physical side effects are often multiple with the 
greatest impact during the first 30 days and can include fatigue, disturbed sleep, weakness, 
nausea, pain, graft-versus-host disease (GVHD where donor immune cells attacks the 
patient’s organs), and even death [1-3].  Long-term complications are also a concern such as 
elevated risk of mortality compared to the general population [4] and chronic health 
conditions with 20% of patients experiencing severe complications [5-7]. 
 
Psychological distress in HSCT and its sequelae 
In light of the physical burden associated with the procedure, it is not surprising that 
patients undergoing HSCT experience considerable psychological distress.  Patients report a 
consuming effort to prepare and an ongoing struggle with loss of agency, describing the 
procedure as “walk to hell and back” or “really, really hard” [8, p. 404].  Studies in adult 
HSCT have observed considerable loss of personal control and psychological distress, 
particularly during hospitalisation, with up to a quarter of patients meeting clinical criteria for 
anxiety and/or depression during the procedure [3, 9-13].  Following transplantation, 
psychological distress improves but can persist with studies reporting up to 40% of patients 
experiencing depression and up to 30% anxiety even one year later [14].   
Apart from psychological well-being, the consequences of distress appear to affect 
physical well-being and recovery although research remains limited and correlational.  
Nevertheless, studies have observed a range of associations between psychological distress 
and worse treatment adherence, reduced pain and symptom tolerance, longer hospital stay, 
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and higher mortality [11, 12, 15].  In addition, stress, even in transient forms, has been 
associated with greater subsequent incidence of illness, harmful physiological changes, 
greater pain perception, suppression of the immune system, and higher risk of infections 
more generally [16].  In a procedure such as HSCT, which involves pain and substantial 
immune system recovery [1], distress may increase patients’ vulnerability and impede the 
process.   
 
The contribution of psychological intervention 
The above research findings highlight the potential benefits of psychological 
intervention in alleviating distress in HSCT to enhance psychological well-being and 
supporting recovery.  Research in the psychological needs of HSCT patients has indicated 
some potential areas for intervention.  Findings suggest that pretransplant avoidance, lack of 
professional emotional and informational input, and a threatening perception of the illness 
and future together with loss of agency often present in HSCT patients can predict higher 
distress and physical symptoms [17-22].  Conversely, optimism and self-efficacy have 
predicted improved physical and emotional functioning following HSCT [23].  These 
findings are also in line with the wider theoretical literature of adjusting to health-related 
difficulties suggesting that illness appraisals and coping can play an important part in the 
process [24, 25]. 
In spite of evidence indicating the potential of psychological intervention in HSCT, 
relevant research remains limited compared to an extensive body of literature in related 
clinical areas and particularly cancer [26, 27].  For example, psychological therapies with 
educational, cognitive-behavioural, coping skills components, and so forth, have been shown 
to facilitate physical and emotional functioning, improve immune function, and enhance 
survival in cancer patients [26-28].  Such reviews of the literature have also been helpful in 
highlighting limitations of existing research such as poor methodology in participant 
selection, limited use of blinding, non-equivalent control interventions, and so forth.  This is 
important to not only guide clinical judgment but also identify research needs towards better 
evidence base.  However, while psychological interventions have begun to emerge in HSCT 
[e.g., 29, 30], such a resource does not exist at present.  In light of marked discrepancies in 
outcomes and methods [e.g., 29, 30] this can be problematic as lack of clarity can misguide 
and hinder both clinical and research progress.  To address this need, the present project aims 
to conduct a systematic review of the literature to answer the following questions: 
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1. What are the characteristics and efficacy of psychological interventions 
aiming at alleviating psychological distress in adult HSCT recipients? 
2. What is the methodology and quality of the research evidence? 
3. What participant, methodological, and intervention characteristics are 
common in studies demonstrating positive effects?    
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Methods 
This review follows standardised guidelines of reporting systematic reviews and 
meta-analyses [31, 32]. 
 
Search strategy 
A computerised search of major psychological, medical, and nursing literature and 
doctoral theses databases with a moderate degree of overlap was conducted [33, 34]: 
PsycINFO (1806 to June Week 1, 2014), MEDLINE (1946 to May Week 4, 2014), EMBASE 
(1980 to Week 4 May 2014), CINAHL (1982 to June 6, 2014), and ProQuest Theses (1862 to 
June 5, 2014).  In addition, the first 300 results of Google Scholar (until June 20, 2014, listed 
by relevance) were screened for additional references together with hand searching tables of 
contents of the specialist journals Bone Marrow Transplantation, Psycho-oncology, and 
Journal of Psychosocial Oncology.  Reference lists of all identified publications were also 
screened for additional publications.  An attempt to trace unpublished research was made by 
contacting authors of research identified by these means (e.g., conference abstracts in 
journals) and the European Group for Blood and Marrow Transplantation. 
Search terms were identified from a range of sources including systematic reviews of 
psychological interventions and distress in HSCT and analogous populations [14, 26-28] and 
terminology used in studies already identified during preliminary scoping of the literature 
[e.g., 29, 35, 36].  Additional related terms and relevant subject headings were further 
identified via the databases.  Terms for the target population (e.g., stem cell$, bone marrow, 
etc.), intervention (intervention$, therap$, etc.), and outcomes (e.g., psycho$, distress, etc.) 
were grouped separately using OR and then combined using AND operators.  Terms were 
added to the script sequentially from general to specific (where applicable) and were 
excluded for economy when they did not add any further publications.  This process resulted 
in different but equivalent scripts for each database, presented in the online supplement2. 
 
Selection of studies 
Consistent with the aims of the review, the following inclusion criteria were applied: 
                                            
2 The search strategy can be found as supplement at the end of the references, to evidence 
scope for the purposes of the RLS assessment though the same detail may not be required in a 
journal article. 
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 The target population included HSCT patients. 
 Patients were adults (at least 18 years old). 
 Psychological interventions were those that had explicitly included at least one 
component relevant to psychological theory, for example, coping, emotional 
processing, appraisals, and so forth.  This excluded solely physical (including 
relaxation), art, occupational, medical interventions, or hypnosis. 
 Outcomes were evaluated using at least a quasi-experimental design.  
Uncontrolled designs such as pre and postintervention comparisons were not 
included due to limited internal validity stemming from lack of control for 
concurrent effects [37] including that of undergoing HSCT. 
 Interventions explicitly targeted and assessed psychological distress defined in 
affective terms (e.g., anxiety, depression, negative affect, etc.). 
 
Data abstraction 
To answer the research questions and aid the evaluation of study quality (see below), 
the following data were extracted by the first author: 
1. Reference: author names, publication year. 
2. Research design: Type (Randomised Controlled Trial [RCT], etc.), conditions, 
randomisation, allocation, blinding, confounder control. 
3. Sampling: Site, selection, inclusion and exclusion criteria, accrual, attrition, 
sizes. 
4. Disease information: Disease, transplant type, conditioning, side effects 
(particularly GVHD), functional impairment, admission days, time since 
transplant, number of readmissions, and differences between groups. 
5. Demographic information: age, gender, ethnicity, marital status, socio-economic 
status (income, employment, or education), and differences between groups. 
6. Intervention: components, timing, delivery (sessions, duration, and schedule), 
interventionist role, and adherence. 
7. Outcome measures: Names, constructs, timing of administration, standardisation, 
reliability, and validity.  Planned (e.g., as stated in published protocol) versus 
reported outcomes. 
8. Analysis: Tests, intention to treat analysis, confounder control. 
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9. Key findings and data for meta-analysis: Significant effects, relevant comments, 
pre and postintervention or difference means and standard deviations per group, 
and sample sizes.  Unpublished data were requested by authors. 
 
Study quality 
Use of composite scales with overall study quality ratings has not been empirically 
supported [38], therefore, a component quality assessment was employed consistent with 
Cochrane Foundation practice for clinical trial reviews [39].  It examined several sources of 
bias including: 
 Selection (e.g., group equivalence): random assignment and allocation 
concealment 
 Performance (e.g., group differences in treatment other than the intervention): 
blinding of participants and personnel 
 Detection (group differences in outcome assessment): blinding of outcome 
assessors 
 Attrition (e.g., groups differences in withdrawal): intention to treat analyses; 
however, high bias was assigned if attrition exceeded 60% due to potential 
unreliability of intention-to-treat analysis. 
 Reporting (differences between reported and unreported findings): incomplete 
reporting of outcome data. 
 
As blinding of the interventionists is generally not possible for psychological 
interventions, a decision was made to consider this criterion satisfactorily met where the 
comparison group was treatment as usual, the interventionist did not have major involvement 
with participants other than the intervention, and other care staff remained broadly unaware 
of the allocation. 
Two further components were added: confounders and common factors.  Because 
randomisation may not have been successful particularly in smaller studies, the former 
required either evidence that groups were comparable on confounding variables to 
demonstrate success or appropriate statistical control.  Confounders included demographics 
(age, gender, ethnicity, marital status, socio-economic status), disease-related characteristics 
(disease, transplant type, side effects, hospital days, functional impairment, time since 
transplant, and readmission), and baseline outcomes.  Having measured at least 70% of these 
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together with control for differences was considered low risk.  These criteria followed 
relevant reviews, literature on predictors of distress in HSCT, and quality assessment practice 
[14, 26, 38, 40-42]. 
Common factors were incorporated because improvement in psychological therapies 
may reflect the therapeutic relationship, increased contact, common understanding of the 
problem, or other factors not specific to the intervention [43].  This component examined 
whether comparison groups involved some attentional equivalent to provide evidence that 
effects were more likely attributed to the intervention per se than common factors whilst 
recognising that constructs such as therapeutic relationship, common understanding, and so 
forth, may only be partially achieved with attentional control. 
 
Quantitative data synthesis 
To examine the efficacy of interventions, mean pre and postintervention change 
differences were calculated and standardised for each group.  Signs were reversed so that a 
positive sign always reflected improvement.  Where studies provided data for more than one 
relevant outcome, these were pooled to form a mean effect size per study.  Data were then 
entered in a meta-analysis to estimate the overall weighted intervention effect of pre/post 
change difference between the two groups.  Data were pooled using the generic inverse 
variance method with Hedges’ g representing standardised mean differences (as described in 
[44]) selected to accommodate use of different outcome measures.  This contains an 
adjustment for small samples [45], as expected in the present review.  Where multiple 
postintervention data were available, data from the time point closest to the end of the 
intervention were entered first.  Sensitivity analysis was then conducted using data from the 
final follow up instead. 
Fixed effects models were used where heterogeneity was not significant otherwise 
random effects with the DerSimonian and Laird method were employed (as described in [44, 
45]).  Random effects generally produce wider confidence intervals and are considered more 
conservative as they adjust for considerable (and unexplained) heterogeneity [34, 44, 46].  
However, this can be misleading if greater weight is assigned to smaller studies with higher 
risk of bias [44, 45] in which case fixed effects were preferred.  Effect sizes were interpreted 
using Cohen’s [47] guidelines with 0.2 considered small, 0.5 medium, and 0.8 large.   
Heterogeneity was examined visually via the Forest plot and statistically using a Chi2 
test (Q statistic [44]).  The I2 statistic quantified heterogeneity with values up to 40% 
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representing relatively inconsequential, 30%-60% moderate, 50%-90% substantial, and 75%-
100% considerable heterogeneity [44].  Publication bias, primarily due to underreported 
studies with null effects [34], was assessed via visual inspection of the funnel plot.  Review 
Manager (Version 5.3) software [48] was employed with alpha level of significance set at 
0.05 except for the Q statistic where an alpha level of 0.10 was adopted due to loss of power 
with smaller sample sizes and few studies [34].  
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Results 
Included studies 
Eleven studies met the inclusion criteria (Figure 1).  The relatively large number of 
initial abstracts appeared due to the generic nature of search terms (e.g., distress also 
encompassing physical symptom distress, intervention often referring to HSCT itself).  Of the 
included studies, nine were already published in peer-reviewed journals [29, 30, 49-55], two 
were in press [54] of which one was identified by its author via a conference abstract query 
[56], and another [57] was an unpublished doctoral thesis.  Of these, one study was in 
Spanish [49] and translated by the author.  Details of included studies are presented in Table 
1 with overall effects in Figure 2.  Hand searching and contact with the European Group of 
Blood and Marrow Transplantation did not reveal any additional studies. 
 
 
Figure 1.  Flowchart of the selection of studies investigating psychological interventions in 
haematopoietic stem cell transplantation. 
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Figure 2.  Forest plot of standardised pre/post change comparison between intervention and control groups with funnel plot for the evaluation of 
publication bias.  Studies are listed in increasing risk of bias.  Overall, there was a small pooled effect size estimate with non-significant 
heterogeneity.  Follow up effects were calculated where available but not included in this estimate, as shown above, with sensitivity analysis 
yielding comparable results.  Std.=standardised; IV=inverse variance; CI=confidence intervals; m=months; yr=year. 
in press [54] 
[56] 
[29] 
[29, 1yr] 
[50] 
[51] 
[52, 1yr] 
[30, 53] 
[30, 53; 6m] 
[57] 
[57] 
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General characteristics 
The 11 studies described and evaluated nine interventions since 1998.  Seven studies 
(six interventions) were from the United States of America [29, 51, 52, 54-57] and four (three 
interventions) were from European countries [30, 49, 50, 53].  All samples consisted 
primarily of white participants.  Haematological malignancies (lymphoma, myeloma, and 
leukaemia) were the most frequently targeted disease with only two interventions for breast 
cancer patients.  Two thirds of the interventions did not discriminate between allogeneic and 
autologous transplant patients. 
 
Intervention characteristics 
Interventions varied in timing, intensity, delivery, content, and the extent to which 
they targeted solely psychological distress or additional areas of functioning.  Seven intended 
to alleviate distress following transplantation of which three also targeted distress during the 
procedure.  Another two focused on distress during transplantation only.  Regarding 
outcomes, only two interventions [29, 49] were aimed solely at psychological distress 
targeting either posttraumatic symptomatology or more generally anxiety and depression.  
The others had a broader scope also aiming at improving non-psychological functioning such 
as physical or social quality of life which were not in the focus of the present review. 
Seven of nine interventions incorporated Cognitive Behaviour Therapy (CBT) 
methods (see [58] for an overview of such methods) with emphasis on cognitive components 
and two [50, 54] employed other approaches.  CBT-based components included 
informational input or psychoeducation regarding various aspects of distress (e.g., stress) or 
cognitive processes (e.g., cognitive biases), cognitive restructuring, and coping skills training 
often with problem solving.  One intervention [29] also included a behavioural component of 
graded exposure to traumatic memories.  Relaxation and/or exercise featured in three of the 
interventions [29, 30, 51-53, 56] alongside psychological input and formed a major 
component in two interventions [30, 53, 56] which incorporated considerably less 
psychological input compared to others.  The interventions using components other than 
CBT-based were less problem and more emotion-focused (active approach) aiming at 
fostering emotional processing via expressive means.  Overall, five interventions involved a 
substantial psychotherapy component [29, 49-52, 57] with the remainder being less specialist 
(e.g., psychoeducation with relaxation, task instructions, etc.). 
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All interventions were delivered individually and for seven out of nine this was face 
to face during admission.  One [51, 52] also had some remote input and the remaining two 
were delivered via telephone several months following HSCT [29, 54].  Interventions also 
involved varying degrees of guided and self-directed work with five out of nine incorporating 
both [29, 30, 51-54, 56] and only two consisting primarily of self-directed work [55, 56].  
Self-directed components included relaxation, cognitive or coping skills practice, and 
expressive writing and were supplemented by printed material and/or verbal instruction.  
Four interventions involving substantial psychotherapy input [29, 49-52, 57] were delivered 
by healthcare professionals or specifically trained researchers.  Less specialist interventions 
were facilitated by site staff or researchers.  Generally, interventions with substantial 
psychotherapy input were delivered over four and up to fifteen sessions while delivery was 
more frequent for others and often over several weeks though this was mostly self-directed.  
Session length began at approximately 20 minutes and rarely exceeded an hour. 
 
Methodological features 
Most studies were RCTs comparing the intervention to a control group with only two 
using a quasi-experimental design (non-equivalent controls).  All studies examined 
longitudinal change with all but one [49] including a baseline measurement prior to 
administering the intervention.  Otherwise, methodology varied in sample size, type of 
control, outcomes, follow ups, data analysis, and confounder control. 
Sample sizes per group ranged between those appropriate for pilot with approximately 
ten participants [49, 55, 57] to a large RCT with an excess of 300 participants while the 
remainder [29, 30, 50-54] were modest with 21 to 91 participants.  Seven of eleven studies 
recruited consecutively prior to HSCT, two [49, 55] did not report sufficient information, one 
[29] screened participants for high distress (primarily trauma), and another [54] for at least 
mild survivorship difficulties (including distress).  In five of eleven studies control groups 
were treatment as usual (TAU), in one [29] patients received no care, and in another [56] half 
of controls also engaged in regular exercise.  In a further two studies [50, 54] comparison 
groups received input in addition to TAU including components of the intervention, 
attentional control, or a delayed intervention.   
Regarding measurements and outcomes, seven of the nine interventions were 
evaluated near their completion.  Follow ups (between three and twelve months) were 
reported for five interventions.  Psychological distress was assessed with measures of anxiety, 
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depression, posttraumatic stress, affective functioning, and general distress or psychological 
well-being.  Five of nine interventions included more than one relevant outcome measure.  
Only one study also assessed process change (coping, [55]).  All measures were standardised 
with acceptable validity and reliability as discussed in all studies and were self-reported with 
the exception of a clinician-administered trauma scale in one study [29]. 
Regarding analyses, multiple regression, analysis of variance, or equivalent non-
parametric techniques were conducted as appropriate for the design except for four studies of 
which three [30, 49, 56] reported pairwise comparisons only and one [54] which reported an 
incomplete analysis.  Where groups were found not to be equivalent in demographic, disease-
related, or baseline information, most studies attempted statistical control except two [49, 55] 
which did not examine such confounding with one [49] also failing to measure baseline 
scores for controls.  With the exception of three studies [51, 52, 56], sufficient information 
regarding adherence was also provided (attendance, logbooks, etc.).  Only one study [55] 
demonstrated poor adherence (45%) but this was factored in the analysis. 
 
Study quality 
The quality of the included studies varied considerably.  Figure 3 provides component 
ratings for each together with a graphic summary.  Overall, the rating method appeared to 
differentiate between the types and degrees of bias across studies.  Regarding selection bias, 
most studies were RCTs with low risk but this was limited by having neglected allocation 
concealment which all but one study did not comment on or address. 
Performance, detection, and common factor bias were also poorly addressed.  
Regarding the first, four studies exhibited high risk of bias but this was less clear for five 
studies where the degree of interventionist involvement with TAU was uncertain, some 
control participants received other types of intervention, the success of participant blinding 
was uncertain, or there was insufficient information.  Detection bias was high in two studies 
where the investigator was the outcome assessor but had been better addressed in three 
studies where the assessor was either blind or independent to the study.  The remaining 
studies did not comment on assessor blinding.  Common factor bias was only addressed by 
one study [54] via an active form of intervention.  This type of bias was particularly 
problematic for another study [29] where controls received no therapeutic attention and 
results from the same project published elsewhere [59] observed a therapeutic relationship 
effect suggesting a common factors effect. 
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Figure 3.  Overall summary and details of component quality ratings for risk of bias for the studies included in the systematic review.  Studies 
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Attrition, reporting, and confounder biases were moderately addressed.  Intention to 
treat analyses in approximately half of the studies indicated suitable attrition control but this 
was neglected in the remainder.  Approximately half of the studies appeared to report 
outcomes as planned, outcomes were comparable to previous studies by the authors, or 
distress outcomes were a subset of the intervention targets thereby involving less risk of 
reporting bias.  However, four studies failed to provide data for some of the administered 
outcome measures discussed in the method or measures used in preceding work, which 
questioned the validity of reporting.  Finally, five of eleven studies demonstrated appropriate 
confounder control.  This was unclear for two studies where control for baseline differences 
did not appear statistically valid (overfitting & incomplete analysis/Type II error).  High risk 
of bias in the remaining studies included poor evidence of control for individual differences 
[49, 55, 57] or no baseline control [49, 50]. 
 
Key findings 
Main results are summarised in Table 1 and overall effect sizes in Figure 2.  Seven of 
the eleven studies (seven of nine interventions) reported some benefits including lower 
distress, improved emotional functioning, and less posttraumatic symptomatology.  Of these, 
five were evaluated in the longer-term (three to twelve months) with benefits also present at 
the longest follow up.  One of these [52] had not been effective during transplantation 
suggesting a possible delayed effect or lack of power though this discrepancy may be due to 
questionable baseline outcome control at follow up.  In addition, three interventions appeared 
effective in HSCT patients that were more distressed due to close proximity to the time of 
transplantation [50] or relevant screening [29, 54].  However, the result reported as 
significant in one of these [54] did not reflect published statistical data which indicated a null 
effect (cf. Figure 2) with the significant outcome likely reflecting a statistical artefact; 
therefore, it was treated here as not significant. 
Notwithstanding some intervention benefits, results appeared mixed both between and 
within studies.  It was notable that none of the five interventions evaluated with more than 
one outcome measure resulted in benefits on all of them indicating potentially inflated Type I 
error.  One study [57] also reported a (non-significant) effect in favour of the control group.  
The authors explained this as increased awareness and acceptance of distress in the 
intervention group but this had not been observed in any other study with a similar 
therapeutic approach and design and therefore did not appear plausible.  This was also the 
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smallest study in the group and demonstrated poor controls in most quality domains.  The 
resulting lack of precision suggests that the reported effect may have indeed been due to 
chance. 
Differences in findings did not appear consistently related to many study 
characteristics.  These included general characteristics, some intervention characteristics (use 
of CBT, & mode of delivery except for the interventionist), and some methodological 
features (screening for distress, design, outcome measure, and pairwise versus more 
appropriate statistical analyses).  High risk of selection, detection, attrition, and reporting bias 
did not appear consistently related to effects either.  Notably, the same was observed in 
relation to timing of the intervention to target distress during HSCT, following HSCT, or 
both. 
Other study characteristics and risks of bias appeared related to results but were 
generally confounded.  With one exception [57], interventions with more intensive 
psychotherapy components and substantial interventionist input [29, 49, 50, 52, 55] appeared 
to yield larger and more frequently significant effects compared to those where delivery was 
less psychotherapy-specific and more self-directed (e.g., instructions, workbook, physical 
methods as main component, etc.).  This included both studies with psychological distress as 
sole target.  Poorer adherence particularly in self-directed studies may have contributed to 
this, as evidenced in one study [55]. 
It was notable that the five interventions with substantial psychological input were 
among six [29, 49, 50, 52, 54, 55] of the seven studies reporting intervention benefits whose 
results exhibited considerable threats to internal validity.  These were due to either poor 
confounder control (individual differences, baseline outcomes) or possible influence by 
common factors.  Notably, the study demonstrating the largest effect and the only study 
involving relatively highly distressed patients was also the only one with no care as control 
[29].  This was in contrast with the only study including at least attentional control [54] 
which yielded a null average effect (in spite of some screening for higher distress).  In 
addition, all studies with high risk of performance bias reported some significant intervention 
effects.  Overall study quality appeared unrelated to effect size (Figure 2) but studies with 
lower risk of bias generally appeared to involve larger samples and yield smaller confidence 
intervals. 
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Meta-analysis 
A meta-analysis using fixed effects models was conducted with data from nine of the 
eleven studies.  The effect sizes of two studies [30, 53] were averaged as they referred to the 
same project.  All data were published except for one study [56] for which data were obtained 
via the authors.  Two studies were not included following no response to the data request [55] 
or due to untraceable contact details [49].  Available data from the more distressed subgroup 
were included for one study [54] as more representative of the patients that might be offered 
psychological input in practice.  Only the attentional control group was considered from the 
same study, as it did not involve any of the components of the intervention.  Results are 
presented in Figure 2. 
There was a small but significant pooled effect size estimate 0.19, [0.05, 0.33] with 
relatively inconsequential and non-significant heterogeneity, Chi2=9.49, df=6, P=0.15, 
I2=37%.  Sensitivity analysis with the longest follow up data yielded comparable results.  All 
of the contribution to heterogeneity appeared due to the study by Allocca [57] with I2 
decreasing to 0% when this study was removed.  This outlying effect may have been due to 
imprecision and poor methodology in this small study. 
The loss of two studies due to data unavailability may have introduced bias in the 
meta-analysis.  However, both were small with high risk of bias overall, therefore, their 
exclusion may have resulted in a more accurate and valid pooled estimate.  The funnel plot 
(Figure 2) appeared approximately symmetrical (visual inspection) and even suggested a 
potential absence of small studies showing a positive intervention effect primarily due to the 
inclusion of Allocca’s study [57].  However, this was the only unpublished report in the 
group thereby highlighting a potential risk of publication bias. 
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Conclusions 
The present review examined the efficacy, characteristics, and quality of 
psychological interventions to alleviate distress in HSCT.  An emerging body of literature 
was identified consisting of RCT (including pilots) and quasi-experimental designs.  Eleven 
studies were identified for nine interventions and the evidence suggested some benefits that 
were maintained up to a year posttransplantation.  Results varied and multiplicity of outcome 
measures indicated lack of clarity but a meta-analysis revealed limited overall benefits and a 
small pooled effect size estimate.  A range of methodological limitations was also present 
suggesting a need to interpret evidence with caution. 
Interventions were timed to target distress during HSCT and up to nine months 
postdischarge with diversity in terms of therapeutic modality, components, format, intensity, 
and delivery.  Most interventions incorporated CBT-based components addressing appraisals, 
coping, problem solving, and so forth, or involved active emotional processing.  All were 
supported by a professional in varying degrees and most involved some self-directed work.  
These were similar to interventions identified in other relevant clinical populations and more 
widely in health psychology [26, 60-66] though there was a notable absence of group 
delivery in HSCT. 
Results appeared homogenous overall and the small number of studies limited 
conclusions but some patterns emerged.  Interventions involving substantial psychological 
and interventionist input tended to be more efficacious compared to those with less 
psychological or more self-directed focus.  However, this was confounded with 
methodological limitations and potentially adherence while the only unpublished study was 
contradictory [57].  In spite of an almost symmetrical funnel plot, this indicated possible 
publication bias although the study’s limitations also suggested potential imprecision.  Other 
characteristics did not appear consistently related to efficacy in light of small samples 
including whether interventions were timed and intended for distress during HSCT, following 
HSCT, or both. 
The small pooled effect size estimate was comparable and often higher than similar 
contemporary interventions in other cancer populations when assessed with analogous 
measures of distress [60, 62].  However, they were generally lower than those reported in 
similar research in other illnesses such as diabetes [63] and coronary heart disease [65].  
Possible floor effects may have contributed to attenuated efficacy, as studies did not generally 
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limit recruitment to patients with higher distress.  This has been consistently observed in 
cancer literature more generally [67-69] though lack of screening at recruitment is also 
relatively common in other illnesses [e.g., 63, 64-66].  Such practice and its effects can prove 
misguiding when evaluating interventions and limit external validity thus highlighting a need 
for routine subgroup analyses and better screening where possible.  The difference in effect 
size could also reflect the unique needs and many uncontrollable challenges faced by HSCT 
and other cancer patients [27] potentially indicating a need for more tailored interventions. 
 
Mechanism of change 
Support of the efficacy of interventions involving CBT-based or active emotion 
processing components is consistent with the HSCT literature highlighting avoidance coping, 
appraisal of HSCT as threat, or loss of self-efficacy as predictors of distress [17-21].  It is 
also supported by the wider theoretical literature of adjustment to health-related difficulties 
indicating that more benign appraisals about the situation and its sequelae, greater sense of 
control, and approach versus avoidance coping are considered important predictors of 
adaptation [24, 25].  The interventions aimed to address these in various ways, for example 
cognitive restructuring and psychoeducation for appraisals (e.g., [29, 49, 51]), problem-
solving (e.g., [57]) and skills training (e.g., [51]) for coping, or emotional acceptance and 
processing (e.g., [50]).  Relaxation, on the other hand, may reflect avoidance coping with 
stressors potentially contributing to smaller effects when used as a primary component (e.g., 
[56]). 
These considerations are plausible but it was not possible to establish from the studies 
in this review whether the interventions operated via the above processes versus other 
mechanisms.  There are three reasons for this.  First, the majority of interventions 
incorporated more than one component but were assessed as a whole and without within-
group control.  Second, with one exception [55], no study employed a process measure to 
investigate the mechanism of change and even that study did not examine the relationship 
between process and outcome.  Third, lack of control for common factors limited the present 
body of evidence almost in its entirety leaving open the possibility that reductions in distress 
may have reflected the influence of the therapeutic relationship, increased input, or other 
factors other than the intervention content per se. 
In light of these considerations, several methodological improvements could enhance 
intervention studies in the field.  These could include process change measurements, 
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experimental within-subjects control, and between-subjects control equivalent in 
interventionist attention.  Multiple components with unclear benefits also pose an ethical 
issue in a population that is already burdened considerably which may contribute to poor 
outcomes.  Therefore, it is important to improve intervention efficiency aiming at highest 
impact with fewest components.  Delivery in a group format may also be helpful in reducing 
burden. 
 
Quality of the evidence 
The method of assessing quality appeared to capture the diversity of risk of bias 
together with some meaningful findings, for example, larger studies demonstrating lower risk 
of bias.  However, lack of statistical analyses due to the small number of studies limited 
conclusions.  In spite of the majority of studies classed as RCTs the quality assessment 
revealed several areas of weakness relating to allocation concealment, common factors, 
detection, and performance bias though the latter is inherent in delivering psychological 
interventions.  While there was little variation in common factors ratings, the inclusion of this 
component was critical in evaluating the body of evidence and conclusions.  Largely 
insufficient information on allocation and blinding highlighted a much neglected area in the 
literature and a need for better control and explicit reporting.  Other areas of bias including 
randomisation, attrition, reporting, and confounder control were less problematic but could 
improve further.  Overall, most information was from studies at unclear or high risk of bias 
which lowers confidence in the evidence.  
 
Limitations 
The review employed a comprehensive search strategy using six databases including 
theses and was supplemented by manual searches to maximise retrieval.  However, the 
process was undertaken by one person and involved subjective judgement at different stages, 
for example, identifying publications, abstracting data, rating study quality, and analysis 
including visual inspections of distributions of effects and results.  It follows that it is 
possible to have missed studies or data and alternative analyses by different individuals could 
yield different results. 
A major limitation arose from a relative lack of studies, which restricted many 
analyses to visual inspections.  Together with variability in interventions, methods, outcomes, 
methodological limitations, and risk of bias this made the results difficult to interpret and the 
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conclusions regarding efficacy and study characteristics associated with it tentative.  Lack of 
power also indicated that the pooled effects might not be genuine while there was also a 
possibility of publication bias in spite of an effort to include unpublished studies.  Finally, as 
studies were of western origin with primarily white participants, it is unclear whether findings 
would generalise to individuals from different backgrounds. 
 
In conclusion, results suggested a potential albeit small benefit of psychological 
interventions for distress in HSCT particularly when involving a major psychological 
component such as CBT or emotional expression together with substantial interventionist 
input.  Further research could examine individual components and process change together 
with developing interventions that are more efficient.  Conclusions remain tentative in light 
of methodological limitations and threats to internal validity such as lack of control for 
common factors, high risk of bias, and possible publication bias.  Future studies could 
address methodological limitations and improve reporting in order to increase confidence in 
the evidence and benefit clinical practice.   
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Table 1.  Summary of studies examining the efficacy of psychological interventions to alleviate distress in HSCT 
Sources & 
design 
Disease, 
transplant, 
& follow up 
ni/nc Intervention Comparison Relevant outcomes 
Target Key findings/comments 
 
Interventions timed to target distress during HSCT only 
 
Allocca 1998 
[57] 
 
Quasi-
experiment 
 
Breast cancer 10/10 
 
Components: 
Problem and cognitive biases 
identification, cognitive techniques 
(restructuring, problem-solving, etc.), 
review and future planning 
Delivery: 
Individual (face to face) by CBT-trained 
nurse specialist 
Timing & intensity: 
Start within 48 hrs post-transplant 
5x, approx. 35 mins, over 5-10 days. 
 
TAU Anxiety & 
Depression 
(HADS) 
Psychological 
well-being 
(QOLS) 
Significant overall improvement in anxiety 
and psychological well-being but no 
significant differences between groups 
 
Non-significant increase in depression in 
intervention group 
 
 
 
Jarden, 
Baadsgaard 
2009 [30]; 
Jarden, 
Nelausen 
2009 [53] 
 
RCT 
79% haem.  
malignancy 
 
Allogeneic 
 
Follow up: 6 
months 
21/21 
 
Components & delivery: 
CBT-based psychoeducation, exercise, & 
relaxation training 
Individual exercise (face-to-face) by 
researcher & self-directed relaxation 
Timing & intensity: 
During admission 
5x pw psychoeducation & exercise, 
2x pw relaxation 
TAU Anxiety & 
Depression 
(HADS) 
Emotional 
functioning 
(QLQ-C30) 
 
Affective 
functioning 
(SCT-SAS) 
No significant effects 
 
 
 
 
 
 
Significantly lower distress and less 
severity in intervention group 
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Interventions timed to target distress following HSCT only 
 
DuHamel 
2010 [29] 
 
RCT 
 
 
 
 
 
 
71% haem.  
malignancy 
 
Mixed 
 
Follow up: 
3-12 months 
 
 
 
 
 
 
 
47/34 
 
 
 
 
 
 
 
 
 
 
Components: 
CBT for trauma – Education, self-
monitoring & cognitive restructuring, 
graded exposure, communication skills 
training, relaxation training 
Delivery: 
Individual (telephone) by trained 
postdoctoral fellows & self-directed 
practice 
Timing & intensity: 
10-16 wks post-HSCT 
10x, approx. 1 hour 
Assessed only Trauma (PCL-
C) 
Distress (BSI) 
Trauma 
Diagnosis 
(CAPS) 
 
 
 
 
Total and intrusive thoughts scores 
improved similarly in both groups 
Faster improvement for intervention group 
Diagnosis less likely for intervention group 
at end of therapy 
 
Retained throughout follow up 
 
Possible common factors effect 
       
Frick 2006 
[50] 
 
RCT 
 
 
 
92% haem. 
malignancy 
 
Autologous 
 
 
88/91 
 
 
 
 
 
Components & delivery: 
Daydream imagery for emotional 
processing 
Individual (face-to-face) by researcher 
(trained psychotherapist) 
Timing & intensity: 
1-6 months postdischarge 
15x, 15-30 mins 
Delayed timing 
(6-12 months 
postdischarge) 
 
Emotional 
functioning 
(QLQ-C30) 
 
Significantly better improvement for early 
intervention group; potentially explained by 
increased disease severity 
 
Possible floor effects for late intervention 
group 
       
Rini (in 
press) [54] 
 
RCT 
87% haem.  
malignancy  
 
Mixed 
 
69/ 
59-69 
 
Components & delivery: 
Expressive helping (expressive writing to 
help prospective patients) 
Instructions only (telephone) by study 
interviewer, otherwise self-directed 
Timing & intensity: 
1. Expressive 
writing only 
 
2. Writing to help 
peers only 
 
Distress (BSI) Lower in expressive helping group 
compared to peer helping and neutral 
writing in participants with high but not low 
survivorship difficulties. 
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Follow up: 3 
months 
9 months to 3 years post-HSCT 
4x weekly, 20 mins 
3. Neutral writing Incomplete analysis & possible Type II 
error.  Expressive helping group appeared 
to have lower baseline distress also but 
control for this was questionable while 
published data indicated null effect. 
       
Trask 2003 
[55] 
 
RCT 
n/k 26 in total Components & delivery: 
Workbook psychoeducation – coping, 
problem-solving, CBT principles 
Instructions only (face to face) by author, 
otherwise self-directed 
Timing & intensity: 
Discharge onwards, self-directed 
TAU Distress (BSI) 
Anxiety 
(STAI) 
 
Coping 
(WOC) 
No significant effects 2 & 6 months 
postdischarge 
 
45% of intervention participants had not 
utilised workbook 1 month postdischarge.  
Anxiety was significantly lower in those 
who did 2 & 6 months postdischarge 
compared to those who did not 
 
Unclear influence of individual differences 
on adherence 
 
Interventions timed to target distress during & following HSCT 
 
de Linares 
2007 [49] 
 
Quasi-
experiment 
Haem.  
malignancy 
 
Follow up: 
100 days 
10/6 Components: 
Informational, practical coping skills, 
stress management (psychoeducation & 
cognitive restructuring), communication 
with family 
Delivery: 
Individual (face to face) 
Timing & intensity: 
4x since and during admission 
 
TAU Anxiety & 
Depression 
(HADS) 
Fewer clinical criteria for anxiety and 
depression in intervention group on 
transplant day and 100 days later 
 
No baseline measurement for controls 
Gaston-
Johansson 
2000; 2013 
[51, 52] 
Breast cancer  
 
Autologous 
 
52/58 
 
 
 
Components: 
Coping – psychoeducation, cognitive 
restructuring education & coping, coping 
TAU Anxiety 
(STAI) 
Depression 
(BDI) 
No significant effects 
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RCT 
 
Follow up: 
1 year 
 
38/35 
skills training, relaxation with guided 
imagery training 
Delivery: 
Individual (1st session face-to-face then 
computer/telephone) by social worker, 
nurse, researchers, & self-directed 
practice 
Timing & intensity: 
2 wks prior to then during admission & 
top-up 3 months later 
5x (3x during admission) 
1st 1.5 hours, then 20 mins 
 
Psychological 
functioning 
(QOLI-CV) 
 
Higher in relation to intervention 
 
Possible overfitting: limited baseline 
outcome control 
       
Jacobsen (in 
press) [56] 
 
RCT 
89% haem.  
malignancy 
 
Mixed 
356/ 355 Components & delivery: 
Stress management with relaxation, 
imagery, and coping elements (50% also 
engaged in exercise) 
Individual (face-to-face) by trained site 
personnel & self-directed 
Timing & intensity: 
Since admission, ongoing 
3x instruction (introduction & 
reinforcement 30 & 60 days post-HSCT) 
otherwise self-directed. 
TAU (50% also 
engaged in 
exercise) 
Psychological 
functioning 
(SF-36) 
No significant effects 100 days and 6 
months posttransplantation 
 
Intervention adherence was unclear 
Note.  Sources are listed by name of first author with studies and outcomes supporting intervention benefits in bold lettering.  Follow up period 
mentioned where available. ni/nc=intervention and comparison group sample sizes respectively; RCT=randomised clinical trial; 
HSCT=haematopoietic stem cell transplantation; haem=haematological; CBT=Cognitive-Behavioural Therapy; #x = number of sessions (e.g., 
2x=2 sessions); pw=per week; TAU=treatment as usual; HADS=Hospital Anxiety and Depression Scale; QLQ-C30= The European 
Organization for Research and Treatment of Cancer Quality of Life Questionnaire; SCT-SAS= Stem Cell Transplantation Symptom Assessment 
Scale; wks=weeks; PCL-C=Posttraumatic Stress Disorder Checklist-Civilian Version; BSI=Brief Symptom Inventory (global scale only); 
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CAPS=Clinician-Administered Posttraumatic Stress Disorder Scale for Diagnostic and Statistical Manual for Mental Disorders, 4th edition; 
mins=minutes; n/k=not known; QOLS=Quality of Life in Bone Marrow Transplant Survivors, City of Hope National Medical Centre 
Questionnaire; WOC=Ways of Coping; STAI=State-Trait Anxiety Inventory; BDI=Beck Depression Inventory; QOLI-CV=Quality of Life 
Index-Cancer Version; SF-36=Medical Outcomes Short-Form 36 (version 2.0). 
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Supplemental material: search terms 
Population 
 MEDLINE 
(Hematopoietic Stem Cell Transplantation/ OR Bone Marrow Transplantation/) 
OR ((Stem cell$ OR bone marrow) AND (transplant$)) 
 
 PsycINFO 
(Stem cell$ OR bone marrow) AND (transplant$) 
 
 EMBASE 
(exp hematopoietic stem cell transplantation/ OR exp bone marrow transplantation/) OR 
((Stem cell$ OR bone marrow) AND (transplant$)) 
 
 CINAHL 
(“Stem cell*” OR “bone marrow”) AND (“transplant*”) 
 
 ProQuest 
AB,TI(((Stem-cell*) OR bone-marrow) AND (transplant*))   
 
 Google Scholar 
((“Stem cell” OR “bone marrow”) AND (transplant OR transplantation)) 
 
Intervention 
 MEDLINE 
(exp Psychotherapy/ OR exp Counseling/ OR Patient education as topic/) OR 
(intervention$ OR therap$ OR counsel$ OR self-help group$ OR support 
group$) 
 
 PsycINFO 
(exp Prevention/ OR exp Treatment/ OR exp Counseling/ OR exp 
Psychotherapy/ OR Support groups/) OR (intervention$ OR therap$ OR 
counsel$ OR self-help group$ OR support group$) 
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 EMBASE 
(exp “psychological and psychiatric procedures”/ OR exp counselling OR exp 
self help/ OR exp support group/) OR (intervention$ OR therap$ OR counsel$ 
OR self-help group$ OR support group$) 
 
 CINAHL 
(MH “Clinical Trials+”) OR ((“intervention*” OR “therap*” OR “counsel*” OR 
“self-help group*” OR “support group*”)) 
 
 ProQuest 
AB,TI(intervention* OR therap* OR counsel* OR (self-help-group*) OR (support-
group*)) 
 
 Google Scholar 
(intervention OR therapy OR therapies OR counselling OR ((“self-help” OR “self 
help”) AND group) OR (support AND group)) 
 
Outcomes 
 MEDLINE 
(exp emotions/ OR exp affective symptoms/ OR exp affect/ OR adaptation, 
psychological/ OR interpersonal relations/ OR Exp mental disorders/) OR 
(psycho$ OR social OR distress OR anxi$ OR depress$ OR stress OR quality of 
life OR mental health OR psychiatr$ OR mental disorder$) 
 
 PsycINFO 
(exp Adjustment/ OR exp Emotions/ OR exp Satisfaction/ OR exp Life 
experiences/ OR exp Mental Disorders/ OR exp Psychiatric Symptoms/) OR 
(psycho$ OR social OR Distress OR anxi$ OR depress$ OR stress OR quality of 
life OR mental health OR psychiatr$ OR mental disorder$) 
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 EMBASE 
(exp emotion/ OR mental disease/) OR (psycho$ OR social OR Distress OR 
anxi$ OR depress$ OR stress OR mental health OR psychiatr$ OR mental 
disorder$) C 
 
 CINAHL 
(MH “Psychological Processes and Principles+”) OR (“psycho*” OR “social” 
OR “distress” OR “anxi*” OR “depress*” OR “stress” OR “quality of life” OR 
“mental health” OR “psychiatr*” OR “mental disorder*”) 
 
 ProQuest 
AB,TI(Psycho* OR social OR Distress OR anxi* OR depress* OR stress OR (quality-
of- life) OR (mental-health) OR psychiatr* OR (mental-disorder*)) 
 
 Google Scholar 
((psychological OR psychology OR psychologic OR psychosocial OR “psycho social” 
OR “psycho-social”) OR social OR distress OR distressed OR anxiety OR anxious OR 
depression OR depressed OR stress OR stressed OR (“quality of life”) OR (“mental 
health”) OR (psychiatry OR psychiatric) OR (mental AND (disorder OR disorders))) 
 
 
 
                                            
C Quality of life added 2127 irrelevant papers mostly in relation to quality of life of 
HSCT as intervention.  Consequently, quality of life terms were excluded from the final 
EMBASE script to reduce the probability of human error whilst screening the pooled 
database list of abstracts. 
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Abstract 22 
This study tests whether a widely used psychological model of 23 
adjustment to illness, the self-regulatory model, predicts the patterns of distress 24 
observed in the acute phase of hematopoietic stem cell transplantation (HSCT). 25 
We argue that efforts to develop effective psychological interventions for this 26 
population will benefit from being grounded in an already well developed 27 
psychological approach. Consecutively referred adults (n=45) from two 28 
transplant centres were assessed at baseline on transplant day, and two and 29 
four weeks after transplantation for psychological distress, perceptions of 30 
HSCT, and coping. Anxiety peaked two weeks following transplantation but 31 
depression increased throughout the acute phase with 42% reporting clinical 32 
levels of distress at any time. As predicted by the self-regulatory model, higher 33 
distress was reliably associated throughout the period with negative perceptions 34 
of HSCT, controlling for the effects of confounding variables. More mixed 35 
support was found for the model’s predictions about the impact of coping styles 36 
upon distress. The findings provided initial evidence for the impact of HSCT 37 
perceptions and coping on distress during acute HSCT. They also suggest the 38 
basis for psychological intervention, though replication and further investigation 39 
for the use and impact of coping strategies remains necessary. 40 
  41 
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IntroductionE 42 
Haematopoietic stem cell transplantation (HSCT) is a complex and 43 
intensive procedure whose acute phase can last several weeks, involves high 44 
toxicity, prolonged isolation, and a range of debilitating side effects (e.g., fatigue 45 
and nausea).1-3 Patients report an overwhelming experience and loss of 46 
agency, describing the procedure as “walk to hell and back” and “really, really 47 
hard”.4 Surveys of psychiatric morbidity in HSCT patients have found that 48 
approximately half of patients meet clinical criteria for anxiety or depression 49 
during the first weeks with anxiety often highest around admission and 50 
depression increasing thereafter.3, 5-7 The impact of such distress on recovery 51 
from HSCT has been documented and may include reduced pain and symptom 52 
tolerance, longer hospital stay, and poorer treatment adherence, immune 53 
recovery, and survival rates.8-13 F 54 
Clinical and demographic predictors of psychiatric morbidity during HSCT 55 
have been extensively investigated.3, 5, 10, 14-16 However, the literature on 56 
psychological predictors of distress is less well developed. From this work, 57 
disparate factors such as personal control and meaning-making,5 sense of 58 
coherence,17 acceptance of distress,18 and diversion of attention from pain10 59 
appear to be important. However, we argue the absence of a unifying and well-60 
developed psychological theory from this research has hampered the 61 
development of timely and effective psychological interventions for HSCT 62 
patients. This may partly explain the sparse and limited effectiveness of such 63 
interventions in HSCT and lack of clarity regarding what contributes to 64 
outcome.19 G 65 
The most widely applied model of psychological adjustment to illness is 66 
the self-regulatory model.20-23 It conceptualises the process of psychological 67 
adjustment to illness as comprising three interacting components: interpretation, 68 
coping, and appraisal of coping. A person’s interpretation, or illness perception, 69 
includes their view of the severity of its consequences, duration, identity (its 70 
                                            
E The extended background of the thesis (Section 4) discusses the literature presented 
herein in further detail within the broader framework of the intervention examined in the 
project but not included in the present paper. 
F See Section 4.1 in the thesis for further information on HSCT and its sequelae. 
G See Section 4.2 in the thesis and the systematic review (Baliousis et al., 2015) for 
further details on the HSCT psychological intervention literature. 
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label and symptoms for the person), concern, level of understanding, and 71 
emotional impact. Coping describes the process of implementing strategies to 72 
reduce the psychological threat perceived by the person, and any resultant 73 
negative emotions. Appraisal of coping forms a feedback loop, evaluating the 74 
effectiveness of the person’s coping efforts.22 75 
All three elements of the model have been investigated extensively and 76 
largely validated in other health populations. For example, more negative illness 77 
perceptions have been found to predict a range of health-related outcomes 78 
including emotional and physical well-being.22, 24-32 Distinctive coping patterns 79 
appear to yield different results.  Avoidant coping may be unhelpful, whilst 80 
engaging with the challenges of the illness and accessing social resources to 81 
support coping may be more helpful.32-34 Positive appraisals of coping have also 82 
been found to predict emotional well-being.22, 32 Crucially, all three elements of 83 
the model have also been associated with physical recovery, predicting 84 
complications, treatment adherence, return to work, and general physical 85 
functioning.22, 26, 29, 35, 36 Should such findings be replicated in an HSCT 86 
population, the model, which has supported the development of effective 87 
interventions in other health populations,25, 26 may be a promising guide to 88 
effective interventions in HSCT. H 89 
Of the self-regulatory model's components only coping has been studied 90 
in HSCT. However, these studies have focussed on the recovery period several 91 
months after HSCT,37-39 therefore, the impact of coping during the acute phase 92 
remains unclear since coping styles can have different effects depending on 93 
circumstances.34 The self-regulatory model refers to illness and the extent to 94 
which it might apply to HSCT, where it is treatment-related toxicity that poses 95 
the greatest challenge in the acute phase, requires corroboration. Therefore, 96 
the present study examined the applicability of the self-regulatory model20-22 to 97 
acute HSCT. We hypothesised that: (a) more negative perceptions of HSCT will 98 
be associated with higher levels of distress; (b) avoidance-based coping styles 99 
(e.g., disengaging, denial, self-distraction, etc.) will be associated with higher 100 
                                            
H See Section 4.3 in the thesis for further details on the self-regulatory model and the 
evidence on the role of perceptions and coping strategies in adjustment and well-being. 
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levels of distress; and (c) approach-based coping styles (e.g., active coping, 101 
planning, seeking support) will be associated with lower distress. I 102 
 103 
MethodJ 104 
ParticipantsK 105 
Participants were recruited from consecutive referrals between January 106 
and September 2015 at two haematology departments in different regions of 107 
England. Inclusion criteria were: (a) HSCT for haematological malignancy; (b) 108 
18 years or older; and (c) sufficient command of the English language to 109 
participate in the study. Where appropriate, ambulatory care was offered and 110 
accepted by some patients, although in practice an admission took place for all 111 
participants during the study.  112 
MaterialsL 113 
We used brief, well established self-report measures. We followed 114 
standard practice by assessing the elements of the self-regulatory model via the 115 
Brief Illness Perceptions Questionnaire (Brief IPQ)40 and Brief Coping with 116 
Problems Experienced (Brief COPE) questionnaire.22, 41 117 
In light of the complex distress patterns in HSCT (anxiety, depression, 118 
traumatic stress, etc.)3, 5, 6, 9, we measured the dependent variable of distress 119 
using the Depression Anxiety Stress Scales (DASS-21) due to its coverage of 120 
three constructs and clinical validity in this respect.42, 43 DASS-21 measures 121 
depression, anxiety, and stress, and provides a total distress score.42, 43 Each 122 
subscale comprises seven items rated on a 4-point Likert scale with total scores 123 
between 0-21 for each (higher scores denote higher distress).43 Moderate level 124 
cut-offs are representative of clinical populations.44, 45 The instrument has good 125 
to excellent internal consistency (Cronbach’s α = 0.82-0.94), good criterion 126 
validity, acceptable discriminant validity, moderate sensitivity to clinical change, 127 
                                            
I See Section 5 of the thesis for further information on aims and objectives including 
those of the broader feasibility study regarding the intervention. 
J Section 6 of the thesis also contains information on the intervention and treatment as 
usual. 
K See Section 6.1 in the thesis for further information on sampling. 
L See Section 6.4 in the thesis for further details on measures, the pro-forma for 
collecting demographic and clinical information, and rationale for their selection. 
 Page 61 of 263 
and acceptable to good temporal stability (r = 0.71-0.81) in clinical samples.42, 128 
43, 46-48  129 
The Brief COPE has been widely used and is relatively short yet 130 
comprehensive41, 49, 50 consistent with the study’s aims. It measures several 131 
theoretically-derived coping styles. Self-distraction, denial, disengagement, 132 
venting, and self-blame are generally considered avoidance-based whilst active 133 
coping, support, positive reframing, planning, humour, and acceptance (vs. 134 
denial) are considered approach-based but groupings can vary across 135 
contexts33, 34, 49 and have not been established in HSCT. Each style comprises 136 
two items rated on a 4-point Likert scale with total scores from 0-6 (higher 137 
scores denoting more frequent use).41 The instrument has good construct, 138 
concurrent, and predictive validity in relation to emotional well-being and 139 
adjustment in different clinical populations including HSCT.33, 38, 51-55 Some 140 
limitations to reliability similar to other coping measures have been reported 141 
with Cronbach’s α between 0.50-0.90 and test-retest reliability coefficients 142 
between 0.42-0.89 (6-8 weeks).33, 41, 49, 50  143 
The Brief IPQ is based on the self-regulatory model and assesses illness 144 
and coping appraisals (consequences, timeline, identity, concern, 145 
understanding, emotional impact, personal, and treatment control). It contains 146 
eight items rated on an 11-point Likert scale with higher scores reflecting higher 147 
endorsement.40 A higher summary score (0-80) reflects more negative 148 
perceptions (items 3, 4, and 7 are reverse-scored).55, 56 The measure has been 149 
validated in several clinical populations.22, 55-58 It has acceptable internal 150 
consistency (Cronbach’s α = 0.58-0.82) and stability (r = 0.42-0.88 up to six 151 
weeks),40, 56 and good concurrent, predictive, and discriminant validity.40, 55, 56, 58 152 
We adapted it for HSCT (see online supplement) as the original measure refers 153 
to illness. 154 
Design and procedureM 155 
We used a longitudinal design with four time points (Figure 4) to examine 156 
the relationships between emotional distress and psychological processes over 157 
time. A member of the clinical team invited eligible patients to take part following 158 
                                            
M See Sections 6.5, 6.6, 6.8, and .9 in the thesis for further details on design, 
procedure, ethics, and service user involvement respectively. 
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referral to the service. Interested patients provided consent after reviewing the 159 
study materials and were given the opportunity to ask questions. At time point 1, 160 
participants completed baseline questionnaires on site or returned them via the 161 
post. Participants completed the same questionnaires over the telephone at 162 
three further time points: on transplant day, and two and four weeks after the 163 
transplant. In light of HSCT’s physical side effects (mucositis, etc.)2, we also 164 
asked participants to attribute physiological symptoms of DASS-21 anxiety 165 
(items 2, 4, 7, and 19, referring to dry mouth, breathing difficulty, etc.) to clarify 166 
whether they reflected HSCT side effects rather than anxiety, and remove them 167 
in the case of the former. We recorded participant characteristics and 168 
nonconcordant events (intensive care, patient leaving isolation, psychological 169 
input) from clinical records. A National Research Ethics Service Committee in 170 
the UK approved the study. A patient panel helped develop the study 171 
procedure. 172 
 173 
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Assessed for eligibility (n=103)
Consented (n=45)
(Not eligible, n=4)
Deaf (n=1)
Nonhaematological cancer (n=3)
(Declined, n=54)
Unable to contact/consent prior to 
transplant (n=18)
Procedure burden (n=18)
Unwell (n=7)
Taking part in other studies (n=3)
No benefit (n=4)
Distressed (n=1)
None given (n=3)
Completed (n=37)
Delayed (n=2)
Unavailable               (n=1)
Unwell (n=1)
Not completed (n=8)
Unwell (n=2)
Transplant cancelled   (n=6)
2. Day 0
3. Day 0 + 2 weeks
Completed (n=35)
Delayed: unwell           (n=6)
Not completed (n=10)
Unwell (n=2)
Transplant cancelled  (n=6)
No response               (n=1)
Withdrew (n=1)
4. Day 0 + 4 weeks
Completed (n=32)
Delayed (n=8)
Unavailable           (n=4)
Unwell (n=3)
Change in contact
details    (n=1)
Not completed            (n=13)
Transplant cancelled  (n=6)
Withdrew (n=3)
No response               (n=3)
Deceased (n=1)
Analysed (n=44)
Completed (n=40)
Time points:
1. Baseline
 
Figure 4. Diagram of procedure and participant flow. Responses were delayed 
if they exceeded two days from their due time. All available data were included 
in analyses. Day 0 = Day of transplantation. 
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Data analysisN 174 
Preliminary analyses examined descriptives, input errors, outliers, 175 
assumptions, and missing data.59, 60 We used Cronbach’s α coefficients to 176 
assess internal consistency59 and removed DASS-21 items that could not be 177 
differentiated from HSCT’s side effects. In light of missing data and assumption 178 
violations, we used Multilevel Modelling (MLM) with nonparametric bias-179 
corrected bootstrapping to include all available information and improve 180 
accuracy.60, 61 We examined the effect of time (categorical predictor) and 181 
participant characteristics (covariates, including site) on distress and the effect 182 
of time on HSCT perceptions and coping styles. For the main analyses, we 183 
used MLM to examine the change of HSCT perceptions and coping style over 184 
time and their relationship with distress across all time points whilst controlling 185 
for previously significant covariates. We assessed model improvements (Δχ2) 186 
and explained variance (R12) at each step of model development.60 We also 187 
examined improvements by taking account of variance across participants 188 
(random effects) for significant predictors.60 The level of significance was 189 
α=0.05.  190 
 191 
Results 192 
Preliminary analysesO 193 
  194 
                                            
N See Section 6.7 in the thesis for further details on computations, initial analyses, 
assumption violation checks, analyses relating to the feasibility component of the 
project, analyses regarding the theoretical component featuring in this paper, and 
software. 
O See Sections 7.1 in the thesis for further details on participant characteristics, results 
relating to the intervention feasibility component, Cronbach’s α coefficients, and 
assumption checks. 
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Table 2 presents characteristics of the 45 participants recruited. We 195 
removed DASS-21 items 2 (dry mouth) and 7 (trembling) as these reduced 196 
reliability coefficients, and 56% of participants indicated that these items 197 
reflected side effects of HSCT rather than anxiety. Cronbach’s α coefficients 198 
determining internal consistency across time were 0.72-0.95 for total distress, 199 
depression, and stress, and 0.46-0.78 for anxiety (lower at later time points). 200 
For HSCT perceptions, coefficients were 0.63-0.68. Two items (both coping 201 
appraisals) appeared to reduce coefficients from over 0.70. Acceptance, 202 
positive reframing, behavioural disengagement, denial, self-blame, self-203 
distraction, and venting showed at least one coefficient below 0.50 (common in 204 
coping research)50 suggesting limitations to reliability. Other coefficients were 205 
up to 0.94. 206 
 207 
  208 
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Table 2. Participant characteristics (n=45) 
Characteristics Overall (n, %) 
Gender: male 31 (69%) 
Marital status 
Married/cohabiting 
Single 
Other 
 
34 (76%) 
5 (11%) 
6 (13%)  
Education 
Mainstream only 
Further 
Higher 
Not known 
 
19 (42%) 
12 (27%) 
10 (22%) 
4 (9%) 
Diagnosis 
Multiple myeloma 
NHL 
Other 
 
27 (60%) 
12 (27%) 
6 (13%) 
Transplant: Autologous 40 (89%) 
Age on transplant day (years) (Mean, SD) 
59.5 (11.7) 
Years since diagnosis 2.40 (3.47) 
Performance status (ECOG) 0.58 (0.60) 
Length of admission 
 
Ambulatory (n=11, 28%) 
9.40 (5.27) 
Nonambulatory (n=28, 72%) 
21.1 (5.5) 
Note. SD = Standard deviation; NHL = Non-Hodgkin’s 
lymphoma; ECOG = Eastern Cooperative Oncology Group 
scale; Ambulatory = Patients initially attending day ward.
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Of the 184 possible data points (45 participants completing 209 
questionnaires up to four times) 144 were completed (Figure 4). Of these, 15% 210 
were delayed (more than two days overdue). Regarding missing data, Little’s 211 
test was significant, χ2(127)=163.99, P=0.015, and missing data were related to 212 
poorer baseline performance status (physical functioning) at time points 2 and 213 
3, ts(3.6-7)≥3.4, Ps≤0.03, and higher baseline and time 2 stress at time point 3, 214 
t(8.9-34)≥2.5, P≤0.04. Missing data could, therefore, be considered mostly 215 
random for MLM.60 Of noncondordant events, one participant received 216 
psychological input (time point 3), which may have affected distress. 217 
Effects of time and participant characteristicsP 218 
We observed a significant main effect of time for all distress scales 219 
except stress (Table 3). This was also reflected in the proportion of patients 220 
reporting at least moderate distress (Table 3), reaching 42% at any time during 221 
the acute phase (time points 2-4). Compared to baseline, total distress was 222 
significantly higher at time point 3, depression was higher at time points 3 and 223 
4, and anxiety was higher at time point 3. As covariates, younger participants 224 
reported less depression, males reported less distress overall, and those with 225 
better baseline performance status reported less anxiety and stress across time 226 
points, Δχ2(Δdf=1)≥4.58, Ps≤0.03. No other covariates reached statistical 227 
significance, Δχ2(Δdf≤2)≤5.51, Ps≥0.06 (see online supplement for fixed 228 
parameter estimates). Estimation terminated (converged) when random effects 229 
were added for performance status (total distress), ambulatory treatment 230 
(depression), and length of admission (total distress) only (models did not 231 
improve significantly). 232 
                                            
P See Section 7.1.5 in the thesis for further details on effects of time, participant 
characteristics on distress, and parameter estimates.  Section 7.2. contains details on 
the analysis regarding intervention effects. 
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Table 3. Mean distress over time (with percentage of patients reporting at least moderate levels) using multilevel modelling 
Measure M(SD) Effect of time 
 T1 T2 T3 T4 Δχ2 R12 β(SE) 
       T2 T3 T4 
Total distress 9.84(10.93) 9.89(6.87) 15.0(10.5) 13.6(10.2) 10.6* nil 0.08(1.60) 3.74* 
(1.48) 
2.74(1.47) 
Depression 3.84(4.60) 
(13%) 
2.47(2.64) 
(9%) 
4.90(3.94) 
(18%) 
5.39(5.13) 
(24%) 
31.1*** 
 
15% -0.83(0.57) 1.56** 
(0.56) 
2.17** 
(0.78) 
Anxiety 1.45(2.49) 
(7%) 
1.38(1.78) 
(11%) 
2.42(2.32) 
(27%) 
1.00(1.24) 
(4%) 
28.2*** 
(Δdf=4) 
<0 0.46(0.27) 1.53*** 
(0.38) 
0.16(0.32) 
Stress 4.55(4.94) 
(11%) 
4.58(3.41) 
(4%) 
4.64(5.09) 
(9%) 
4.80(4.34) 
(9%) 
18.2** <0 -0.05(0.76) 0.63(0.60) 0.66(0.67) 
Note. M = Mean; SD = Standard deviation; T1-4 = Time points 1-4; Δχ2 = -2log Likelihood change compared to baseline, Δdf = 3 for fixed 
effects models and 5 for random effects models unless specified otherwise; R12 = Explained variance compared to intercepts-only model; 
β = Fixed parameter estimate (compared to baseline); SE = Standard error; Shading = Predictor set random at Level 2. 
***P<0.001; **P<0.01; *P<0.05. 
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Psychological processesQ 233 
Overall, negative HSCT perceptions were higher at time points 3 and 4 234 
compared to baseline, Δχ2(Δdf=3)=31.4, P<0.001, but the difference did not 235 
reach significance for subscales, Δχ2(Δdf=3)≤6.61, Ps≥0.09.  More negative 236 
perceptions of HSCT and the majority of subscales measured were significantly 237 
associated with higher distress across the study period (with identity and 238 
understanding showing no relationship with stress [Table 4]). 239 
Of the coping styles, use of self-distraction, active coping, emotional and 240 
instrumental support, humour, and positive reframing was higher compared to 241 
baseline across time points 2 to 4 (time point 2 only for humour and time points 242 
2 and 3 for reframing), Δχ2(Δdf=3)≥8.42, Ps≤0.04, but not use of other styles, 243 
Δχ2(Δdf=3)≤7.48, Ps≥0.06. As shown in Table 4, more frequent use of 244 
avoidance-based (unhelpful) styles was significantly associated with higher 245 
distress.  However, more frequent use of approach-based or coping styles 246 
considered helpful was also associated with higher distress. The effects of 247 
HSCT perceptions and coping remained unchanged after controlling for age, 248 
gender, and performance status. 249 
                                            
Q See Section 7.3 in the thesis for further details on the analyses concerning HSCT 
perceptions and coping including change over time, random parameters (variance 
across participants), and resilience in relation to distress. 
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Table 4. Summary of multilevel models for distress with negative HSCT perceptions and coping styles as predictors 
Scale Total distress Depression Anxiety Stress 
 Δχ2 R12 β(SE) Δχ2 R12 β(SE) Δχ2 R12 β(SE) Δχ2 R12 β(SE) 
Negative HSCT 
perceptions 
60.5*** 34% 0.37*** 
(0.07) 
53.8*** 28% 0.17*** 
(0.04) 
42.2*** 38% 0.07*** 
(0.20) 
36.9*** 28% 0.13** 
(0.04) 
Consequences 24.8*** <0 0.85*** 
(0.22) 
18.8*** 6% 0.45*** 
(0.11) 
6.23* 3% 0.15* 
(0.06) 
47.5*** <0 0.29** 
(0.12) 
Timeline 40.1*** <0 1.18** 
(0.41) 
33.1*** <0 0.42* 
(0.19) 
41.4*** <0 0.26* 
(0.11) 
33.7*** <0 0.45* 
Identity 42.0*** <0 0.75** 
(0.26) 
25.3*** 4% 0.49*** 
(0.10) 
23.9*** <0 0.19** 
(0.06) 
28.6*** <0 0.14(0.14) 
Concern 16.4*** <0 1.30*** 
(0.28) 
34.9*** <0 0.50*** 
(0.13) 
31.1*** <0 0.21** 
(0.07) 
35.5*** <0 0.56*** 
(0.15) 
Understanding 25.6*** <0 -1.15* 
(0.50) 
11.4*** 7% -0.53** 
(0.19) 
32.1*** <0 -0.26* 
(0.12) 
1.72 5% -0.37(0.20) 
Emotional impact 71.7*** <0 1.72*** 
(0.24) 
41.0*** 35% 0.79*** 
(0.11) 
42.9*** <0 0.30*** 
(0.08) 
38.0*** 37% 0.79*** 
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Personal control -0.35 nil 0.02(0.20) 0.02 nil -0.02(0.13) 16.2** <0 0.08(0.12) 0.15 nil 0.05(0.13) 
Treatment control 2.13 nil 0.11(0.36) 0.32 1% -0.10(0.18) 0.79 nil 0.08(0.09) 0.54 nil 0.13(0.18) 
Coping             
Self-distraction 2.38 5% 0.66(0.42) 0.48 1% 0.15(0.20) 1.83 1% 0.14(0.10) 4.52* 10% 0.45* 
(0.21) 
Denial 28.0*** 35% 3.53** 
(1.04) 
23.3*** 28% 1.98*** 
(0.36) 
27.9*** 33% 0.46(0.28) 6.58* 16% 1.16** 
(0.42) 
Behavioural 
disengagement 
29.6*** 
(Δdf=2) 
33% 4.28** 
(1.47) 
35.0*** 
(Δdf=2) 
34% 2.64*** 
(0.69) 
24.4*** 32% 0.38(0.44) 11.6*** 10% 1.51** 
(0.46) 
Venting 28.8*** 28% 2.54** 
(0.73) 
14.1** nil 0.70* 
(0.33) 
19.5*** 18% 0.56*** 
(0.14) 
28.0*** 
(Δdf=2) 
33% 1.32*** 
(0.32) 
Self-blame 44.0*** 47% 3.44** 
(1.05) 
19.6*** 28% 1.20* 
(0.46) 
47.1*** 44% 0.58* 
(0.25) 
28.4*** 34% 1.51*** 
(0.34) 
             
Active coping 2.71 5% 0.66(0.40) 2.09 3% 0.28(0.19) 1.54 1% 0.12(0.10) 2.23 9% 0.30(0.19) 
Emotional support 9.69** 6% 1.02* 
(0.40) 
3.5 5% 0.44* 
(0.21) 
3.15 2% 0.16(0.11) 6.01* 6% 0.50* 
(0.20) 
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Instrumental 
support 
12.0*** 15% 1.34*** 
(0.37) 
8.18** 10% 0.54** 
(0.19) 
7.36** 4% 1.76** 
(0.29) 
9.06** 16% 0.63** 
(0.20) 
Positive reframing 1.13 2% 0.42(0.39) 0.01 nil -0.02(0.19) 2.83 2% 0.16(0.10) 2.62 4% 0.31(0.19) 
Planning 10.4** 13% 1.24** 
(0.39) 
3.77 5% 0.37* 
(0.18) 
2.50 5% 0.15(0.09) 29.0*** 42% 0.76** 
(0.25) 
Humour 0.25 nil 0.20(0.40) 1.08 nil -0.20(0.19) 20.7*** 29% 0.25(0.13) 0.88 nil 0.18(0.19) 
Acceptance 0.01 nil 0.04(0.44) 0.001 nil 0.01(0.22) 0.001 nil 0.003(0.110) nil nil 0.002(0.213) 
Note. HSCT = Haematopoietic stem cell transplantation; Δχ2 = -2log Likelihood change compared to the baseline model, Δdf = 1 for fixed 
effects models and 3 for random effects models unless specified otherwise; R12 = Explained variance compared to intercepts-only model; 
β = Fixed parameter estimate; SE = Standard error; Shading = Predictor set random at Level 2; Random effects models did not converge 
for consequences (depression and anxiety), personal control (depression), treatment control (anxiety), understanding (stress), emotional 
impact (depression, stress) and instrumental support (total distress and depression). 
***P<0.001; **P<0.01; *P<0.05.
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DiscussionR 250 
We examined whether HSCT perceptions and coping predict distress 251 
during the acute phase of HSCT in line with the self-regulatory model.20-22 The 252 
results supported the model given that negative HSCT perceptions and coping 253 
styles predicted distress during acute HSCT. This extends the literature during 254 
this period of HSCT, which has previously focused predominantly on clinical 255 
and demographic variables.3, 5, 10, 14-16 256 
Perceptions of HSCT and copingS 257 
The results support the hypothesised role of negative interpretations 258 
about HSCT in maintaining distress, including how physical symptoms are 259 
perceived. This is consistent with qualitative research findings highlighting loss 260 
of meaning and interpretations of threat in HSCT4, and with the wider literature 261 
on cognitions in depression, anxiety, and stress, suggesting the relevance of 262 
negative outlook, perceptions of threat, and challenge respectively.62, 63 The 263 
effect of perceived emotional impact of the procedure was particularly high, 264 
indicating that patients experiencing distress generally attributed this to HSCT 265 
and, in conjunction with other perceptions of HSCT (e.g., lengthy course), may 266 
compound distress. However, the large association between distress scales 267 
and this Brief IPQ item also suggests the measures may overlap conceptually.  268 
The lack of association between coping appraisals (personal and 269 
treatment control) and distress was contrary to expectations. However, these 270 
items did not appear internally consistent within the Brief IPQ. This has also 271 
been observed in other studies64 and the items have shown variable ability to 272 
predict distress,22 which might suggest a limitation to the contribution of coping 273 
appraisals (and the self-regulatory model) in some populations, including HSCT. 274 
However, the complexity of HSCT, heterogeneity of care2, and social desirability 275 
when rating helpfulness of treatment (treatment control) may have introduced 276 
complexity in these appraisals that was not possible to capture in the project. 277 
The null results may also reflect the findings in relation to coping. 278 
The findings indicated that several coping styles were ineffective.  Whilst 279 
this was expected for avoidance-based styles, it was not for those that are 280 
                                            
R See Section 8 in the thesis for further discussion of the findings. 
S See Section 8.2 in the thesis for further discussion of the findings on HSCT 
perceptions and coping. 
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considered helpful in the wider literature such as planning and seeking 281 
support.34, 49 Studies examining the post-acute period of HSCT have not 282 
observed reliable effects of these latter styles38, 39 but it is possible that the 283 
circumstances of acute HSCT may render many coping strategies ineffective or 284 
counterproductive.  For example, an adverse effect of planning has been noted 285 
in acute cancer care but not subsequent periods.65 Furthermore, social support 286 
is believed to provide a resource for coping34 but the acute phase of HSCT, with 287 
isolation and disabling side effects,2 may render attempts to use this resource 288 
inert.10 These observations may also explain the lack of reliable associations 289 
between distress and perceptions of personal and care control. 290 
Distress patterns 291 
Results replicated the pattern of high but declining anxiety and increasing 292 
depression that has been found in HSCT studies, including the acute phase.3, 5-7 293 
The pattern of anxiety may reflect perceptions of uncertainty and threat at the 294 
beginning of the procedure, the increase in depression may reflect perceptions 295 
of a lengthening timeline, severe consequences, and ineffective coping, whilst 296 
stable stress may suggest a sustained level of challenge. However, anxiety 297 
peaked after transplantation in the present sample rather than closer to the 298 
transplant day reported previously.3, 5, 7, 10, 14 This could be due to using the 299 
DASS-21 which separates stress from anxiety, possible confounding in the 300 
latter by physical symptoms after transplantation, and ambulatory care resulting 301 
in later admission which may be unexpected. Patients also wait to see whether 302 
the transplant is engrafting well or not during the period following HSCT, which 303 
may contribute to anxiety. Lower distress in younger individuals, men, and 304 
those with better performance status supports findings from previous studies.3, 305 
10, 14 Overall, our findings highlighted considerable complexity in patients’ 306 
psychological needs. 307 
Limitations and strengthsT 308 
The findings need to be viewed in light of some limitations. The 309 
correlational evidence was unable to establish causation. HSCT perceptions 310 
and coping may also interact with physical functioning in predicting distress but 311 
such effects were not examined. Social desirability may have resulted in more 312 
                                            
T See Section 8.4 in the thesis for further discussion of strengths and limitations. 
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favourable reports, for example of coping style use. Results may not generalise 313 
to individuals with poorer physical functioning or higher stress, in light of the 314 
attrition. They may also not generalise to other settings, minority groups, 315 
younger individuals, allogeneic patients, or patients with rarer diagnoses than 316 
the present sample. The novel Brief IPQ adaptation requires further validation 317 
whilst the Brief COPE is not exhaustive so that the observed effects regarding 318 
coping may not apply to other styles. Statistically, lack of convergence in some 319 
random effects models, limited internal consistency of some scales, and the 320 
small sample may have introduced bias. Finally, the number of tests may have 321 
inflated Type I error, particularly for coping styles where overall analysis was not 322 
conducted. However, the findings are strengthened by a longitudinal design 323 
showing reliable and enduring effects, and a new and promising scale for HSCT 324 
perceptions. Consecutive referrals with reasons for nonparticipation, two sites, 325 
and the heterogeneity of the sample enhanced external validity. Finally, MLM 326 
with bootstrapping maximised the dataset, accounted for variability across 327 
participants, and improved statistical validity. 328 
Overall, the findings highlighted complex emotional needs during HSCT 329 
and a potential role for perceptions of HSCT and coping in underpinning 330 
distress. Addressing the diverse negative HSCT perceptions via well-331 
established approaches such as psychoeducation,66, 67 self-regulatory 332 
interventions,25, 26, targeted provision of information to patients during routine 333 
care, and cognitive restructuring68, 69 may be beneficial. Promoting helpful 334 
coping may require a shift from problem-engagement alone featuring heavily in 335 
HSCT interventions and cancer generally19, 70, 71 towards experience-336 
engagement (e.g., via mindfulness18, 72) and extending support resources (e.g., 337 
peer network).73 This may also promote physical and immune recovery in light 338 
of relevant findings.8-10, 22 However, replication with larger samples and other 339 
clinical subgroups and settings remains necessary. Future studies into the role 340 
of physical functioning, perceptions, coping, and distress, and establishing 341 
causality (e.g., via psychological intervention) appear necessary. U 342 
 343 
                                            
U See Sections 8.5-8.7 in the thesis for further discussion of clinical and research 
implications and overall conclusion. 
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3 EXTENDED PAPER 
 
  
 Page 87 of 263 
3.1  EXTENDED BACKGROUND 
 
3.1.1  Haematopoietic stem cell transplantation and its sequelae 
Haematopoietic stem cell transplantation (HSCT) is a complex procedure 
to treat a range of haematological and autoimmune illnesses and malignancies 
that are primarily life-threatening such as myeloma, lymphoma, leukaemia, 
anaemia and immunosuppressive diseases (Copelan, 2006).  It involves 
transfer of haematopoietic stem cells harvested either from the patient 
(autologous) or a matched donor (allogeneic; Copelan, 2006).  At a cost of up to 
£100,000 per transplant, over 3,000 individuals undergo the procedure every 
year in the UK which often results in substantial benefits including cure for some 
patients (Copelan, 2006; National Health Service [NHS] Commissioning Board, 
2013).   
The acute phase of HSCT is very intensive.  At first, the patient’s bone 
marrow and cancerous cells are ablated (killed off) with chemotherapy and/or 
radiotherapy exposing the person to very high levels of toxicity often in addition 
to previous chemotherapy (Copelan, 2006).  This is followed by infusion 
(transplantation) of the new stem cells and a period of recovery lasting several 
weeks and requiring prolonged isolation to allow the marrow, blood, and 
immune systems to return to healthy levels of functioning (Copelan, 2006).  At 
this stage, the side effects are diverse and often very aggressive including 
mucositis (pain and inflammation of the body’s mucous membrane causing 
ulcers, etc.), Graft versus Host Disease (GVHD, when transplanted immune 
cells attack the patient’s organs), pain, fatigue, weakness, nausea, sleep 
disruption, gastroenteritis, infections, and so forth (Anderson et al., 2007; 
Copelan, 2006; Larsen, Nordstrom, Ljungman, & Gardulf, 2004; Prieto, Atala, 
Blanch, Carreras, Rovira, Cirera, & Gastó, 2005).  These often subside beyond 
the first 30 days of the procedure but sometimes can burden patients for several 
years and more than the illness which HSCT was originally intended to alleviate 
(Copelan, 2006; Mosher, Redd, Rini, Burkhalter, & DuHamel, 2009).  
Consequently, HSCT is often the last course of treatment after previous 
treatment failure or relapse of cancer (Copelan, 2006). 
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In light of the intensity, toxicity, and side effects of the procedure, it is not 
surprising that patients undergoing HSCT experience considerable loss of 
personal control and psychological distress.  Studies describe the distress as 
multi-faceted including stress, anxiety, depression, anger, uncertainty, and so 
forth, with levels being highest during the acute phase and decreasing only after 
several weeks (Dakanalis, Assunta Zanetti, & Clerici, 2013; Fife et al., 2000; F. 
Keogh, O'Riordan, McNamara, Duggan, & McCann, 1998; Lee et al., 2005; 
McQuellon et al., 1998; Molassiotis, van den Akker, Milligan, Goldman, & 
Boughton, 1996; Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 2005; 
Prieto et al., 2002; Tecchio et al., 2013).  Notably, pretransplant distress is 
reported to be highly predictive of distress following the transplant (Lee et al., 
2005), indicating an early onset and poor outlook. 
The impact of such distress on recovery has been documented.  The 
literature on HSCT highlights negative outcomes of distress such as worse 
treatment adherence, reduced pain and symptom tolerance, longer hospital 
stay, and higher mortality (Akaho et al., 2003; Hoodin & Weber, 2003; Prieto, 
Atala, Blanch, Carreras, Rovira, Cirera, Espinal, et al., 2005; Prieto et al., 2002; 
Schulz-Kindermann, Hennings, Ramm, Zander, & Hasenbring, 2002; Syrjala & 
Chapko, 1995).  In other health populations, distress (even transient) has been 
associated with greater incidence of illness, harmful physiological changes, 
greater pain perception, suppression of the immune system, and higher risk of 
infections (Glaser & Kiecolt-Glaser, 2005; Godbout & Glaser, 2006; Ogden, 
2012).  As HSCT involves substantial immune system suppression and then 
recovery prior to discharge (Copelan, 2006), the presence of distress can 
prolong the process and increase patients’ mortality.  The consequences of 
distress on emotional and physical wellbeing during HSCT highlight a need for 
robust psychological intervention. 
 
3.1.2  Psychological interventions in HSCT 
The literature on psychological interventions in HSCT is very limited 
(Baliousis, Rennoldson, & Snowden, in press).  Interventions involving 
psychological components (e.g., cognitive behavioural input, emotional 
processing, coping skills training) supported by trained staff tend to show more 
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effectiveness (Baliousis et al., in press).  However, the literature is sparse and 
shows small effects, lack of or poor controls, high risk of bias, and lack of clarity 
regarding psychological mechanism (Baliousis et al., in press; Bauer-Wu et al., 
2008; Bevans et al., 2010; Horton-Deutsch, O'Haver Day, Haight, & Babin-
Nelson, 2007; Lounsberry, Macrae, Angen, Hoeber, & Carlson, 2010).  
Furthermore, few interventions seek to address distress during the acute phase 
of the procedure when the need appears highest and those that do show very 
limited benefits and fail to address distress at its onset prior to transplantation 
(Baliousis et al., in press; Dakanalis et al., 2013; Fife et al., 2000; F. Keogh et 
al., 1998; Lee et al., 2005; McQuellon et al., 1998; Molassiotis et al., 1996; 
Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 2005; Prieto et al., 
2002; Tecchio et al., 2013). 
A plausible reason for the lack of effective intervention during acute 
HSCT may be the barriers to accessing and delivering interventions posed by 
the logistics, intensity, and clinical burden of the procedure, such as many 
medical treatments, complications, and so forth (Antin & Raley, 2013; Copelan, 
2006).  Studies have identified such barriers in other cancer populations 
(Moyer, Knapp-Oliver, Sohl, Schnieder, & Floyd, 2009) but the empirical 
evidence from HSCT is indirect such as poor overall adherence to interventions 
and smaller samples in studies examining more intensive interventions during 
the acute phase relative to self-directed ones (Allocca, 1998; Baliousis et al., in 
press; Bauer-Wu et al., 2008; de Linares et al., 2007; Horton-Deutsch et al., 
2007).  However, the limited benefits associated with self-directed interventions 
(Baliousis et al., in press) highlight a need to develop a better balance between 
intensity of input and burden so that interventions remain effective as well as 
accessible to patients.  For this to occur, a better understanding of feasibility 
issues with delivering interventions during acute HSCT appears essential.  The 
present study included a feasibility component to address this need. 
Another possible reason for the scarcity and limited effectiveness of 
interventions is lack of application of a coherent theoretical model.  Evidence 
from psychotherapy suggests that a coherent theoretical framework appears 
essential for the success of interventions (Wampold, 2001) but the intervention 
literature on HSCT shows little theoretical grounding (Baliousis et al., in press).  
As argued in the journal paper, this limitation appears to reflect the focus on 
 Page 90 of 263 
disparate factors that characterises the wider research on psychological 
underpinnings of distress during HSCT (Bauer-Wu et al., 2008; Fife et al., 2000; 
Pillay et al., 2015; Schulz-Kindermann et al., 2002).  It follows, that establishing 
firm theoretical grounding is likely to be important in developing effective 
interventions in this population and is in line with the Medical Research 
Council’s (MRC’s) guidance for developing interventions (Craig et al., 2008).  
The self-regulatory model provided this basis in the present study, as the most 
widely applied model of psychological adjustment to illness (Hagger & Orbell, 
2003; Leventhal et al., 1997; Ogden, 2012; Sharpe & Curran, 2006).  The model 
has received extensive support in other health populations but has not been 
applied to HSCT.  The theoretical component of the present study sought to 
explore the model’s applicability as a basis for intervention in HSCT. 
 
3.1.3  The self-regulatory model 
Illnesses such as haematological malignancies involving disrupting 
procedures like HSCT can impact adversely on many domains in an individual’s 
life (Ogden, 2012).  Adjustment often reflects a process of adaptation towards 
more positive views of self and the world and more helpful coping strategies to 
improve psychological, social, and physical wellbeing (Ogden, 2012; Sharpe & 
Curran, 2006).  Leventhal and colleagues (Leventhal et al., 1997; Leventhal, 
Nerenz, & Purse, 1984) have described this process in the self-regulatory 
model which has been applied widely in health-related psychological research 
(Ogden, 2012; Sharpe & Curran, 2006).   
According to the self-regulatory model, helpful mechanisms in the 
process of adaptation to HSCT may include updating perceptions of the 
procedure so that they are more in line with its reality and coping strategies 
(Leventhal et al., 1997; Leventhal, Nerenz, & Purse, 1984; Ogden, 2012; 
Sharpe & Curran, 2006).  Helpful coping strategies might include meaning-
making, reprioritising goals, active coping, and promoting helpful health 
behaviours, both as means of prevention and intervention, leading to a sense of 
being able to cope (positive coping appraisals) and further adjustment. 
The self-regulatory model formed the theoretical basis for developing a 
psychological intervention to address distress during acute HSCT in the present 
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project via addressing perceptions of HSCT, coping, and appraisals of coping.  
The evidence relating both to the relevant theoretical assumptions and the 
benefits of their application in health populations is discussed below. 
 
3.1.3.1  Illness perceptions 
Interpretations of a health difficulty is one of the core components of the 
self-regulatory model (Leventhal et al., 1997; Leventhal, Nerenz, & Purse, 1984; 
Ogden, 2012; Sharpe & Curran, 2006).  Interpretations is mediated by social 
messages and reflects understanding of the problem in the form of various 
perceptions about it (Broadbent, Petrie, Main, & Weinman, 2006; Hagger & 
Orbell, 2003; Leventhal et al., 1997; Leventhal et al., 1984; Moss-Morris et al., 
2002; Ogden, 2012).  In the context of HSCT, these perceptions might include: 
 
 Consequences: Beliefs about the effects of HSCT on the patient’s life.  
These consequences may be physical (e.g., disability, pain, etc.), social 
(e.g., isolation, restricted social life, etc.), and so forth. 
 Timeline: Predictions about how long the process (e.g., symptoms, 
appointments) of HSCT will last, for example, anticipating that the 
process will end soon after hospitalisation versus continuing over several 
years. 
 Identity: The extent to which the patient constructs HSCT in terms of the 
side effects and complications surrounding the procedure. 
 Concern: The extent to which the patient perceives HSCT as a cause for 
concern. 
 Understanding: The extent to which the patient believes they are able to 
comprehend the HSCT process. 
 Emotional impact: Patients’ beliefs about the extent to which HSCT 
affects them emotionally. 
 Cure or control: The degree to which patients believe they or the 
treatment they receive can control the HSCT process.  These 
perceptions reflect coping appraisals. 
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These different perceptions may operate on an abstract or concrete level 
(Leventhal et al., 1997; Leventhal et al., 1984; Ogden, 2012; Sharpe & Curran, 
2006).  They can change over time under the influence of a range of factors 
such as knowledge and experience (Sharpe & Curran, 2006), individual 
differences (e.g. Kohlmann, Ring, Carroll, Mohiyeddini, & Bennett, 2001; Miller, 
Brody, & Summerton, 1988), mood (Cropley & Steptoe, 2005; Mora, Halm, 
Leventhal, & Ceric, 2007; Stegen, Van Diest, Van de Woestijne, & Van den 
Bergh, 2000; Wright, Ebrecht, Mitchell, Anggiansah, & Weinman, 2005), 
underlying cognitive processes such as focus of attention (Eiser, 2000; Stegen 
et al., 2000; van Zuuren, 1998), and cultural context (Gureje, Simon, Ustun, & 
Goldberg, 1997; Minsky, Vega, Miskimen, Gara, & Escobar, 2003; S.-J. Wang 
et al., 1997).   
A breadth of evidence favours the self-regulatory model’s 
conceptualisation of illness perceptions and their role in adjustment (Hagger & 
Orbell, 2003; Ogden, 2012).  Cross-sectional and longitudinal research 
suggests that illness perceptions are able to predict a range of outcomes 
including health-related behaviours (e.g., adherence to treatment), emotional 
wellbeing, social functioning, quality of life, and physical outcomes in a variety 
of clinical populations (Christensen & Ehlers, 2002; Hagger & Orbell, 2003; Hall, 
Weinman, & Marteau, 2004; Helder et al., 2002; Parry, Corbett, James, Barton, 
& Welfare, 2003; Petrie, Broadbent, & Meechan, 2003; Petrie, Cameron, Ellis, 
Buick, & Weinman, 2002; Sharpe, Sensky, & Allard, 2001; Vaughan, Morrison, 
& Miller, 2003).  However, this evidence is correlational, therefore, a causal link 
between illness perceptions and the different areas of functioning remains 
tentative.  Furthermore, the extent to which illness perceptions exist prior to the 
research examining them (i.e. they are “real”) as opposed to having been 
constructed by the research process (e.g., by asking theory-led questions) is 
unclear (Ogden, 2012) which poses a threat to the internal validity of the 
findings.  On the other hand, the suggestions of the self-regulatory model 
regarding the role of perceptions in underpinning adjustment are in line with the 
broader cognitive perspective in psychotherapy, particularly in relation to 
anxiety, worry, and depression which indicates that reducing threat appraisals 
(Clark & Beck, 2010) fostering a concrete and realistic representation of the 
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problem (Watkins, 2008), and addressing negative beliefs (Hollon & Beck, 
2013) can be helpful. 
 
3.1.3.1.1  The value of informational input 
In light of the above theoretical considerations, providing information on 
HSCT and its sequelae may foster more accurate and helpful perceptions of the 
procedure and facilitate adjustment as HSCT progresses.  The information 
could address issues that have been previously identified by HSCT patients as 
affecting their perceptions of the procedure, for example potential outcomes, 
recovery times, side effects such as fatigue, potential complications, the 
availability of medical care, friends’ and family’s reactions, and so forth (e.g., 
Andrykowski et al., 1999; Jim et al., 2014). 
The benefits of information-based (psychoeducational) interventions 
about the process of the illness and outcomes have been documented as 
improving physical and psychological wellbeing in a range of clinical populations 
including organ transplantation (Engle, 2001), cancer (Beatty, Koczwara, Rice, 
& Wade, 2010; David, Schlenker, Prudlo, & Larbig, 2013; Fawzy, Fawzy, Arndt, 
& Pasnau, 1995; Kangas, Milross, Taylor, & Bryant, 2013), surgery preparation 
(O'Halloran & Altmaier, 1995), and adjustment during recovery several years 
after HSCT (DuHamel et al., 2010; DuHamel et al., 2000; Gaston-Johansson et 
al., 2013).  Psychoeducation on the emotional response to the illness has been 
particularly helpful for psychological  adjustment to cancer (Greer, Park, 
Prigerson, & Safren, 2010; Greer et al., 2012; Kangas et al., 2013) and organ 
transplantation (Hodges, Craven, & Littlefield, 1995) and could be helpful in 
HSCT in light of the emotional impact of the procedure.  Such a component 
could include discussions relating to anxiety, depression, and their 
manifestations and day-to-day implications (Greer et al., 2010; Greer et al., 
2012; Hodges et al., 1995; Kangas et al., 2013) with an additional therapeutic 
benefit of providing validation to patients (Elliott, Bohart, Watson, & Greenberg, 
2011; Gilbert, 2010; M. J. Lambert & Barley, 2001).  The range of physical and 
emotional outcomes achieved in a small number of sessions when perceptions 
are targeted according to the self-regulatory model (Petrie et al., 2003; Petrie et 
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al., 2002) support the use of the model in promoting the needed efficiency in the 
highly burdened HSCT population. 
In sum, there is a breadth of literature documenting the effectiveness of 
interventions that include an informational component, thus supporting its 
application in HSCT within the self-regulatory model.  However, the 
informational component was not administered in isolation in the above 
literature (except in Jones et al., 2001 and Petrie et al, 2002) and control for 
effects not specific to the intervention such as common factors (Wampold, 
2001) was unclear in several of the trials (e.g. Beatty et al., 2010; David et al., 
2013; DuHamel et al., 2010; Gaston-Johansson et al., 2013).  These limitations 
raise some doubt regarding the benefits of informational input.   
 
3.1.3.2  Coping 
Adaptation in the self-regulatory model is influenced by coping as well as 
illness perceptions (Leventhal et al., 1997; Leventhal, Nerenz, & Purse, 1984; 
Ogden, 2012).  Coping strategies used by patients can be different for 
diagnosis, crisis, and the course of illness and can be accompanied by a series 
of coping appraisals (e.g. “can I cope with this?”) towards increased self-
regulation (Folkman & Moskowitz, 2004; Ogden, 2012; Taylor & Stanton, 2007; 
Tennen, Affleck, Armeli, & Carney, 2000).  The use and benefit of coping 
strategies are also dependent on coping resources of which social support is 
considered prominent (Taylor, 2007; Taylor & Stanton, 2007).  Coping with the 
stress of a crisis and adaptation may reflect the context of HSCT in particular.  
The coping literature delineates a range of coping conceptualisations that could 
apply in this context, of which problem- and emotion-focused and approach 
versus avoidance have been dominant (Folkman & Moskowitz, 2004; Ogden, 
2012). 
 
3.1.3.2.1  Problem and emotion-focused coping 
Folkman and Lazarus proposed that coping with stress is primarily 
problem- or emotion-focussed (Folkman & Lazarus, 1980; Folkman & 
Moskowitz, 2004).  These are complementary with the former addressing the 
stressor via planning, information-seeking, and so forth, while the latter aims at 
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alleviating the negative consequences of stress in ways such as seeking 
emotional support.  A large body of evidence has supported the validity of this 
model.  The application of problem- and emotion-focussed styles has been 
observed in different populations and factors such as type of stressor, age, 
gender, controllability, and available resources can discriminate meaningfully 
between the two conceptualisations (Folkman & Moskowitz, 2004; Ogden, 
2012; Tennen et al., 2000).  The conceptualisations of problem- or emotion-
focussed coping provides a helpful guide for developing and organising the 
content of the coping aspect of the present intervention.   
 
3.1.3.2.2  Approach versus avoidance coping 
An alternative conceptualisation to Folkman and Lazarus’ (Folkman & 
Lazarus, 1980; Folkman & Moskowitz, 2004) has been approach versus 
avoidance coping (Ogden, 2012; Taylor & Stanton, 2007).  Approach involves 
confronting the stressor (e.g. problem-solving, planning, acceptance, use of 
support, etc.) while avoidance reflects disengaging from it (e.g. denial, 
distraction, etc.).  This model has also received considerable support in the 
literature and has been found to represent a higher level categorisation relative 
to problem- versus emotion-focused coping instead of providing a competing 
model (Tobin, Holroyd, Reynolds, & Wigal, 1989). 
What is likely to be helpful in distinguishing between approach and 
avoidance styles in the intervention is that these coping style groups have been 
able to predict distress, self-regulation, and adaptation relatively consistently, 
unlike problem- and emotion-focused coping (Folkman & Moskowitz, 2004; 
Ogden, 2012; Taylor & Stanton, 2007).  On the one hand, avoidant coping 
strategies may be effective in alleviating distress with short-term, specific, or 
uncontrollable stressors (Heckman et al., 2004; Ogden, 2012; Taylor & Stanton, 
2007) but have been associated with detrimental long-term psychological and 
physical outcomes.  For example, a substantial body of cross-sectional and 
longitudinal research in various clinical populations indicates that avoidant 
strategies can predict poorer long-term adjustment and more distress (Holahan, 
Moos, Holahan, Brennan, & Schutte, 2005; Levine et al., 1987; Rayburn et al., 
2005; Stanton & Snider, 1993; Taylor & Stanton, 2007; Young, 1992), less 
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helpful health behaviours (Weaver et al., 2005), pronounced symptoms 
(Rosenberger, Ickovics, Epel, D’Entremont, & Jokl, 2004), poorer recovery 
following surgery (Stephens, Druley, & Zautra, 2002), and worse disease 
progression/mortality (Epping-Jordan, Compas, & Howell, 1994; Leserman et 
al., 2000; Murberg, Furze, & Bru, 2004).  Similar effects of avoidance coping 
alongside low levels of support, access to coping resources, and a poor sense 
of self-efficacy has also been observed during HSCT (Ho, Horne, & Szer, 2002; 
Hochhausen et al., 2007; Mytko et al., 1996; Wells, Booth-Jones, & Jacobsen, 
2009). 
Approach coping, on the other hand, can be more helpful for mental and 
physical wellbeing, particularly in connection with enduring stressors (Billings, 
Folkman, Acree, & Moskowitz, 2000; de Ridder, Geenen, Kuijer, & van 
Middendorp, 2008; Keefe et al., 1997; Kneebone & Martin, 2003; Sharkansky et 
al., 2000; Taylor & Stanton, 2007; Young, 1992).  Links between approach 
coping and physiological processes such as enhanced immune function 
(Stowell, Kiecolt-Glaser, & Glaser, 2001) and a better-regulated blood 
circulation during stress (Aschbacher et al., 2005) have also been observed, 
which would provide additional advantages to the physically challenged HSCT 
patients (Copelan, 2006). 
Nonetheless, the benefits of approach coping in alleviating distress per 
se have been less robust compared to the pitfalls of avoidant coping (de Ridder 
et al., 2008; Kneebone & Martin, 2003; Taylor & Stanton, 2007).  This could 
partly reflect contextual constraints on approach coping such poor resources 
limiting its utility (Taylor & Stanton, 2007).  It is also possible that approach 
coping safeguards against stress via improving positive affect rather than 
decreasing negative affect (Folkman & Moskowitz, 2000, 2004; Taylor & 
Stanton, 2007).  Consequently, the benefits of approach coping in affective 
regulation should not be underestimated while taking account of what method of 
approach coping is feasible for patients remains paramount, particularly in the 
constraining context of HSCT (isolation, etc.; Copelan, 2006). 
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3.1.3.2.3  Limitations of coping conceptualisations 
Notwithstanding the support for and broad use of problem and emotion-
focused and approach versus avoidance coping, the extensive coping literature 
has featured many different coping mechanisms and conceptualisations (Coyne 
& Racioppo, 2000; de Ridder, 1997; Folkman & Moskowitz, 2004; Skinner, 
Edge, Altman, & Sherwood, 2003).  This marked lack of consensus has posed a 
major limitation in the advancement of the coping research and its applications 
(Coyne & Racioppo, 2000; Folkman & Moskowitz, 2004).  Furthermore, different 
situations can involve different needs, goals, and options for coping therefore 
coping conceptualisations and styles do not appear to be as fixed as 
researchers often assume (Coyne & Racioppo, 2000; de Ridder, 1997; Folkman 
& Moskowitz, 2004).  As the self-regulatory model does not endorse any 
particular conceptualisation (Leventhal et al., 1997), these observations call for 
caution in the adoption of any coping model in the present project.  
Furthermore, recognising the importance of exploring in a bottom-up manner 
what coping styles are helpful in specific clinical populations such as HSCT 
remains paramount. 
 
3.1.3.2.4  Coping interventions 
In spite of extensive theoretical coping research, the application of 
coping theory into clinical psychology has been limited (Coyne & Racioppo, 
2000; de Ridder & Schreurs, 2001; Somerfield & McCrae, 2000).  A possible 
reason may be that coping interventions can be demanding, thereby limiting 
uptake (Coyne & Racioppo, 2000).  Nevertheless, interventions incorporating 
coping skills training, often within a Cognitive Behaviour Therapy (CBT) 
framework, have been helpful in a variety of domains including distress 
tolerance, problem-solving, pain reduction, symptom tolerance, procedural 
adherence, mortality, and overall health status in a variety of populations 
(Antoni et al., 2001; Coyne & Racioppo, 2000; Tatrow & Montgomery, 2006; 
Watson et al., 2013). 
Coping-specific interventions have also shown benefits.  Coping 
Effectiveness Training (Folkman et al., 1991), which focuses on coping 
appraisals, controllability, and encouraging identification of specific coping 
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strategies, has been effective in ameliorating anxiety and depression (the latter 
inconsistently) in HIV-positive men (Carrico et al., 2006; Chesney, Chambers, 
Taylor, Johnson, & Folkman, 2003; Cruess et al., 2002).  Mechanisms are 
thought to involve enhancing coping self-efficacy and approach coping 
(Folkman et al., 1991). 
Coping skills training has also been helpful in a variety of clinical 
populations.  This has included enhanced skills, self-efficacy, and pain control in 
arthritis (Rhee et al., 2000), enhanced pain tolerance and reduced 
complications in a sample with sickle cell disease (Gil et al., 2000), and 
improved social, emotional, and physical functioning in cancer patients (Allison 
et al., 2004; Beatty, Koczwara, & Wade, 2011; K. M. Carpenter, Stoner, 
Schmitz, McGregor, & Doorenbos, 2012; David et al., 2013; Gaston-Johansson 
et al., 2013; S. D. Lambert et al., 2012; Rose, Radziewicz, Bowmans, & 
O'Toole, 2008).  Coping skills training in this literature includes problem-solving, 
activity scheduling, goal prioritising, identification of specific coping skills, 
relaxation training, improving communication with staff, and so forth.  The 
purpose is to promote controllability, coping appraisals, and appropriate use of 
approach and avoidance coping strategies within the context of each illness 
(Allison et al., 2004; Beatty et al., 2011; K. M. Carpenter et al., 2012; David et 
al., 2013; Gaston-Johansson et al., 2013; S. D. Lambert et al., 2012; Rose et 
al., 2008).  However, some of the studies combined coping skills training with 
psychoeducation (e.g. Beatty et al., 2011; Carpenter et al., 2012; Gaston-
Johansson et al., 2013), which limits conclusions regarding what contributes to 
outcome and the benefits of the coping-based component. 
An important development in available coping-based interventions 
involves reduced intensity over time.  Many of the recent interventions cited 
above are delivered via workbooks, the internet, telephone, and so forth.  They 
are, therefore, less demanding than earlier coping interventions involving face-
to-face delivery over a series of sessions (Coyne & Racioppo, 2000).  Such 
reduced demands may have resulted in increasing uptake of coping 
interventions over the years, as suggested by the chronology the literature, and 
support their suitability for the highly burdened HSCT patients (Copelan, 2006). 
 
 Page 99 of 263 
In sum, the above evidence indicates that addressing coping in 
intervention may be beneficial in alleviating distress and physical difficulties in 
HSCT.  Approach strategies may be encouraged in areas where patients can 
exercise a degree of control, such as planning for transfer to hospital and 
isolation, identifying activities to engage with, access to staff support and 
information regarding current and long-term concerns, utilising emotional 
support, and so forth.  Avoidant strategies such as distraction may be identified 
for use in the short-term in domains which patients are not able to control, 
though discussing the caveats of continuing to use these strategies as the 
procedure progresses will need to be highlighted.  The lack of conceptual clarity 
in coping theory and the resulting heterogeneity of styles examined in coping 
intervention research highlight the need for facilitating exploration and self-
determination in identifying helpful coping strategies in HSCT patients.  Doing 
so may be paramount in facilitating positive coping appraisals of personal and 
care control, within the self-regulatory model. 
 
3.1.3.3  Broader caveats in the self-regulatory model 
The model is supported by a breadth of evidence but there are several 
conceptual inconsistencies.  The model assumes that illness perceptions, 
coping, and coping appraisals interact with each other but does not provide a 
way of dissociating between them (Odgen, 2012; Sharpe & Curran, 2006).  For 
example, perceiving a characteristic of an illness as less threatening could 
reflect a coping mechanism such as denial.  This lack of dissociation becomes 
even more problematic when considering that an illness may be seen as 
threatening when an individual is unable to cope with it and vice versa, as 
theories of anxiety suggest (Clark & Beck, 2010).  Such lack of clarity can limit 
the model’s explanatory power. 
A further caveat lies in the centrality of information processing, as the 
self-regulatory model assumes that cognition precedes emotion in the process 
of adjustment (Leventhal et al., 1997; Leventhal et al., 1984; Ogden, 2012; 
Sharpe & Curran, 2006).  This hypothesis has received extensive scrutiny in the 
broader literature on cognitive theories including some supportive experiments 
(Bennett, Lowe, & Honey, 2003; Kuppens, Van Mechelen, Smits, & De Boeck, 
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2003; Mathews & MacLeod, 2002; Mathews, Ridgeway, Cook, & Yiend, 2007; 
Roseman & Evdokas, 2004; C. A. Smith & Lazarus, 1993).  Furthermore, 
cognitive shifts may precede therapeutic breakthroughs and improvement in 
mood and symptoms (Bieling, Beck, & Brown, 2004; Crits-Christoph et al., 
2003; Kuyken, 2004; Tang & DeRubeis, 1999). 
However, several findings are contrary to the notion that cognition 
precedes emotion and the specific role of perceptions in underpinning distress 
as suggested by the self-regulatory model.  Research suggests that the role of 
cognition in underpinning emotion appears to be much broader than information 
processing alone (Storbeck & Clore, 2007), which highlights limitations to the 
scope of the self-regulatory model and its application.  Furthermore, the diverse 
cognitive operations – from perception to reasoning – have been found to be 
strongly influenced by emotional processes (Phelps, 2006), perceptions have 
been reported to account for only a minority of variance in emotions, different 
perceptions often relate to the same emotion, and their effects are confounded 
with situational exposure (Bennett et al., 2003; Kuppens et al., 2003; Mathews 
& MacLeod, 2002; Mathews et al., 2007; Roseman & Evdokas, 2004; C. A. 
Smith & Lazarus, 1993).  Finally, there are indications that change in distress 
may reflect shifts in coping with perceptions rather than cognitive change per se 
(Adler, Strunk, & Fazio, 2015; Dozois et al., 2009; M. J. Lambert, 2013). 
Overall, the evidence raises questions regarding the centrality of 
cognition in the self-regulatory model and the assumed mechanism of altering 
perceptions to alleviate distress.  Alongside the lack of clarity in the distinction 
between illness perceptions and coping, these considerations highlight a need 
to develop the model further.  Whilst the limitations suggest that benefits of 
using the model to guide therapy in the present project could be limited, there 
is, nevertheless, sufficient evidence to support its current scope and potential as 
a pragmatic rather than definitive basis for a short and targeted intervention.  
The theoretical component of the present study focused on the applicability of 
the model as a basis for intervention in HSCT. 
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3.1.4  Summary 
HSCT is an intensive procedure associated with considerable 
psychological distress particularly during the acute phase.  Relevant 
interventions are few, show limited benefits, and have failed to address distress 
at its onset immediately prior to the procedure when the need appears to be 
highest (Baliousis et al., in press; Lee et al., 2005).  An intervention was 
developed to meet this need. 
The lack of effective psychological interventions targeting the acute 
phase of HSCT may reflect barriers to delivering and evaluating interventions 
(which remain poorly understood) and a failure to use psychological models to 
guide interventions in the field.  Consequently, the self-regulatory model 
(Leventhal et al., 1997; Leventhal et al., 1984; Ogden, 2012; Sharpe & Curran, 
2006) was used as a basis for the present intervention leading to the inclusion 
of psychoeducational and coping components.  These components purported to 
address negative perceptions of HSCT, foster realistic expectations, and 
support patients in identifying helpful coping styles leading to positive coping 
appraisals.  In light of the limitations to the psychological intervention literature 
in HSCT, the present study aimed both to assess the feasibility of delivering and 
evaluating the new intervention and to evaluate the applicability of the self-
regulatory model as a promising basis for intervention in this clinical population.  
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3.2  AIMS AND OBJECTIVES 
 
The intensity of HSCT, barriers to accessing interventions, and the many 
physical needs of patients, highlighted the complexity of delivering 
psychological interventions and evaluating them in this population.  The Medical 
Research Council’s guidance on developing complex interventions emphasises 
the need to assess feasibility issues and theoretical underpinnings prior to a full 
trial (Craig et al., 2008).  Consequently, the present study had three aims: (a) to 
evaluate the feasibility of delivering a psychological intervention for distress 
during acute HSCT; (b) to evaluate the feasibility of conducting a trial to assess 
the efficacy of the intervention; and (c) to evaluate the applicability of the self-
regulatory model (Leventhal et al., 1997; Leventhal et al., 1984; Ogden, 2012; 
Sharpe & Curran, 2006) in the context of acute HSCT as a basis of the 
intervention. 
A decision was made to proceed with a Phase II trial focusing on 
preliminary efficacy as well as procedural feasibility (Arain, Campbell, Cooper, & 
Lancaster, 2010; Stolberg, Norman, & Trop, 2004; D. Wang & Bakhai, 2006), as 
safety and preliminary acceptability had been established during an earlier pilot 
of the intervention (see Section 6.2 for details).  The objectives of this Phase II 
study were to assess: 
 
1. The feasibility of delivering the intervention and the trial’s procedures 
for patients and staff.  This included examining accrual of referrals, 
the impact of participant eligibility criteria on accrual, uptake 
(willingness to participate), willingness to be randomised to and 
attend the intervention (patients), willingness to recruit participants 
and facilitate the group (staff), attrition, response rates, and 
adherence to the protocol. 
 
2. The reliability and validity of assessments since most measures 
including primary outcomes had not been used in HSCT previously. 
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3. Sample size calculations by taking account of intraclass correlations 
(ICCs) for clustered data, outcome variability (standard errors), and 
effect sizes (i.e., β coefficients and variance). 
 
4. The trajectory of distress over time in order to determine the optimal 
endpoint for analysis (i.e., transplant day, two weeks, or four weeks). 
 
5. Initial evidence of efficacy with the expectation that individuals 
allocated to the intervention will report less distress during acute 
HSCT compared to those allocated to the control group. 
 
The hypotheses regarding the second aim of the study in relation to the 
applicability of the self-regulatory model (Leventhal et al., 1997; Leventhal et al., 
1984; Ogden, 2012; Sharpe & Curran, 2006) were outlined in the journal paper.  
An additional hypothesis was that lower distress will reflect better adaptation, as 
suggested by the model. 
 
3.2.1  Epistemological position 
The present project approached the research from a logical positivist 
viewpoint (as discussed in Barker, Pistrang, & Elliott, 2002).  Therefore, the 
investigation was deductive and was pursued on the basis of experimentation 
rather than personal experience.  The project assumed a degree of observable 
reality and objective measurement, sufficient regularity to enable the study of 
aggregate effects, and ability to control for contextual influences and threats to 
validity (e.g. via randomisation).  Some uncertainty in the observations was 
considered inevitable but it was deemed possible to assess this phenomenon to 
some extent via reliability and validity analyses.  Remaining sensitive to 
information disconfirming expectations was important to prevent the fallacies of 
naïve realism (Barker et al., 2002). 
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3.3  EXTENDED METHOD 
 
3.3.1  Participants 
Participants were recruited from consecutive referrals in order to 
minimise the threat of selection bias to internal and external validity (McBurney 
& White, 2007).  For example, a more opportunistic method of recruitment may 
have resulted in overrepresentation of individuals with more active coping or 
underrepresentation of patients with avoidant coping, more stress, and so forth 
(McBurney & White, 2007).  Aiming to recruit from consecutive referrals was 
also important in estimating accrual of eligible patients, uptake to the study, and 
capture barriers to participation.  Both autologous and allogeneic patients were 
included in light of comparable distress between the two groups despite 
differences in physical symptomatology (Fife et al., 2000; Lee et al., 2005; 
Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 2005; Prieto et al., 
1996).  However, the earlier pilot of the intervention had taken place with 
allogeneic patients at one of the sites (see below for details) and had become 
treatment as usual for that group.  Consequently, only autologous patients were 
able to participate at that site.  
The initial target sample size was 60 patients with an estimated drop-out 
rate of 25% as observed in HSCT and other cancer populations (Billingham, 
Whitehead, & Julious, 2013; Braamse et al., 2010; DuHamel et al., 2010; 
Herzog, 2008; S. D. Lambert et al., 2012).  To obtain initial evidence of efficacy 
in this Phase II study (D. Wang & Bakhai, 2006) this target sample size was 
estimated as sufficient to detect a small to medium intervention effect size.  
G*Power (Buchner, Erdfelder, Faul, & Lang, 2009; Faul, Erdfelder, Lang, & 
Buchner, 2007) was used, with effect size f = 0.175, α = 0.05, power = 0.80, 
and correlation among repeated measures of 0.5.  Such a sample size was also 
considered sufficient and not excessive to gather information on feasibility in 
line with other feasibility studies in HSCT (Bauer-Wu et al., 2008; Horton-
Deutsch et al., 2007; Trask, Jones, & Paterson, 2003). 
The target sample size of 60 was also sufficient for meeting the second, 
theoretical aim of the study.  As each patient was expected to contribute up to 
four time points (as discussed in the journal paper), data for a total of 180 time 
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points were expected after attrition.  This exceeded the 43 participants required 
to detect a medium effect size. 
The cut off of 43 was estimated via the equation m x n = N x [1 + (n – 
1)ρ]; m = number of required participants in the multilevel model; n = 4, number 
of time points for each participant; N = number of participants according to the 
nonmultilevel sample size calculation; ρ = intercorrelation coefficient (Twisk, 
2006).  Essentially, this method adjusts the sample size N based on the 
assumption that successive data from the same patient are likely to provide 
diminishing information due to their intercorrelation (Browne, Golalizadeh, & 
Parker, 2009; Twisk, 2006).  An intercorrelation coefficient of 0.7 was assumed 
among the four measurements of each participant as expected for highly 
overlapping or equivalent measures (Field, 2013).  A sample size N = 55 was 
estimated as required to detect a medium effect size with independent data in 
standard, nonmultilevel regression (f2 = 0.15, α = 0.05, power = 0.80) using 
G*Power (Buchner et al., 2009; Faul et al., 2007).  This method of estimating 
multilevel sample sizes is considered the most conservative relative to other 
options (Twisk, 2006).   
 
3.3.2  The intervention 
The intervention was a preparation group prior to hospitalisation for 
HSCT aiming at addressing distress during the acute phase at its point of onset 
prior to transplantation.  Based on the self-regulatory model, the intervention 
purported to alleviate distress by: (a) reducing negative and threatening 
perceptions of HSCT via the provision of information; (b) encouraging helpful 
coping within the context of the procedure; and (c) enhancing coping appraisals 
by demonstrating that aspects of HSCT are controllable.  The information 
discussed in the group was standardised as it followed the content of The 
Seven Steps book (Kenyon, 2012).  In order to reduce burden, maximise 
uptake, and enable access to social resources for coping, the intervention was 
delivered in a single, 90-minute, group session.  The sessions took place 
monthly and were facilitated by the Transplant Coordinator, Clinical 
Psychologist, and Physiotherapist. 
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The rationale for the group format was twofold.  First, this format has 
been found to validate the experience of cancer patients (Moyer et al., 2009).  
Secondly, the group format was aimed at facilitating access to social resources 
for patients about to undergo transplantation, as the effectiveness of coping is 
thought to depend on availability of such resources (Taylor & Stanton, 2007).   
As the length of the intervention was relatively short, it was essential to 
include the highest-impact ingredients identified in the relevant literature to 
maximise benefits, leading to focus on its four core components.  Details of 
these components, their content, aims, delivery methods, and psychological 
targets are shown in Table 5.  The intervention was provided in addition to 
treatment as usual (TAU) which comprised informal discussions with and 
support from members of the multi-professional team alongside written 
information packs. 
The intervention was trialled for six months prior to the study with 
allogeneic patients participating opportunistically at one of the sites. The 
decision to pilot it to allogeneic patients alone was made due to the increased 
likelihood of physical complications in this group as a way of fast-tracking the 
process of formalising delivery and content.  As the procedure is similar though 
less severe in nature for autologous patients, the content of the intervention 
applied to both patient groups.  Patients and staff found the group acceptable 
and feasible during the trial.  Its development over this period focused on 
structuring the four components based on the theory underpinning the 
intervention via consensus, peer supervision among facilitators, emerging 
discussions, and feedback from patients.  No adverse effects were identified. 
Treatment fidelity between the two sites was also examined.  This aimed 
to ascertain whether the key elements listed in the intervention schedule were 
included during delivery and whether delivery was broadly comparable across 
sites.  The first group session from one site was recorded and was discussed in 
peer supervision between the facilitators across sites.  Discrepancies from the 
intervention schedule were identified and delivery was amended accordingly.  It 
was not possible to record the intervention in the second site on ethical 
grounds, as allogeneic patients participated in the group at that site but had not 
consented to the use of their information for the study.   
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Table 5 
Schedule of the psychological intervention evaluated in the study 
Component Description Aim Psychological target 
1. Introduction Introductions, including role of staff. 
Describe aims and plan of the session 
  
2. Transplant 
coordinator 
Pretransplant tasks: Arranging caregiver, childcare, financial & 
personal affairs, etc. 
Information on practicalities of the process: Pretransplant 
investigations, donor work, transplant day onwards, medication, 
recovery 
Anticipating difficulties & dealing with difficult days/times: Isolation & 
implications, what to bring to hospital, what to expect (side effects 
and complications), going home 
Importance of liaising with healthcare staff: Assistance with symptoms, 
emotional difficulties, concerns regarding going home, etc. 
Challenge myths 
surrounding 
HSCT; promote 
clarity 
Reduce negative and 
threat appraisals in 
connection with 
HSCT 
Facilitate concreteness 
of the HSCT 
experience 
Introduce staff as a 
coping resource 
3. Psychology: 
i. Foster 
adjustment 
Information on the emotional response to life-threatening illness and 
subsequent intense treatment. 
(Elicited through Socratic dialogue) 
Normalise & 
validate 
psychological 
response 
Reframe coping self-
appraisals influenced 
by the emotional 
response 
 Page 108 of 263 
ii. Coping 
skills 
Managing worry (e.g., worry time, distraction) 
Identifying previous coping strategies 
Managing emotion (e.g., self-soothing & relaxation, PMR, safe place) 
Problem-solving & goal priorities 
Communication skills with healthcare professionals to meet needs 
(Psychoeducation and eliciting from group using Socratic dialogue) 
Prepare patients 
for psychological 
challenge 
Provide patients 
with ways of 
coping 
Improve patient’s 
effective use of 
approach & 
avoidance coping. 
Enhance coping 
appraisals 
(controllability) 
4. Physio-
therapy 
Importance of daily routine (e.g., meals, personal hygiene) 
Activity scheduling 
Breathing exercises 
Importance of physical activity & examples 
Introduction to rehabilitation group (postHSCT) 
Dealing with physical symptoms (e.g., pain, fatigue) 
(Psychoeducation and eliciting from group using Socratic dialogue) 
Improve patients’ 
understanding of 
the role of 
activity/ exercise 
& their 
willingness to 
use it. 
Improve effective use 
of approach & 
avoidant coping. 
Enhance coping 
appraisals 
(controllability) 
5. Close Summarise discussion 
Reinforce take-home messages regarding misconceptions of threat, 
normalisation, active coping, and support from the healthcare team 
  
Note.  HSCT=Haematopoietic stem-cell transplantation; PMR=Progressive muscular relaxation 
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3.3.3  Treatment-as-usual 
Unlike the psychological intervention, treatment as usual did not aim to 
address negative appraisals and coping though this may have occurred 
unsystematically as HSCT progressed.  Patients participated in at least two 
discussions about the procedure with members of the multi-professional team 
(medical, nursing staff, etc.).  Patients were also provided with written 
information packs about the procedure and the hospital stay, including The 
Seven Steps book (Kenyon, 2012) that was discussed in the intervention.  
Specialist nursing staff provided informational and emotional support as 
required.  Patients who experienced considerable distress were referred for 
psychological input; information on the reasons for referral can be found in 
Appendix A. 
 
3.3.4  Materials 
The study measured psychological distress, HSCT perceptions, coping, 
and adaptation.  The latter was measured with the Brief Resilience Scale (BRS; 
B. W. Smith et al., 2008).  Measures were selected on the basis of their 
reliability and validity in relation to the relevant concepts.  Samples of the 
materials can be found in Appendices B-F. 
 
3.3.4.1  Proforma 
Demographic, illness, and treatment characteristics can predict coping 
and illness perceptions in general (Folkman & Moskowitz, 2004; Ogden, 2012; 
Taylor & Stanton, 2007) and adjustment and distress in HSCT (Andersson, 
Ahlberg, Stockelberg, Brune, & Persson, 2009; Andersson, Ahlberg, 
Stockelberg, & Persson, 2011; Barata et al., 2014; Braamse et al., 2014; Hefner 
et al., 2014; Mosher et al., 2009; Prieto et al., 1996; Tecchio et al., 2013).  
Consequently, demographic and clinical information such as gender, age, 
disease, transplant type, and so forth, were recorded for each participant.  
These were also important in evaluating the external validity of the findings 
(McBurney & White, 2007).  The proforma with coding details can be found in 
Appendix B. 
 Page 110 of 263 
 
3.3.4.2  Short Depression Anxiety Stress Scales 
The Short Depression Anxiety Stress Scales (DASS-21; Appendix C) 
was selected over alternatives due to its ability to provide a total distress score 
(thus conserving statistical power in the assessment of efficacy in the present 
project) and its balanced content.  The stress subscale is conceptualised as 
sustained tension and worry in response to ongoing life challenges rather than a 
fearful response to threat characterising the anxiety subscale (Lovibond, 1998). 
The three-factor structure of the DASS-21 appears suitable for a 
comprehensive assessment of distress in HSCT relative to other scales often 
used in cancer populations (Antony, Bieling, Cox, Enns, & Swinson, 1998; 
Brown, Chorpita, Korotitsch, & Barlow, 1997; Henry & Crawford, 2005; 
Thekkumpurath, Venkateswaran, Kumar, & Bennett, 2008; Vodermaier, Linden, 
& Siu, 2009; Yeh, Chung, Hsu, & Hsu, 2014).  For example, the Hospital 
Anxiety and Depression Scale (Zigmond & Snaith, 1983), Beck Depression 
Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961), and so forth, 
appeared too focused for the present project as distress in the self-regulatory 
model, coping theories, and HSCT, includes depression, anxiety, stress, and 
negative affect more generally (Fife et al., 2000; Lee et al., 2005; Mitchell, 
Meader, & Symonds, 2010; Ogden, 2012; Prieto, Atala, Blanch, Carreras, 
Rovira, Cirera, & Gastó, 2005; Prieto et al., 2002; Thekkumpurath et al., 2008; 
Vodermaier et al., 2009; Yeh et al., 2014).  In addition, the DASS-21 retains a 
focus on the psychological experience of distress compared to other general 
measures of wellbeing used in cancer (Thekkumpurath et al., 2008; Vodermaier 
et al., 2009; Yeh et al., 2014).  For example, the General Health Questionnaire 
(Goldberg et al., 1997) has some items relating to emotional wellbeing but also 
examines social functioning and somatic symptoms. 
The validity of the DASS-21 and its three-factor structure has received 
extensive support.  Evidence of criterion validity includes significant and 
meaningful correlations with established clinical measures of psychological 
distress and overall mental health such as the Beck Depression Inventory, Beck 
Anxiety Inventory, State-Trait Anxiety Inventory (STAI), Health of the Nation 
Outcome Scales, and so forth (Antony et al., 1998; Henry & Crawford, 2005; Ng 
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et al., 2007; Ronk, Korman, Hooke, & Page, 2013).  Results from the long 
version of the DASS extend this evidence to additional measures of distress, for 
example Hospital Anxiety and Depression Scale (HADS) and the Positive and 
Negative Affect Scales (Brown et al., 1997; Crawford & Henry, 2003; P. F. 
Lovibond & S. H. Lovibond, 1995; Page, Hooke, & Morrison, 2007). 
Apart from correlations with other instruments, the DASS-21 has good 
discriminant validity as evidenced by its ability to differentiate between different 
clinical populations, although this has been more consistent for the stress 
subscale scale relative to depression and anxiety (Anthony et al., 1998), 
thereby highlighting a potential threat to validity.  In addition, evidence suggests 
that the depression scale may be susceptible to ceiling effects in populations 
with depression (Page et al., 2007) but that ought not to be problematic in the 
present project where lower levels are expected (Lee et al., 2005; Prieto, Atala, 
Blanch, Carreras, Rovira, Cirera, & Gastó, 2005; Prieto et al., 2002; Prieto et 
al., 2006).  The factor structure of the DASS-21 has been stable across cultures 
although subscale inter-correlations may differ (Norton, 2007).  Crucially, the 
moderate sensitivity to clinical change and acceptable to good temporal stability 
in diverse clinical populations (Brown et al., 1997; Ng et al., 2007; Page et al., 
2007; Ronk et al., 2013) were important in ensuring meaningful repeated 
measurements in the present project. 
Notwithstanding extensive support for its validity, there were caveats in 
the use of the DASS-21 that highlighted the necessity of a feasibility study.  The 
instrument is relatively new compared to the alternatives discussed above and 
its psychometric properties have not been examined as extensively in cancer 
populations.  Furthermore, some of the items in the DASS-21, for example, “I 
was aware of dryness of my mouth” and “I experienced trembling”, may reflect 
somatic side effects of HSCT.  This might affect both the construct validity and 
the reliability of the scale.  Consequently, it was important to examine the 
internal consistency of the DASS-21 in HSCT and collect information from 
participants regarding whether the somatic items reflected emotional distress 
versus side effects of HSCT. 
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3.3.4.3  Brief Resilience Scale 
The Brief Resilience Scale (B. W. Smith et al., 2008) assessed the ability 
to adapt to and recover from a stressor (mainly health-related) such as HSCT.  
Therefore, it was considered theoretically relevant to the conceptualisation of 
adaptation within the self-regulatory model (Leventhal et al., 1997; Leventhal et 
al., 1984).  The scale consists of six items rated on a 5-point Likert scale and 
provides a single score ranging from 6 to 30 (higher scores reflect more 
resilience; B. W. Smith et al., 2008).  It assesses trait adaptation but was 
amended for measurement over one week as required by the present study 
(Appendix D). 
The BRS is a new instrument but initial research has shown it has good 
psychometric properties.  It has good construct validity both in clinical and 
nonclinical samples as reflected in meaningful correlations with personal 
characteristics (e.g., optimism), social relationships, coping, health-related 
outcomes such as fatigue and other physical symptoms, anxiety, depression, 
negative affect, and so forth (B. W. Smith et al., 2008; B. W. Smith, Epstein, 
Ortiz, Christopher, & Tooley, 2013; B. W. Smith, Tooley, Christopher, & Kay, 
2010).  It also has good internal consistency (Cronbach’s α = 0.78-0.91), and 
acceptable test-retest reliability up to three months (r = 0.62-0.69; B. W. Smith 
et al., 2008; B. W. Smith et al., 2010).  The latter may reflect sensitivity to 
variability in resilience (a benefit for the present project) or limitations to 
reliability that could affect statistical validity and power adversely.  The 
psychometric properties of the scale over one week and validity with HSCT 
patients were examined as part of the study. 
The BRS is the briefest scale of its kind and its psychometric properties 
place it among the highest rated among alternatives (Windle, Bennett, & Noyes, 
2011).  Compared to alternatives with similar psychometric properties, such as 
the Connor-Davidson Resilience Scale (Connor & Davidson, 2003) and the 
Resilience Scale for Adults (Friborg, Hjemdal, Rosenvinge, & Martinussen, 
2003), the BRS appears more relevant to the process of adaptation rather than 
describing protective factors underlying adjustment (e.g., social competence, 
social support, acceptance of change, self-efficacy, etc.).  Consequently, the 
BRS also overlaps less with coping styles. 
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In addition, the items of the BRS appear well suited for rewording to 
measure adaptation over shorter periods of time relative to other measures.  
For example “I prefer to plan my actions” from the Resilience Scale for Adults 
(Friborg et al., 2003) or “Can deal with whatever comes” from the Connor-
Davidson Resilience Scale (Connor & Davidson, 2003) appear less able to 
retain the meaning of adaptability when reworded for measurement over the 
short-term compared to, for example, “I tend to bounce back quickly after hard 
times” of the BRS. 
 
3.3.4.4  Brief Coping with Problems Experienced questionnaire 
The Brief Coping with Problems Experienced questionnaire (Brief COPE; 
Appendix E) is the short version of the COPE (Carver, Scheier, & Weintraub, 
1989).  The Brief COPE can be used for different time periods flexibly as 
required by the present project whilst showing relatively better psychometric 
properties in comparison to alternatives (Carver et al., 1989; de Ridder, 1997).  
Of the 14 coping styles, Substance Use and Religion were not included in the 
present project.  This was due to the environmental restrictions during HSCT 
not permitting substance use, the relatively small number of patients expected 
to use religious coping due to demographic changes in this domain (Office of 
National Statistics, 2011), and ethical barriers with addressing religious coping 
as part of the intervention.  It was also important to minimise the burden of the 
questionnaire as it was the lengthiest in the study. 
The Brief COPE was considered suitable for the present study as it is 
more theoretically flexible compared to alternatives (de Ridder, 1997).  It was 
designed to assess distinct coping styles rather than broader conceptualisations 
(as in other coping measures; Carver et al., 1989; de Ridder, 1997) that may 
not apply to HSCT.  Some studies have grouped the coping styles of the 
measure into higher order factors (e.g., problem-, emotion-focused, etc.) in 
populations such as dementia and inflammatory bowel disease (Coolidge, 
Segal, Hook, & Stewart, 2000; Cooper, Katona, Orrell, & Livingston, 2006; 
Knowles, Cook, & Tribbick, 2013).  However, such practice is incompatible with 
the purpose of the scale as it was developed to enable the study between 
conceptually distinct coping styles and overcome the limitations of problem- and 
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emotion-focused coping (Carver et al., 1989).  In addition, using a priori coping 
style groups in HSCT does not appear appropriate in light of the general lack of 
consensus regarding overarching coping styles in the literature (Coyne & 
Racioppo, 2000; de Ridder, 1997; Skinner et al., 2003) and lack of research 
regarding the function of coping styles and validity of overarching categories in 
the context of acute HSCT. 
The validity of the Brief COPE has been examined in clinical populations 
involving both physical and mental health difficulties with meaningful results 
such as predicting depression, anxiety, burden, positive and negative affect, 
and differentiating between clinical and nonclinical presentations, (Bautista & 
Erwin, 2013; Bautista, Rundle-Gonzalez, Awad, & Erwin, 2013; Cooper, Katona, 
& Livingston, 2008; Cooper et al., 2006; Cooper, Katona, Orrell, & Livingston, 
2008; Fletcher, Parker, & Manicavasagar, 2013; Hooper, Baker, & McNutt, 
2013; Knowles et al., 2013; Meyer, 2001).  It has promising predictive validity in 
HSCT consistent with the wider literature in indicating that avoidant coping (e.g., 
denial) predicts worse physical outcomes in the recovery period after HSCT, 
though the avoidant style grouping does not appear internally consistent 
(Schoulte, Lohnberg, Tallman, & Altmaier, 2011).  However, as the coping 
styles in the Brief COPE are not specific to HSCT and the challenges facing this 
patient population, it may be limited in capturing the process of coping in this 
context. 
The evidence on the reliability of the questionnaire appears mixed.  Its 
factor structure appears acceptable (Carver, 1997), relatively low temporal 
stability has been suggested to reflect meaningful fluctuations in the use of 
coping styles (de Ridder, 1997), and relatively low coefficients of internal 
consistency are expected in small scales (Field, 2013) such as the Brief COPE 
where each coping style is measured by only two items (Carver, 1997).  
Although Cronbach’s α coefficients of the Brief COPE are not ideal for 
measuring psychological constructs, the COPE appears one of the most reliable 
measures in the field (de Ridder, 1997).  However, low reliability is likely to limit 
statistical validity and power (Gravetter & Wallnau, 2009; McBurney & White, 
2007).  It was, therefore, important to assess the reliability of the Brief COPE 
prior to a full trial. 
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3.3.4.5  Brief Illness Perceptions Questionnaire 
The Brief Illness Perceptions Questionnaire (Brief IPQ) is the short and 
simplified version of the widely applied, 80-item IPQ-Revised (Broadbent et al., 
2006; Moss-Morris et al., 2002; Ogden, 2012; Weinman, Petrie, Moss-Morris, & 
Horne, 1996).  Regarding support for the concurrent, predictive, and 
discriminant validity of the measure, the evidence includes meaningful 
concurrent and longitudinal correlations with health behaviours, physical, and 
mental health functioning, change in illness perceptions following informational 
input, and ability to distinguish between different illnesses in a variety of 
populations (Bean, Cundy, & Petrie, 2007; Broadbent, Ellis, Thomas, Gamble, & 
Petrie, 2009; Broadbent et al., 2006; Knowles et al., 2013; Løchting, Garratt, 
Storheim, Werner, & Grotle, 2013; Sluiter & Frings-Dresen, 2008). 
However, limitations to validity are also present.  The findings have been 
less robust for the individual items of the Brief IPQ (Bean et al., 2007; 
Broadbent et al., 2009; Broadbent et al., 2006; Knowles et al., 2013; Løchting et 
al., 2013; Sluiter & Frings-Dresen, 2008), suggesting some caution.  The 
literature also indicates comparable results to the original IPQ-Revised but 
further corroboration is required since the Brief IPQ was developed primarily by 
summarising the items from the IPQ-Revised but the correlations between the 
two instruments (coefficients between 0.32 and 0.63) were not as high as 
expected if they measured the same constructs (Broadbent et al., 2006; Field, 
2013).  Furthermore, the validity of the version of the Brief IPQ in the present 
project may be compromised as it assesses perceptions of a procedure rather 
than an illness. 
The Brief IPQ has variable reliability.  Cronbach’s α coefficients suggest 
mixed albeit acceptable internal consistency.  The modest test-retest reliability 
coefficients indicate fluctuating stability (potentially affected by illness 
progression).  These could limit statistical validity and power in the present 
study (Gravetter & Wallnau, 2009; McBurney & White, 2007) and emphasised a 
need to examine the internal consistency of the present adaptation of the Brief 
IPQ for HSCT. 
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3.3.5  Design 
Overall, a prospective 2x4 mixed between-within-subjects randomised 
controlled trial (RCT) design was adopted (D. Wang & Bakhai, 2006).  The 
within-subjects factor was time, with four levels (four time points: prior to HSCT, 
on the day of the transplant, two, and four weeks after the transplant).  The two 
levels of the between-subjects factor were intervention plus TAU versus TAU 
alone (control).  Primary outcome was distress (DASS-21) while HSCT 
perceptions (Brief IPQ), coping (Brief COPE), and adaptation (BRS) were 
secondary outcomes. 
An RCT design appears important in improving the quality of the 
intervention evidence in HSCT (Baliousis et al., in press).  The presence of a 
control group can mitigate individual differences and covariates that have not or 
cannot be assessed reliably, which can compromise the analysis and has been 
a major limitation in coping research (Coyne & Racioppo, 2000; McBurney & 
White, 2007; Tabachnick & Fidell, 2013; D. Wang & Bakhai, 2006).  
Furthermore, a control group involving therapeutic contact without the active 
ingredients of the intervention can mitigate the maturation and common factor 
effects that limit current HSCT intervention literature (Baliousis et al., in press; 
Bauer-Wu et al., 2008; Horton-Deutsch et al., 2007; Lounsberry et al., 2010). 
However, the randomised trial design can be demanding, many trials fail 
to be completed timely due to infeasibility, and cancer populations often do not 
accept randomisation (Bower, Wilson, & Mathers, 2007; Howard, de Salis, 
Tomlin, Thornicroft, & Donovan, 2009; Moyer et al., 2009; Sully, Julious, & 
Nicholl, 2013; Toerien et al., 2009).  The many potential barriers immediately 
prior to and during acute HSCT may increase the challenges of implementing 
an RCT.  Therefore, examining the feasibility of such a design was important 
prior to a full study. 
The purpose of including four time points in the within-subjects factor 
was threefold.  The evidence on distress during HSCT (Dakanalis et al., 2013; 
Fife et al., 2000; F. Keogh et al., 1998; Lee et al., 2005; McQuellon et al., 1998; 
Molassiotis et al., 1996; Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 
2005; Prieto et al., 2002; Tecchio et al., 2013) suggests considerable variability 
and a need for frequent measurement.  Furthermore, frequent measurement in 
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the project facilitated an accurate estimation of attrition at different time points 
and, therefore, was useful for estimating a target sample size for the full trial.  
Data for multiple time points were also helpful in increasing statistical power for 
the theoretical component in light of the small sample (Field, 2013; Tabachnick 
& Fidell, 2013). 
Block randomisation with block size of four and one-to-one sequential 
allocation ratio with separate randomisation codes for each site was used to 
ensure the resulting groups were equal in size (Altman & Bland, 1999; Schulz & 
Grimes, 2002b; D. Wang & Bakhai, 2006).  Randomisation codes were 
computer-generated prior to recruitment with Random Allocation software 
(Saghaei, 2004a).  The software has been found to be reliable in producing 
random sequences using a pseudorandom method based on the computer 
timer as numerical seed (Saghaei, 2004b).  The codes were stored in digital 
files that were password protected by an NHS medical professional not involved 
in the study otherwise.  These files were held by the outcome assessor who did 
not possess the password.  Upon receipt of consent and allocation of participant 
number, each code was made available to the interventionists (who possessed 
the password) in order to allocate participants and invite them to the 
intervention as appropriate.  The professional who generated the codes kept a 
log of participant numbers and codes as the latter ones were released to 
interventionists in order to ensure that the allocation was adhered to.  The 
outcome assessor and participants were intended to be blind to the allocation.  
 
3.3.6  Procedure 
Participants were invited using the sheet in Appendix G.  The timing of 
the initial approach was before the transplant at the discretion of the multi-
professional team.  Interested patients were then able to review the study 
material in the participant information sheet shown in Appendix H at their 
convenience.  The consent form is presented in Appendix I.  Baseline measures 
were completed as soon as practically possible after enrolment but prior to the 
intervention.  Participants were then randomised, were invited to the 
intervention via letter, and confirmed attendance or otherwise via telephone.  
Subsequent data collection took place over the telephone by the outcome 
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assessor who made up to three attempts to collect data per day up to two 
weeks following each time point.  During the telephone calls to fill in the 
questionnaires, participants were reminded frequently that all questions referred 
to their experience over the past week.  Participants were asked for feedback 
on the procedure (calls, timing, burden, etc.) and materials (comprehensibility, 
ease of completion, etc.) at the end of the final telephone call.  If participants 
made relevant comments throughout data collection, these comments were also 
noted.  Breaches of assessor blinding were noted to assist with the evaluation 
of feasibility and internal validity.   
 
3.3.7  Data analysis 
3.3.7.1  Computations 
Total and subscale scores were computed by adding up constituent 
items, reversed as appropriate.  This included the DASS-21 total and subscale 
score (Henry & Crawford, 2005), total score of the BRS (B. W. Smith et al., 
2008), total score of the Brief IPQ (Knowles et al., 2013), and coping styles of 
the Brief COPE (Carver, 1997).   
 
3.3.7.2  Initial and feasibility analyses 
Assumption violations were examined as discussed by Field (2013), 
Pallant (2005), and Tabachnick and Fidell (2013): 
 
1. Accuracy of input and outliers: Out of range values and the 
plausibility of means and standard deviations were examined.  
Univariate and multivariate outliers were set at α = 0.001 (Field, 2013).  
Multivariate outliers were detected via Mahalanobis distance in χ2 
distribution (Pallant, 2005).  Care was exercised not to exclude possible 
outliers due to nonnormal distributions so as not to render samples 
unrepresentative. 
2. Normality: Normality was assessed visually via histogram, normality 
plots, and distributions of residuals (for multivariate analysis of variance, 
MANOVA), the Kolmogorov-Smirnov test, and skewness and kurtosis 
significant at α = 0.001 (Field, 2013; Tabachnick & Fidell, 2013).  For 
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MLM, the normality of residuals, intercepts, and slopes was examined 
via visual inspection of their histograms (Rasbash, Steele, Browne, & 
Goldstein, 2015; Twisk, 2006).  Transformations were attempted for 
nonnormal data (Field, 2013) but were not possible due to different 
distributions across time points. 
3. Linearity: Linearity was evaluated via examination of multilevel 
bivariate scatter plots of continuous variables whose relationships were 
examined in main analyses.  These included outcome variables (BRS 
score, DASS-21 total and subscales) plotted against predictors (Brief 
IPQ total and subscales, Brief COPE styles, days from transplantation, 
and time points). 
4. Homogeneity of variance and homogeneity of covariance 
matrices: These assumptions were examined via Levene’s test and 
Box’s test (α = 0.001; Field, 2013). 
5. Multicollinearity and singularity: Two indicators were examined – 
bivariate correlations with r>0.70 and tolerance approaching zero (in the 
range of 0.1) or condition index exceeding 30 coupled with variance 
proportions greater than 0.5 for at least two different variables (Belsey, 
Kuh, & Welsch, 1980; Tabachnick & Fidell, 2013). 
6. Missing data in MLM: Missing data can be tolerated well in MLM 
particularly when either missing completely at random (MCAR, Little’s 
test is not significant) or missing at random (MAR; Goldstein, 2003; 
Rasbash, Steele, Browne, & Goldstein, 2009; Tabachnick & Fidell, 
2013).  MAR can be assumed when Little’s test is significant but data 
are missing in a predictable pattern which is unrelated to the outcome 
variables (Snijders & Bosker, 2012; Tabachnick & Fidell, 2013).  
Missing value analysis (Tabachnick & Fidell, 2013) was conducted for 
outcomes measured at each time point to determine Little’s test and 
examine whether missing data were related to demographic and clinical 
characteristics, baseline measures, or outcomes measured at previous 
time points. 
 
Descriptive statistics in relation to feasibility variables focused on accrual 
and uptake to the study and intervention, reasons for declining participation, 
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attendance, reasons for nonattendance, response rates (attrition), and reasons 
for attrition. 
Group differences between participants randomised to intervention 
versus control on demographics, clinical characteristics, and baseline measures 
were examined in order to assess the success of randomisation (Lewis & 
Warlow, 2004).  Differences between participants who attended the intervention 
versus those who did not (overall and from those participants randomised to the 
intervention only) were also examined to assess sampling bias.  Chi-square 
tests (with continuity correction for 2x2 tables and Fisher’s exact test when 
expected frequencies did not exceed five; Field, 2013), robust independent t-
tests (with Bonferroni corrections, α = 0.01, and bias-corrected bootstrapping 
with 1000 samples), and robust MANOVA (for theoretically related variables 
such as distress, coping, and HSCT perceptions subscales) were used.  Use of 
robust statistics and bootstrapping aimed at mitigating the influence of potential 
outliers and assumption violations (Field, 2013; Wilcox, 2012; Wilcox & 
Keselman, 2003). 
 
3.3.7.3  Efficacy and psychological processes 
Randomisation (intervention versus control) and its interaction with time 
were entered as predictors to the baseline model (which contained only time). 
Sensitivity analyses also examined the effect of actual group attendance versus 
nonattendance (instead of randomisation).  Sample size estimations for a full 
trial (power = 0.80) used bootstrapped fixed and random parameter estimates 
of the overall effects during the acute phase of HSCT (time points 2-4).  Sample 
size estimations took account of the observed nonresponse rates.  The 
standard sample size calculation was adjusted for the multilevel data structure 
using the method described in Section 6.1.  However, the results of different 
methods for estimating sample size in MLM can vary considerably depending 
on the method (Twisk, 2006); therefore, caution is required regarding their 
interpretation. 
In light of limited attendance to the intervention (see Section 7.1.1), 
multilevel single case analysis (Huber, Klein, Moeller, & Willmes, 2015) was 
also used to triangulate the results of the main analysis and allow for the 
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detection of small effects that may not be possible due to lack of power.  The 
intervention aimed to secure lower increases in distress during acute HSCT 
(time points 2-4) compared to baseline than might be expected otherwise; 
therefore, single case analysis examined the change in distress of intervention 
attendees relative to nonattendees.  To conduct the multilevel single case 
analysis, each case was dummy-coded in the multilevel model.  The change of 
each case compared to nonattendees (β coefficient) was then examined. 
The method of using multilevel models for repeated measures has been 
shown to be mathematically and statistically equivalent to the t-test often used 
in single-measure methods (Crawford & Garthwaite, 2002; Crawford & Howell, 
1998; Huber et al., 2015).  A two-tailed test was selected since the study was 
the first evaluation of the intervention which was, therefore, not assumed to be 
effective (this is in line with Phase II trial practice; Craig et al., 2008).  The 
within-subjects nature of the comparison was a weak design for establishing 
causality and control but frequent lower increases in distress in attendees were 
considered initial evidence of effectiveness prior to further evaluation for the 
purpose of the present study.   
 
3.3.7.4  MLM configuration 
The multilevel data structure was defined with time points as Level 1 (i) 
units and participants as Level 2 (j) units.  With the exception of days from the 
transplant (zero for transplant day), all continuous Level 1 predictors (those 
measures at each time point) were centred around the grand mean in order to 
aid interpretation and improve the stability of the model by mitigating the 
potential multicollinearity (Twisk, 2006).  Predictors were entered first as fixed 
and then, if the model improved significantly, random at Level 2.  Results from 
random effects models were reported when improvements were significant.  
The R12 provided an estimation of the variance that was explained by the 
predictors and random effects added at each stage.  The R12 was computed as 
percentage of 1-((σ22+τ22)/(σ12+τ12)) where σ2 and τ2 represent Level 1 and 
Level 2 variance respectively between two successive models (Snijders & 
Bosker, 2012).  Negative change in variance is generally not interpretable 
(Snijders & Bosker, 2012).  Bootstrap estimation (nonparametric, bias-
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corrected, with five sets of 500 iterations) was used to mitigate bias from 
nonnormal distributions and the small sample size (Rasbash, Steele, et al., 
2015) 
 
3.3.7.5  Software 
Robust MANOVA was conducted using the mulrank() function (Wilcox, 
2012) on R (Version 3.2.2; R Core Team, 2015).  An example of the robust 
MANOVA code testing for differences between the groups as randomised on 
the distress subscales is provided in Appendix J.  MLM was conducted using 
MLwiN software (Version 2.34; Rasbash, Browne, Healy, Cameron, & Charlton, 
2015), power analysis and sample size estimations were conducted using 
MLPowSim software (Version 1.0; Browne & Golalizadeh, 2009), and SPSS 
software (Version 22; IBM Corp, 2013) was used in all other analyses.  Unless 
specified otherwise, α was 0.05. 
 
3.3.8  Ethics 
The study was registered with ClinicalTrials.gov (NCT02212236).  
Approval documents by the NRES Committee East Midlands - Nottingham 1 are 
included in Appendix K.  The Participant Information Sheet and Consent 
documents adhered to the British Psychological Society (2009, 2011) and 
Health Research Authority (National Research Ethics Service, 2011) guidance.  
The decision to participate was voluntary and participants had the right to 
withdraw without negative consequences.  These were made clear in the 
Participant Information Sheet and were reiterated prior to obtaining consent. 
Participants were also informed that their responses would remain strictly 
confidential, anonymous, and securely stored.  Medical records for participant 
and procedural information were accessed only on site by the researchers.  
Data were stored in secure facilities at the University of Nottingham adhering to 
the University’s policies (The University of Nottingham, 2013).  Password 
protected and NHS-approved encrypted digital media were used for temporary 
storage.  Personal data (address, telephone number) will be kept for 12 months 
after the end of the study for participant debriefing regarding the findings 
(unless participants advise that they do not wish to be contacted).  All research 
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data will be kept securely for seven years and will be disposed of securely 
afterwards.   
No adverse effects were anticipated from participating in the present 
study or the new intervention (following the initial pilot preceding this study).  
The participants’ Consultant Haematologist was also notified prior to their 
participation in the event of concern.  In addition, withholding the intervention 
from the control group was not considered ethically controversial, as there was 
no convincing evidence of the intervention’s efficacy at the time of the study and 
the intervention would not have been made available to prospective participants 
outside of the study. 
As it is recognised that patients undergoing HSCT are under 
considerable strain, every effort was taken to minimise any additional burden by 
participating in the study.  This was reflected in the brevity of the intervention 
and the use of short and targeted measures.  If needed, participants were able 
to access support readily by nursing staff and the clinical psychologist on either 
site who were also involved in the study. 
It was not possible to inform participants of the condition they were 
allocated to during their participation in order to preserve binding (D. Wang & 
Bakhai, 2006) though it was recognised that in practice blinding of participants 
taking part in psychological interventions may not be feasible.  All participants 
were debriefed at the end of their participation and were provided with the 
researcher’s contact details should they wish to seek further information at a 
future time.  Participants will receive a brief written summary of the results 
within 12 months following completion via post or email according to their 
preference. 
 
3.3.9  Service user involvement 
A patient panel at one of the sites was consulted on the content of the 
intervention, outcomes, and measures and provided feedback on acceptability 
and feasibility.  This led to several adjustments: 
 
1. Use of the same anchor for the 4-point Likert scales of the DASS-21 
and Brief COPE. 
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2. Recognising the need to clarify some of the questions such as Item 
19 of the DASS-21 verbally over the telephone as required. 
3. Provide a hard copy of the questionnaires as sample including a large 
print of the scales to facilitate completion over the telephone. 
4. Remain mindful of ethical concerns (e.g., stigma, shame) in relation 
to obtaining consent for disclosure of physiological problems within 
certain communities. 
5. The site psychologist to remain mindful of the need to provide 
emotional support to patients who had not been randomised to the 
intervention group should they become aware of their allocation at the 
end of their participation. 
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3.4  EXTENDED RESULTS 
 
3.4.1  Initial analyses 
3.4.1.1  Feasibility 
Bone marrow transplant coordinators were able to approach participants 
at one site but not the other due to resourcing demands (participants were 
recruited by the clinical psychologist at the other site).  In total, 99 of the 103 
approached patients met eligibility criteria (43 of 44 and 57 of 59 per site).  Of 
these, 45 patients (24 and 21 per site) consented to participate.  Accrual was 
five participants per month (43% uptake).  Of the 21 participants randomised to 
intervention, five attended (24%) of whom two did not eventually receive 
transplants.  One of the scheduled groups had to be cancelled due to 
insufficient accrual of participants able to attend.  In most cases, attendance 
was not possible due to transplantation taking place before the scheduled 
intervention (Figure 5).  The need to randomise half of the patient to the control 
group hindered accrual for more frequent interventions.  The probability of 
nonresponse across all time points was 22%. 
Randomisation remained concealed as planned.  One code was not 
used eventually because it was assigned to a patient after the individual 
provided verbal consent but was unable to provide written consent 
subsequently.  This resulted in one of the randomisation blocks containing 
fewer intervention codes and an overall probability of being randomised to 
intervention of 0.48.  Most participants were unlikely to have remained blind as 
information about the nature of the intervention was provided unsystematically 
during recruitment.  The outcome assessor remained blind to randomisation in 
all but one case where a participant commented on having attended the group 
over the telephone.  The outcome assessor became aware that two participants 
did not attend the group prior to completing data collection, as these 
participants returned their signed consent after the final group had taken place. 
Regarding fidelity of intervention, peer supervision indicated that all core 
elements of the intervention were included.  However, delivery was found to be 
more directive at one site compared to the other (where the group had been 
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originally developed).  The resulted in relevant changes to delivery such as 
asking more exploratory questions and eliciting information from the group. 
Overall, participants provided favourable feedback on the procedure.  
The majority (80%) commented on the noninstrusiveness of the procedure and 
found the questionnaires of sufficient length.  The majority (60%) also 
suggested that flexibility with telephone calls was helpful in allowing them to 
continue participating.  Four participants (9%) reported that some questions did 
not apply to them and that this made it difficult to follow what was asked.  
Approximately 10% of participants indicated that rating adaptation (i.e., how well 
or quickly they were recovering from the transplant process) on the day of the 
transplant was ambiguous.  Two participants (4%) indicated that being asked 
questions about distress and their experience with the transplant made them 
reflect on their experience and feelings between time points.  
  
 Page 127 of 263 
Randomised (n=45)
Allocated to intervention (n=21)
Unable to attend (n=16)
Transplant too early (n=7)
Other priorities (n=4)
Travel delay (n=2)
Transplant cancelled (n=2)
Intervention cancelled (n=1)
Treatment as usual (n=24)
Completed (n=17)
Not completed 
Transplant cancelled    (n=4)
Completed (n=20)
Delayed (n=2)
Unavailable               (n=1)
Unwell (n=1)
Not completed                  (n=4)
Unwell (n=2)
Transplant cancelled  (n=2)
Follow up 1
(Day 0)
Completed (n=16)
Delayed: unwell            (n=3)
Not completed                  (n=5)
Transplant cancelled (n=4)
Withdrew (n=1)
Follow up 2
(+2 weeks)
Completed (n=19)
Delayed: unwell           (n=3)
Not completed                  (n=5)
Unwell (n=2)
Transplant cancelled  (n=2)
No response               (n=1)
Completed (n=15)
Delayed (n=3)
Unavailable                (n=2)
Change in contact
details     (n=1)
Not completed                  (n=6)
Transplant cancelled (n=4)
Withdrew (n=1)
Deceased (n=1)
Follow up 3
(+4 weeks)
Completed (n=17)
Delayed (n=5)
Unavailable               (n=2)
Unwell (n=3)
Not completed                  (n=7)
Transplant cancelled  (n=2)
Withdrew (n=2)
No response               (n=3)
Analysed (n=21) Analysis Analysed (n=23)
Consented (n=45)
Completed baseline measures (n=40)
 
Figure 5.  CONSORT diagram of participant flow.  Missing baseline measures 
were not returned following consent.  Procedural burden involved primarily 
competing appointments.  The complexity of the procedure included length and 
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data collection via telephone rather than face to face.  All collected data were 
included in analyses.  Day 0 = Day of transplantation. 
 
3.4.1.2  Reliability coefficients 
Cronbach’s α coefficients are shown in Table 6.  Removal of both Items 3 
and 4 from the Brief IPQ increased Cronbach’s α to between 0.67 and 0.73 
across time points. 
 
Table 6 
Cronbach’s α coefficients prior to removing anxiety items confounded by 
side effects of haematopoietic stem cell transplantation 
Scale Time point 
 T1 T2 T3 T4 
Distress     
Total distress 0.95 0.83 0.90  
Stress 0.90 0.78 0.92 0.86 
Anxiety 0.78 0.54 0.46 0.47 
Depression 
 
0.91 0.72 0.79 0.92 
Adaptation 
 
0.76 0.56 0.81 0.87 
Negative HSCT perceptions 0.63 0.64 0.63 0.68 
     
Coping     
Self-distraction 0.46 0.65 0.42 0.57 
Denial 0.87 No 
variance 
-0.14 0.18 
Behavioural disengagement 0.77 -0.05 0.90 0.39 
Venting 0.59 0.67 0.27 0.48 
Self-blame 0.44 0.65 0.23 0.78 
Active coping 0.61 0.80 0.70 0.75 
Emotional support 0.76 0.86 0.60 0.79 
Instrumental support 0.68 0.64 0.73 0.71 
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Positive reframing 0.54 0.60 0.36 0.63 
Planning 0.77 0.77 0.72 0.86 
Humour 0.86 0.94 0.81 0.92 
Acceptance 0.80 0.23 0.53 0.81 
Note. T1-4=Time points 1-4. 
 
3.4.1.3  Assumption checks 
Overall, assumption violations supported the use of robust tests and 
bootstrap estimation.  Most distributions deviated from normality (Table 7).  
Transformations were not successful due to different distributions across time 
points.  One possible outlier was detected for number of recurrences and 
another for hospital stay.  The latter was related to intensive care admission for 
a patient who eventually died, therefore, his hospital stay was not taken into 
consideration.  At baseline, one possible outlier was detected for total distress, 
anxiety, and depression, another for adaptation, and a further outlier for care 
control.  A few possible outliers were detected in denial, venting, behavioural 
disengagement, acceptance, and self-blame coping styles.  However, all these 
values did not appear unrepresentative as histogram inspection did not suggest 
they were remote based on the degree of skewness and kurtosis.  Removing 
these values was, therefore, likely to render the dataset unrepresentative and 
result in incorrect estimates of standard errors from the robust tests (Wilcox, 
2012).  No additional outliers were identified when data were examined by 
intervention and control groups.  Outliers were not examined for the group of 
participants who attended the intervention due to the small sample size. 
 
Table 7 
Results of statistical screening for normality in measures treated as continuous 
data 
Measure Skewness Kurtosis K-S test 
Age -1.43** 
(0.38) 
1.78** 
(0.74) 
0.14* 
Disease recurrences 1.89*** 
(0.35) 
3.32*** 
(0.70) 
0.42*** 
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Years since diagnosis 1.93*** 
(0.35) 
2.45*** 
(0.70) 
0.39*** 
ECOG 0.48(0.49) -0.58(0.77) 0.31*** 
Length of admission -0.17(0.38) 0.04(0.75) 0.12 
    
Time point 1 (SE=0.40) (SE=0.78)  
Days from transplant -0.82* 0.07 0.15* 
Distress (SE=0.37) (SE=0.73)  
Total 2.07*** 5.18*** 0.22*** 
Depression 1.96*** 4.40*** 0.22*** 
Anxiety 3.18*** 12.23*** 0.28*** 
Stress 1.46*** 1.68* 0.18*** 
Adaptation 1.89*** 7.69*** 0.13 
HSCT perceptions 0.12 1.76* 0.13 
Consequences -0.51 -0.62 0.18*** 
Timeline 0.31 -1.01 0.17*** 
Personal control 1.01** 0.78 0.17*** 
Treatment control -2.00*** 4.03*** 0.34*** 
Identity -0.04 -0.96 0.13 
Concern 0.01 -0.76 0.11 
Understanding -0.51 -0.69 0.17** 
Emotional impact 0.54 0.03 0.13 
Coping    
Self-distraction 0.13 -0.97 0.19** 
Denial 2.56*** 5.81*** 0.42*** 
Behavioural 
disengagement 
3.16*** 10.67*** 0.49*** 
Venting 2.22*** 5.12*** 0.33*** 
Self-blame 1.90** 3.90*** 0.34*** 
Active coping 0.54 -0.14 0.23*** 
Emotional support -0.20 -1.01 0.14* 
Instrumental support 0.52 -0.90 0.19** 
Positive reframing 0.50 -0.13 0.16* 
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Planning 0.77* -0.78 0.24*** 
Humour 0.56 -0.89 0.20*** 
Acceptance -0.97** 0.15 0.18*** 
    
Time point 2 (SE=0.39) (SE=0.76)  
Days from transplant 4.38*** 21.82*** 0.31*** 
Distress    
Total distress 0.51 -0.06 0.12 
Depression 0.88* -0.22 0.18** 
Anxiety 1.43*** 1.65* 0.24*** 
Stress 0.11 -1.13 0.19** 
Adaptation 0.09 -0.77 0.10 
HSCT perceptions -0.51 -0.22 0.14 
Consequences -1.09** 0.19 0.24*** 
Timeline 0.19 -0.13 0.15* 
Personal control 0.77* -0.71 0.21*** 
Treatment control -1.70*** 2.40** 0.27*** 
Identity 0.35 -0.59 0.15* 
Concern -0.34 -1.09 0.16* 
Understanding -1.46*** 2.05** 0.23*** 
Emotional impact 0.23 -1.26 0.15* 
Coping    
Self-distraction -0.24 -1.05 0.14 
Denial 3.33*** 11.64*** 0.50*** 
Behavioural 
disengagement 
4.78*** 23.57*** 0.53*** 
Venting 2.02*** 4.26*** 0.35*** 
Self-blame 2.42*** 6.60*** 0.36*** 
Active coping 0.45 -1.11 0.16* 
Emotional support -1.14** -0.48 0.39*** 
Instrumental support -0.11 -1.13 0.11 
Positive reframing -0.19 -1.18 0.14 
Planning 0.65 -0.84 0.21*** 
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Humour -0.20 -1.39 0.18** 
Acceptance -0.44 -1.36 0.29*** 
    
Time point 3 (SE=0.40) (SE=0.78)  
Days from transplant 1.88*** 2.03*** 0.35*** 
Distress    
Total distress 1.14** 0.73 0.17* 
Depression 1.11** 1.13 0.13 
Anxiety 0.51 -0.97 0.20** 
Stress 1.45*** 1.99*** 0.18** 
Adaptation -0.34 -0.95 0.11 
HSCT perceptions -0.28 0.57 0.13 
Consequences -1.41*** 1.88*** 0.22*** 
Timeline 0.13 -0.14 0.16* 
Personal control 0.95* 0.03 0.24*** 
Treatment control -1.98*** 3.69*** 0.28*** 
Identity -0.62 0.37 0.14 
Concern -0.28 0.53 0.17* 
Understanding -0.68 0.01 0.16* 
Emotional impact 0.01 -1.24 0.13 
Coping    
Self-distraction 0.53 -0.02 0.25*** 
Denial 2.40*** 5.03*** 0.49*** 
Behavioural 
disengagement 
4.08*** 17.95*** 0.50*** 
Venting 0.90* -0.35 0.33*** 
Self-blame 1.54** 0.78 0.45*** 
Active coping 0.65 -0.79 0.20** 
Emotional support -0.99* -0.31 0.30*** 
Instrumental support 0.13 -1.25 0.15* 
Positive reframing 0.34 -0.84 0.17* 
Planning 0.88* -0.71 0.27*** 
Humour 0.45 -1.04 0.21** 
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Acceptance -2.02*** 5.26*** 0.34*** 
    
Time point 4 (SE=0.41) (SE=0.81)  
Days from transplant 1.14** 6.08*** 0.28*** 
Distress    
Total distress 1.26** 1.20 0.19** 
Depression 1.27** 0.98 0.21** 
Anxiety 1.07** 0.21 0.28*** 
Stress 1.02* 0.72 0.15 
Adaptation -0.17 1.26 0.15 
Negative HSCT 
perceptions 
-0.20 0.06 0.09 
Consequences -0.66 -0.36 0.18* 
Timeline 0.11 -0.55 0.13 
Personal control 0.31 -0.91 0.19** 
Treatment control -1.46*** 1.90* 0.22*** 
Identity -0.18 -0.64 0.11 
Concern 0.09 -0.89 0.15 
Understanding -0.98* 1.23 0.17* 
Emotional impact -0.15 -1.16 0.14 
Coping    
Self-distraction 0.09 -0.75 0.15 
Denial 2.13*** 3.26*** 0.48*** 
Behavioural 
disengagement 
1.98*** 2.93*** 0.47*** 
Venting 0.79 -0.31 0.26*** 
Self-blame 3.03*** 9.50*** 0.44*** 
Active coping 0.59 -0.39 0.25*** 
Emotional support -1.28** 0.30 0.35*** 
Instrumental support -0.10 -0.89 0.15 
Positive reframing 0.38 -0.98 0.19** 
Planning 0.56 -1.12 0.23*** 
Humour 0.38 -0.88 0.20** 
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Acceptance -0.96* -0.18 0.29*** 
Note. SE = Standard error, also in parentheses; ECOG = Performance status 
on the Eastern Cooperative Oncology Group scale; HSCT = Haematopoietic 
stem cell transplantation; K-S = Kolmogorov-Smirnov. 
***P<0.001; **P<0.01; *P<0.05 
 
Regarding homogeneity of variance, Levene’s test (relevant to both t-
tests and MANOVA) was significant for several variables and this varied across 
group comparisons.  For participants randomised to intervention versus control, 
Levene’s test was significant for age, distress subscales, denial, self-blame, and 
personal control, Ps≤0.025.  For participants who attended the intervention 
versus those who did not (regardless of randomisation), Levene’s test was 
significant for number of recurrences, years since first diagnosis, emotional 
support, humour, and self-blame, Ps≤0.04.  Finally, for participants who 
attended the intervention versus those who did not from those who were 
randomised to the intervention, Levene’s test was significant for number of 
recurrences, emotional support, humour, and acceptance, Ps≤0.048. 
Additional variance assumptions for MANOVA and multivariate normality 
also appeared violated.  Box’s test (heterogeneity of covariance matrices) was 
significant for distress subscales, Ps<0.001.  One potential multivariate outlier 
was detected for distress subscales but removal did not alter results.  Most 
residuals did not appear normally distributed (visual inspection).  There was no 
evidence of multicollinearity as correlation coefficients between distress 
subscales, coping styles, and illness perceptions were below 0.70 (except 
perceived emotional impact and concern, r=0.76), tolerance exceeded 0.26, 
and condition index was below 5. 
Regarding linearity, bivariate scatterplots revealed approximately linear 
relationships between distress and psychological processes (negative HSCT 
perceptions and coping).  Days from transplantation showed a linear 
relationship with total distress and depression, a curvilinear relationship with 
anxiety, and no observable pattern with stress. 
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3.4.1.4  Success of randomisation and group comparisons 
Randomisation appeared successful as participants randomised to 
intervention were comparable to those randomised to the control group on 
demographics, clinical variables, baseline distress, negative perceptions of 
HSCT, coping style use, and adaptation (Tables 8 and 9).  Results were 
comparable for intervention attendees versus nonattendees except that 
attendees were from the same site and more likely to be ambulatory 
(ambulatory treatment was only available at that site), χ2(1)=5.10, P=0.02. 
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Table 8 
Demographic and clinical characteristics of participants and groups as 
randomised 
Characteristics Intervention (n, %) Control (n, %) Test 
Gender: male 12 (57%) 19 (79%) χ2(1)=2.54 
Marital status 
Married/cohabiting 
Single 
Other 
 
15 (71%) 
3 (14%) 
3 (15%) 
 
19 (79%) 
2 (8%) 
3 (13%) 
 
χ2(1)=0.47 
Education 
Mainstream only 
Further 
Higher 
Not known 
 
11 (52%) 
4 (19%) 
2 (10%) 
4 (19%) 
 
8 (33%) 
8 (33%) 
8 (33%) 
 
 
χ2(1)=4.34 
Diagnosis 
Multiple myeloma 
NHL 
Other 
 
11 (52%) 
7 (33%) 
3 (15%) 
 
16 (67%) 
5 (21%) 
3 (12%) 
 
χ2(1)=1.06 
Transplant: 
Autologous 
18 (86%) 22 (92%) χ2(1)=0.40 
Age on transplant 
day (years) 
(Mean, SD) 
54.4 (14.7) 
(Mean, SD) 
63.4 (6.9) 
t(37)=2.32 
Years since 
diagnosis 
2.0 (3.4) 2.8 (3.6) t(43)=0.72 
ECOG 0.47 (0.61) 0.71 (0.59) t(34)=1.16 
Length of admission 
 
Amb (5, 29%) 
7.40 (4.28) 
Nonamb (12, 71%) 
19.4 (3.5) 
Amb (6, 27%) 
9.50 (7.01) 
Nonamb (16, 73%) 
22.3 (6.3) 
χ2(1)=0.02 
ts(9-25)≤1.55 
Note. SD = Standard deviation; ECOG=Performance status on the Eastern 
Cooperative Oncology Group scale; NHL = Non-Hodgkin’s lymphoma; Amb = 
Ambulatory, autologous patients initially attending day ward; Fisher’s exact test 
replicated χ2 for counts below five; Of participants whose transplants were 
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carried out, only three allogeneic patients (7%, of whom 1 was from the 
intervention group) received reduced intensity conditioning.
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Table 9 
Baseline means and standard deviations (SDs) for outcomes and predictors of 
participants and groups as randomised 
Measure Overall Intervention Control Test 
Distress     
Total distress 9.84(10.93) 7.25(8.72) 6.79(4.84) t(26)=0.01 
Depression 3.84(4.60) 4.92(6.09) 2.86(2.39) F=0.41 
(robust 
MANOVA) 
Anxiety 1.45(2.49) 2.05(3.39) 0.90(1.04)  
Stress 4.55(4.94) 5.79(6.49) 3.43(2.60)  
     
Adaptation 3.75(0.72) 3.93(0.66) 3.96(0.65) t(26)=0.17 
     
Negative HSCT 
perceptions 
35.8(11.1) 34.1(7.06) 31.1(10.8) t(26)=0.86 
Consequences 6.10(2.97) 6.95(2.66) 5.30(3.10) F=0.46 
(robust 
MANOVA) 
Timeline 5.82(2.81) 5.89(2.98) 5.75(2.71)  
Personal control 3.18(2.60) 2.79(1.90) 3.56(3.13)  
Treatment control 8.79(1.98) 8.68(2.36) 8.90(1.59)  
Identity 4.18(2.79) 4.32(2.91) 4.05(2.74)  
Concern 5.13(3.01) 5.32(2.81) 4.95(3.25)  
Understanding 7.44(2.20) 7.26(2.35) 7.60(2.09)  
Emotional impact 3.94(2.61) 4.24(3.06) 3.65(2.13)  
     
Coping     
Self-distraction 2.15(1.73) 1.95(1.68) 2.33(1.80) F=0.40 
(robust 
MANOVA) 
Denial 0.55(1.24) 0.84(1.61) 0.29(0.72)  
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Behavioural 
disengagement 
0.30(0.82) 0.32(1.00) 0.29(0.64)  
Venting 0.75(1.26) 1.05(1.54) 0.48(0.87)  
Self-blame 0.88(1.38) 1.26(1.73) 0.52(0.87)  
Active coping 1.63(1.53) 1.53(1.43) 1.71(1.65)  
Emotional 
support 
3.73(1.74) 3.53(1.93) 3.90(1.58)  
Instrumental 
support 
2.20(1.88) 2.11(2.05) 2.29(1.76)  
Positive reframing 1.83(1.52) 2.05(1.65) 1.62(1.40)  
Planning 1.83(1.99) 1.89(2.18) 1.76(1.84)  
Humour 2.40(2.11) 2.47(2.22) 2.33(2.06)  
Acceptance 4.25(1.84) 4.32(1.83) 4.19(1.89)  
Note. HSCT = Haematopoietic stem cell transplantation; MANOVA = 
Multivariate analysis of variance. 
***P<0.001; **P<0.01; *P<0.05. 
 
3.4.1.5  Effects of time and participant characteristics on distress 
The intercepts-only models highlighted intraclass correlations between 
0.49 and 0.62, with significant variance in intercepts across participants, 
σ0j2≥2.47, χ2(1)≥11.9, P≤0.001.  Such variability across participants justified the 
use of MLM (Twisk, 2006). 
As discussed in the journal paper, there was a significant main effect of 
time on total distress, anxiety, and depression.  There were also significant 
random effects (variability in intercepts and slopes across participants) for 
depression, anxiety, and stress.  For depression, there was significant variance 
in intercepts but not slopes across participants, σ0j2=11.9, χ2(1)=13.0, P<0.001, 
and, σ1j2=7.83, χ2(1)=3.39, P=0.07.  Slopes and intercepts did not covary 
significantly with the intercepts, σ01j2=5.25, χ2(1)=3.14, P=0.08.  For anxiety, 
there was significant variance in intercepts and slopes across participants, 
σ0j2=4.06, χ2(1)=15.3, P<0.001, and, σ1j2=2.09, χ2(1)=4.44, P=0.04, 
respectively.  The slope-intercept covariance was not associated with a 
significant improvement and was not retained for parsimony.  For stress, the 
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effect of time on depression showed significant variance in intercepts and 
slopes across participants, σ0j2=21.0, χ2(1)=15.9, P<0.001, and, σ1j2=9.69, 
χ2(1)=4.65, P=0.03.  The slopes also covaried significantly with the intercepts, 
σ01j2=-12.5, χ2(1)=9.71, P=0.002.  Days from baseline confirmed the results 
regarding the effect of time: stress was stable and total distress, anxiety, and 
depression increased from baseline (Table 10). 
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Table 10 
Summary of final multilevel model results for distress scores with days from transplantation and participant characteristics as 
predictors 
Predictor Total distress Depression Anxiety Stress 
 Δχ2 R12 β(SE) Δχ2 R12 β(SE) Δχ2 R12 β(SE) Δχ2 R12 β(SE) 
Days 12.2*** 4% 0.08(0.02)*** 17.2*** 8% 0.05(0.01)*** 4.6* 2% 0.013(0.006)* 2.64 1% 0.020(0.012) 
Age 4.58* 7% 0.18(0.08)* 
 
5.19* 10% 0.08(0.04)* 
 
1.3 3% 0.02(0.02) 0.45 2% 0.03(0.04) 
Gender 4.82* 6% -6.38(2.88)* 10.7** 13% -3.73(1.08)** 12.4*** 15% -2.20(0.58)*** 4.4* nil -2.49(1.14)* 
Marital 
status 
2.40 
(Δdf=4) 
4% -9.65(6.54) to 
-3.39(6.62) 
2.00 
(Δdf=4) 
2% -3.54(2.67) to 
-1.63(1.82) 
3.40 
(Δdf=4) 
4% -2.21(1.49) to 
-0.61(1.46) 
3.88 
(Δdf=4) 
6% -3.89(2.48) to 
-2.07(2.49) 
Education 1.03 
(Δdf=2) 
nil 1.69(2.33) 
-1.08(3.22) 
0.91 
(Δdf=2) 
nil -0.13(11.5) 
0.48(1.37) 
0.61 
(Δdf=2) 
nil 0.38(0.45) 
-0.14(1.11) 
4.82 
(Δdf=2) 
1% 0.63(1.60) 
-1.11(1.30) 
Diagnosis 0.30 
(Δdf=2) 
nil 3.56(3.32) 
3.94(5.18) 
2.72 
(Δdf=2) 
2% 1.62(1.44) 
2.35(2.22) 
0.48 
(Δdf=2) 
nil 0.77(0.83) 
1.04(1.12) 
5.51 
(Δdf=2) 
nil 1.95(1.15) 
-0.28(3.85) 
Years since 
diagnosis 
2.35 4% -0.60(0.39) 2.35 4% -0.24(0.16) 0.71 2% -0.08(0.09) 2.36 4% -0.23(0.15) 
Transplant 1.00 2% -4.35(4.31) 0.40 1% -1.14(1.76) 0.76 2% -0.89(1.00) 1.82 3% -2.26(1.65) 
Conditioning 2.88 5% 6.33(3.66) 2.10 3% 2.20(1.49) 1.77 4% 0.85(0.62) 3.64 6% 3.53(1.82) 
ECOG 4.99* 12% 6.19(2.38)** 3.59 7% 1.74(0.88) 10.55** 26% 1.35(0.39)** 5.78* 8% 2.68(1.09)* 
Site 0.22 nil 1.31(2.76) 0.22 nil -0.55(1.12) nil nil 0.02(0.64) 0.94 nil 1.02(1.04) 
Ambulatory 2.49 4% 3.58(2.23) 1.14 2% 1.00(0.92) 0.72 1% 0.33(0.38) 1.00 3% 1.13(1.12) 
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Length of 
admission 
0.35 1% -0.08(0.14) 0.30 nil -0.03(0.06) 0.04 nil 0.01(0.02) 1.04 1% -0.07(0.07) 
Note.  Δχ2 = -2log Likelihood change compared to baseline (time as categorical predictor), Δdf = 1 unless specified otherwise; 
R12 = Variance explained compared to baseline; β = Fixed parameter estimate; SE = Standard error; ECOG = Performance 
status on the Eastern Cooperative Oncology Group scale. 
***P<0.001; **P<0.01; *P<0.05. 
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3.4.2  Efficacy 
The analysis did not reveal a significant main effect of group or group x 
time interaction for either set of comparisons (participants randomised to 
intervention versus control and participants who attended the group versus 
those who did not, Table 11 and Table 12).  Whilst the intervention group 
showed significantly less depression on the day of the transplant (time point 2) 
compared to baseline, the overall model improvement was not significant. 
Power analysis used the parameter estimates from the acute phase only 
(time points 2-4, Table 13).  The probability of nonresponse during this period 
was 0.13.  Results indicated that sample sizes of 105, 70, over 1000, and 145 
(for total distress, depression, anxiety, and stress, respectively) would be 
required to detect a significant main effect of group between participants 
randomised to intervention versus control. 
Of the three intervention attendees who received transplants, no 
individual demonstrated change in distress that was significantly different to the 
control group after Bonferroni correction (Table 14).  Distress decreased during 
the acute phase for two patients and increased for the third participant.  
However, the latter also had poorer performance status which was found to 
contribute to distress in the covariates analysis.
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Table 11 
Fixed parameter estimates and standard errors for the main effects of time, randomisation, and their 
interaction in relation to distress using multilevel modelling 
Measure Δχ2 R12 β(SE) 
   T2 T3 T4 Randomisation Randomisation x Time 
       T2 T3 T4 
Total distress 3.48 nil 0.02 
(0.37) 
3.72* 
(1.50) 
2.72 
(1.53) 
2.15 
(2.18) 
   
 8.21 nil 2.19 
(2.11) 
4.35* 
(1.94) 
5.00* 
(2.11) 
4.65 
(3.17) 
-4.60 
(2.82) 
-1.39 
(2.80) 
-4.77 
(2.95) 
Depression 0.43 <0 -0.85 
(0.71) 
1.58** 
(0.51) 
3.51** 
(0.84) 
0.92 
(1.22) 
   
 9.14 3% 0.39 
(0.73) 
1.63* 
(0.78) 
3.11** 
(1.06) 
1.61 
(1.28) 
-2.72* 
(1.18) 
-0.13 
(2.14) 
-2.00 
(1.61) 
Anxiety 3.10 1% 0.45 
(0.30) 
1.52*** 
(0.38) 
0.15 
(0.29) 
1.13 
(0.65) 
   
 4.82 5% 0.41 
(0.30) 
1.56** 
(0.49) 
0.14 
(0.26) 
1.12 
(0.63) 
0.10 
(0.62) 
-0.15 
(0.50) 
0.001 
(0.004) 
Stress -0.61 <0 -0.03 
(0.33) 
0.63 
(0.63) 
0.69 
(0.68) 
-0.11 
(1.24) 
   
 2.63 2% 1.15 0.94 1.54 1.97 -2.55 -0.68 -1.83 
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(1.04) (0.85) (1.00) (1.65) (1.47) (1.31) (1.43) 
Note. T2-4=Time points 2-4; Δχ2 = -2log Likelihood change compared to baseline, Δdf = 1 for 
Randomisation and 4 when the interaction was included; R12 = Variance explained compared to 
baseline or previously improved model; β = fixed parameter estimate; Shading = Model improved with 
predictor set random at Level 2.  
***P<0.001; **P<0.01; *P<0.05. 
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Table 12 
Fixed parameter estimates and standard errors of main effects of time, actual group attendance, 
and their interaction in relation to distress using multilevel modelling 
Measure Δχ2 R12    β(SE) 
   T2 T3 T4 Attendance Attendance x Time 
       T2 T3 T4 
Total distress 3.19 
 
5% 
 
0.06 
(1.37) 
3.73** 
(1.39) 
1.74 
(1.43) 
7.81 
(4.32) 
   
 3.58 6% 0.23 
(1.43) 
3.90** 
(1.46) 
3.03* 
(1.51) 
8.93 
(4.73) 
-1.81 
(4.75) 
-1.81 
(4.76) 
-2.94 
(4.78) 
Depression 3.01 5% -0.79 
(0.57 
1.63** 
(0.58) 
2.18** 
(0.66) 
3.09 
(1.76) 
   
 3.79 6% -0.64 
(0.60) 
1.70** 
(0.61) 
2.22** 
(0.82) 
3.69 
(1.93) 
-1.72 
(1.98) 
-0.72 
(1.98) 
-0.46 
(2.64) 
Anxiety 1.08 2% 0.48 
(0.28) 
1.51*** 
(0.37) 
0.16 
(0.29) 
1.37 
(1.02) 
   
 1.70 3% 0.51 
(0.29) 
1.78*** 
(0.37) 
-0.71 
(1.29) 
1.62 
(1.08) 
-0.31 
(0.96) 
-0.71 
(1.29) 
-0.70 
(1.00) 
Stress 3.69 4% 0.02 
(0.76) 
0.65 
(0.63) 
0.68 
(0.65) 
3.39 
(1.74) 
   
 3.77 4% 0.04 0.67 0.74 3.52 -0.15 -0.19 -0.59 
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(0.80) (0.66) (0.69) (2.42) (2.52) (2.16) (2.16) 
Note. T2-4 = Time points 2-4; Δχ2 = -2log Likelihood change compared to baseline, Δdf = 1 for 
Attendance and 4 when the interaction was included; R12 = Variance explained compared to 
baseline or previously improved model; β = fixed parameter estimate; Shading = Model 
improved with predictor set random at Level 2.  
***P<0.001; **P<0.01; *P<0.05. 
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Table 13 
Parameter estimates used in power analysis 
Parameter Total distress Depression Anxiety Stress 
β -2.66 -1.65 0.19 -1.14 
σ0j2 30.3 6.50 1.33 8.81 
σ0ij2 38.9 10.3 2.48 9.41 
Note. β = fixed parameter estimate of the difference from the control group; σ0j2 
= Level 2 variance; σ0ij2 = residual variance. 
 
Table 14 
Results of single case analysis examining whether change in distress 
during the acute phase of HSCT was different in participants who 
attended the intervention attendees relative to those who did not 
Case β(SE) χ2(1) P 
1 -5.75(4.85) 1.40 0.24 
2 10.46(4.75) 4.85 0.03 
3 -5.17(5.04) 1.06 0.30 
Note. β = fixed parameter estimate of the difference from the control 
group; SE = standard error. 
 
3.4.3 Psychological processes 
3.4.3.1 HSCT perceptions and coping 
As discussed in the journal paper, overall negative HSCT perceptions 
and use of self-distraction, active coping, emotional and instrumental support, 
humour, and positive reframing increased during the acute phase of HSCT.  
The fixed parameter estimates are shown in Table 15.  Random effects models 
did not result in further improvements. 
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Table 15 
Model improvements and fixed parameter estimates with time as categorical 
predictor of HSCT perceptions and coping using multilevel modelling 
Measure Δχ2 R12 β(SE) 
   T2 T3 T4 
Negative HSCT 
perceptions 
31.4*** 2% -0.19(1.15) 8.12*** 
(1.69) 
5.14** 
(1.83) 
Consequences 6.61 nil 29.6(18.5) 30.9(17.6) 31.4(18.6) 
Timeline 2.52 1% 28.0(18.43) 29.8(19.5) 31.6(21.4) 
Personal control 3.34 1% 29.3(19.6) 29.5(20.0) 31.8(20.5) 
Treatment 
control 
3.30 1% 29.4(19.5) 29.6(19.9) 30.6(20.5) 
Symptom identity 3.80 1% 29.1(19.5) 33.5(19.9) 33.9(20.5) 
Concern 3.37 1% 29.3(19.6) 30.9(20.0) 31.0(20.5) 
Understanding 3.42 1% 29.8(19.5) 30.2(19.9) 31.7(20.5) 
Emotional impact 3.41 1% 29.1(19.5) 30.5(19.9) 31.9(20.5) 
      
Coping      
Self-distraction 8.42** 3% 0.79** 
(0.29) 
0.61* 
(0.31) 
0.70* 
(0.30) 
Denial 2.14 4% -0.18(0.14) -0.17(0.14) -0.14(0.15) 
Behavioural 
disengagement 
4.31 2% -0.18(0.14) -0.04(0.14) 0.12(0.14) 
Venting 2.23 nil 0.15(0.24) 0.26(0.25) 0.36(0.25) 
Self-blame 4.96 4% -0.02(0.20) -0.30(0.20) -0.37(0.21) 
Active coping 8.69** 3% 0.71* 
(0.31) 
0.63* 
(0.31) 
0.90** 
(0.32) 
Emotional 
support 
23.9*** 10% 1.26*** 
(0.28) 
1.24*** 
(0.29) 
1.11*** 
(0.30) 
Instrumental 
support 
18.2*** 1% 1.21*** 
(0.30) 
1.11*** 
(0.30) 
1.02** 
(0.31) 
Positive 
reframing 
23.8*** 6% 1.45*** 
(0.31) 
1.11*** 
(0.30) 
0.60 
(0.33) 
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Planning 1.75 nil 0.29(0.32) 0.38(0.32) 0.38(0.33) 
Humour 11.0* 1% 0.77** 
(0.28) 
0.18(0.28) -0.13(0.30) 
Acceptance 7.48 5% 0.41(0.29) 0.83** 
(0.30) 
0.44(0.31) 
Note. Δχ2 = -2log Likelihood change compared to baseline, Δdf = 3; R12 = 
Variance explained compared to baseline or previously improved model; β = 
fixed parameter estimate; SE = standard error; T2-T4 = Time points 2-4. 
***P<0.001; **P<0.01; *P<0.05. 
 
HSCT perceptions and several coping styles predicted distress.  Setting 
these as random predictors improved the models in several instances.  The 
slopes varied significantly and often covaried with intercepts across participants 
(Table 16). 
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Table 16 
Variance and standard errors of intercepts (σ0j2), slopes (σ1j2), and intercept-slope covariance (σ01j2) for random effects models 
with distress as dependent variables and HSCT perceptions and coping as predictors 
Scale Total distress Depression Anxiety Stress 
 σ0j2 σ1j2 σ01j2 σ0j2 σ1j2 σ01j2 σ0j2 σ1j2 σ01j2 σ0j2 σ1j2 σ01j2 
Negative HSCT 
perceptions 
43.6** 
(12.8) 
0.08 
(0.04) 
1.27* 
(0.61) 
8.19** 
(2.65) 
0.01 
(0.01) 
0.27 
(0.16) 
1.29** 
(0.49) 
0.008* 
(0.004) 
0.09* 
(0.04) 
10.38*** 
(2.92) 
0.02 
(0.01) 
0.28 
(0.15) 
Consequences 428.8 
(245.4) 
0.34 
(0.41) 
12.4 
(10.0) 
10.6*** 
(2.94) 
nc nc 2.44** 
(0.73) 
nc nc 148.1 
(93.4) 
0.17 
(0.13) 
4.97 
(3.44) 
Timeline 1867.9* 
(947.2) 
3.79 
(2.01) 
83.4 
(43.4) 
254.3 
(180.6) 
0.45 
(0.35) 
10.5 
(7.88) 
126.0** 
(45.4) 
0.27** 
(0.10) 
5.82** 
(2.13) 
324.1 
(170.9) 
0.62 
(0.35) 
13.90 
(7.63) 
Personal 
control 
64.3*** 
(17.0) 
ns ns 10.4*** 
(2.95) 
nc nc 117.6** 
(42.3) 
0.27** 
(0.10) 
5.59** 
(2.01) 
13.03*** 
(3.47) 
ns ns 
Treatment 
control 
64.9*** 
(18.3) 
ns ns 10.4*** 
(2.95) 
ns ns 2.52** 
(0.73) 
nc nc 13.15*** 
(3.49) 
ns ns 
Identity 868.8** 
(360.6) 
1.32* 
(0.64) 
33.2* 
(15.0) 
11.9*** 
(3.17) 
ns ns 37.8 
(20.4) 
0.06 
(0.04) 
1.45 
(0.86) 
208.0* 
(86.8) 
0.34* 
(0.16) 
8.25* 
(3.70) 
Concern 1058.0** 
(384.5) 
1.73* 
(0.71) 
42.8* 
(16.5) 
191.2* 
(80.7) 
0.30* 
(0.15) 
7.53* 
(3.50) 
49.9* 
(21.0) 
0.09* 
(0.04) 
2.09* 
(0.94) 
248.2 
(130.5) 
0.41 
(0.24) 
10.01 
(5.55) 
Understanding 1940.1 
(1149.0 
5.09 
(2.92) 
98.6 
(57.7) 
9.26** 
(2.84) 
ns ns 123.8 
(70.3) 
0.35 
(0.19) 
6.56 
(3.60) 
12.47*** 
(3.50) 
nc nc 
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Emotional 
impact 
426.3 
(261.0) 
0.57 
(0.52) 
15.7 
(11.6) 
4.75** 
(1.77) 
nc nc 43.9 
(24.3) 
0.08 
(0.05) 
1.88 
(1.09) 
6.41** 
(2.02) 
nc nc 
             
Coping             
Self-distraction 57.2*** 
(15.2) 
ns ns 9.77*** 
(2.81) 
ns ns 2.44** 
(0.71) 
ns ns 11.48** 
(3.33) 
ns ns 
Denial 30.1** 
(11.2) 
8.29 
(6.59) 
-5.60 
(6.66) 
4.44** 
(1.70) 
ns ns 1.05* 
(0.49) 
0.56 
(0.62) 
0.38 
(0.78) 
9.63** 
(2.98) 
ns ns 
Behavioural 
disengagement 
36.2*** 
(11.0) 
13.2 
(11.4) 
exc 5.47** 
(1.97) 
2.95 
(2.64) 
exc 1.13* 
(0.53) 
1.10 
(0.93) 
0.22 
(1.00) 
11.87*** 
(3.22) 
ns ns 
Venting 46.5*** 
(12.7) 
7.02 
(4.31) 
-0.22 
(1.98)) 
13.4*** 
(3.73) 
1.47 
(0.90) 
-2.03 
(1.40) 
1.80** 
(0.56) 
ns ns 8.35** 
(2.48) 
1.34 
(0.84) 
ns 
Self-blame 24.9* 
(9.86) 
14.3 
(7.73) 
4.89 
(6.81) 
6.16* 
(2.49) 
2.10 
(1.45) 
1.08 
(1.86) 
0.77 
(0.45) 
0.83 
(0.53) 
0.52 
(0.42) 
7.78** 
(2.44) 
ns 1.71 
(1.27) 
Active coping 58.4*** 
(15.3) 
ns ns 9.90*** 
(2.83) 
ns ns 2.48** 
(0.72) 
ns ns 11.75*** 
(3.20) 
ns ns 
Emotional 
support 
59.6*** 
(16.7) 
ns ns 9.56** 
(2.93) 
ns ns 2.50** 
(0.73) 
ns ns 12.57*** 
(3.47) 
ns ns 
Instrumental 
support 
48.4*** 
(13.1) 
nc nc 8.48** 
(2.75) 
nc nc 2.55** 
(0.76) 
ns ns 10.15** 
(2.93) 
ns ns 
Positive 
reframing 
60.3*** 
(15.7) 
ns ns 10.4*** 
(2.90) 
ns ns 2.41** 
(0.70) 
ns ns 12.21*** 
(3.28) 
ns ns 
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Planning 49.5*** 
(13.8) 
ns ns 9.53** 
(2.84) 
ns ns 2.16** 
(0.65) 
ns ns 5.59* 
(2.31) 
1.09* 
(0.53) 
0.53 
(0.62) 
Humour 62.4*** 
(16.2) 
ns ns 10.9*** 
(3.02) 
ns ns 1.40* 
(0.65) 
0.29 
(0.16) 
0.43 
(0.23) 
13.17*** 
(3.48) 
ns ns 
Acceptance 63.0*** 
(16.3) 
ns ns 10.4*** 
(2.94) 
ns ns 2.49** 
(0.72) 
ns ns 13.21*** 
(3.51) 
ns ns 
Note. ns = No significant improvement by including random parameter; nc = no convergence; exc = Term excluded when 
model fit did not deteriorate significantly without bootstrapping in order to achieve convergence during bootstrapping. 
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3.4.3.2 Adaptation to HSCT 
Higher reported adaptation to HSCT was significantly associated with 
lower distress (Table 17). 
 
Table 17 
Model improvements, fixed, and random parameter estimates with adaptation to 
HSCT as predictor of distress 
Measure Δχ2 R12 β(SE) σ0j2 σ1j2 σ01j2 
Total distress 68.2*** 36% -4.99*** 
(0.75) 
42.6*** 
(11.1) 
6.33 
(4.51) 
-15.1** 
(5.68) 
Depression 95.6*** 45% -2.73*** 
(0.36) 
6.79*** 
(1.86) 
1.98 
(1.09) 
-3.02** 
(1.13) 
Anxiety 11.9*** 11% -0.66*** 
(0.19) 
2.01** 
(0.61) 
ns ns 
Stress 32.4*** 20% -1.61*** 
(0.38) 
10.99*** 
(2.92) 
0.96 
(1.07) 
-3.19* 
(1.40) 
Note. Δχ2 = -2log Likelihood change compared to the baseline model, Δdf = 1 
for fixed predictors and 3 for random; R12 = Variance explained compared to the 
intercepts-only model; β = Fixed parameter estimate; SE = Standard error; 
Shading = Model improved with predictor set random at Level 2; σ0j2 = intercept 
variance; σ1j2 = slope variance; σ01j2 = intercept-slope covariance; ns = No 
significant improvement by including random parameters. 
***P<0.001; **P<0.01; *P<0.05. 
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3.5  EXTENDED DISCUSSION 
 
HSCT is an intensive procedure posing considerable challenges for 
patients particularly during the acute phase.  As a result, it has been associated 
with distress potentially affecting physical wellbeing and recovery.  There is a 
need for robust research in psychological intervention, further understanding 
into underlying psychological processes underpinning distress, and a careful 
assessment of feasibility issues particularly in relation to preparing patients and 
evaluating interventions during the acute phase.  Consequently, the present 
study sought to evaluate the feasibility of delivering and evaluating a 
psychological intervention aiming to prepare patients for HSCT in an RCT 
design.  It also sought to assess the relevance of the psychological theory used 
to develop the intervention.  Findings indicated considerable feasibility issues 
but were supportive of the theory. 
 
3.5.1  Feasibility 
The results indicated considerable barriers to the evaluation of the 
preparatory psychological intervention.  Several reasons curtailed uptake and 
attendance including insufficient time prior to transplantation, burden in light of 
other priorities (e.g., other appointments), being unwell, travel distance, and so 
forth.  Uptake was slower than studies of inpatient interventions during HSCT 
and cancer (Bauer-Wu et al., 2008; Jarden, Baadsgaard, Hovgaard, Boesen, & 
Adamsen, 2009; Moyer et al., 2009) though more in line with outpatient 
intervention studies, particularly those randomising (DuHamel et al., 2010; 
Goodwin et al., 2000; Lounsberry et al., 2010), highlighting procedural burdens 
and lack of integration with the clinical process (primarily due to the trial setup) 
as possible barriers.  The experience of lower distress prior to HSCT may have 
contributed to lower prioritisation by patients (Moyer et al., 2009).  Time point 3 
may be the optimal endpoint of analysis for anxiety in a full trial and time point 4 
for depression, as these were the time points when each distress subscale was 
highest.  Findings were mixed regarding other feasibility issues regarding the 
research procedure, the intervention, and the assessment used, as discussed 
below. 
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3.5.1.1  Procedure and intervention 
Most aspects of the procedure appeared feasible but the use of 
randomised control appeared to pose a major barrier to conducting the 
research.  Inability to attend the intervention prior to the transplant was a main 
reason both for not consenting to participate and not attending the intervention 
after consent was obtained.  As attendance had not been a problem during the 
earlier pilot of the intervention (prior to this study), the present findings 
highlighted a feasibility issue posed by allocating only 50% of participants to the 
intervention at each site.  It appears that this impacted on accrual of patients for 
the group, which was no longer sufficient to hold the intervention frequently 
enough to allow participants to attend prior to their transplant.  Such effects of 
randomised control are reported in psychooncology more generally (Goodwin et 
al., 2000; Mills et al., 2006) but appear to be completely neglected as a potential 
issue in HSCT feasibility studies, which do not tend to factor in such procedures 
(Bauer-Wu et al., 2008; Bevans et al., 2010; Horton-Deutsch et al., 2007; 
Lounsberry et al., 2010).  The impact on accrual highlights randomised control 
within each site as a potentially major barrier to conducting RCTs of group 
interventions in HSCT alongside already limited uptake in this population. 
The predominance of limited timeframes as reason for not consenting to 
the study and not attending the intervention may have overshadowed 
subsequent feasibility issues with delivering the intervention.  Psychological 
interventions in cancer care including HSCT vary considerably on the level of 
participation they require but limited adherence has been observed across the 
field (Baliousis et al., in press; Moyer et al., 2009; Newell, Sanson-Fisher, & 
Savolainen, 2002).  For example, participants have been found to neglect self-
help materials or even show resistance to engage with interventions 
(Cunningham et al., 1998; Cunningham et al., 2000; Edgar, Rosberger, & 
Collet, 2001; Trask et al., 2003).  Had available timeframes in the present study 
provided participants with the opportunity to attend the intervention prior to the 
transplant, such factors may have emerged in this project also. 
Other aspects of the procedure, such as the process of randomising 
participants, allocation concealment, assessor blinding, and collecting data over 
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the telephone during the acute phase of HSCT appeared feasible.  Attrition was 
in line with HSCT studies using remote data collection but higher compared to 
those collecting data on site (DuHamel et al., 2010; Lee et al., 2005; Prieto, 
Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 2005).  Reasons for attrition 
were not known (except in one case where the participant died) but may reflect 
some of the reasons leading to delays in data collection (e.g., feeling unwell and 
unavailability due to other commitments).  It is possible that direct rather than 
telephone contact might enable outcome assessors to assist participant with 
completing the questionnaires and foster rapport and engagement.  This 
approach may partly circumvent reasons for attrition but may increase the 
chance of deblinding the outcome assessor. 
Participant blinding was more difficult to achieve.  This was because 
information about the intervention was disclosed inadvertently in the course of 
recruitment and suggests that participant blinding may not be possible in a full 
trial.  Recruiters may have to be more mindful of deblinding potential 
participants this way.  However, the difficulties with participant blinding for 
interventions whose nature is not concealed (Schulz & Grimes, 2002a), means 
that it may not be an essential part of the design or technically possible. 
The primary outcome was total distress with the subscales of depression, 
anxiety, and stress.  The estimated required sample size of up to 145 
participants to detect an intervention effect for distress, depression, and stress 
may be feasible.  However, the required sample size for an effect on anxiety 
exceeded 1000 participants and did not appear feasible.  However, these 
estimations may be inaccurate in light of limited attendance to the intervention 
and mixed findings of efficacy when single-case data were examined. 
Overall, findings on the feasibility of the procedure and the intervention 
indicated that barriers to delivering the intervention were compounded by those 
of the RCT design suggesting that such a mode and timing of intervention may 
be very difficult to evaluate using randomised control within each site.  The 
impact of RCT procedures has been neglected in other feasibility studies in 
HSCT (Bauer-Wu et al., 2008; Lounsberry et al., 2010) but are important in 
informing research towards more robust evidence base. 
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3.5.1.2  Assessments 
Findings were mixed regarding the appropriateness of the assessments 
used in the study.  The DASS-21 total distress, depression and stress 
subscales appear applicable to HSCT.  However, two items of the anxiety 
subscale appear confounded by physical symptoms of the procedure and 
reliability coefficients for this subscale decreased over time as physical 
symptoms increased (Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 
2005).  Other anxiety scales (e.g., Hospital Anxiety and Depression Scale) have 
better reliability in HSCT (Gaston-Johansson et al., 2013; Jarden et al., 2009; 
Lee et al., 2005; Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 2005; 
Tecchio et al., 2013; Trask et al., 2003) but they have also shown considerably 
stronger positive correlations and more overlap with the DASS stress rather 
than anxiety subscale (Antony et al., 1998; Crawford & Henry, 2003).  It follows 
that the construct measured by the anxiety subscale of the DASS-21 appears 
be more difficult to assess in HSCT due to confounding with physical 
symptomatology.  In light of the infeasibility of accruing a required sample size 
in excess of 1000 participants to detect an intervention effect on anxiety (as 
measured by the DASS-21), it seems reasonable to exclude this subscale from 
the full trial altogether. 
  The adapted Brief IPQ showed acceptable internal consistency.  
However, the coping appraisal items (personal and care control) may be less 
applicable to HSCT or may not capture the relevant theoretical processes of the 
self-regulatory model adequately (Leventhal et al., 1997; Leventhal et al., 1984; 
Ogden, 2012; Sharpe & Curran, 2006) as they reduced the reliability of the 
scale.  The care control item (“How much do you think the care you receive can 
help you through the transplant process?”) appears particularly problematic.  
The issue with this item may have arisen due to social desirability as the 
question was asked by the researcher who worked with members of the care 
team and participants could have interpreted the item in terms of rating 
satisfaction with care.  It is also possible that the item led participants to focus 
on nursing than overall care (including medication, etc.).  To bring the item more 
in line with the self-regulatory model in rating the ability of the treatment as well 
as care to help control the HSCT process, an adjustment to the item’s wording 
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may be helpful, for example “How much do you think the care and treatments 
you receive can help you through the transplant process?”. 
Low reliability coefficients were observed in coping styles acceptance, 
positive reframing, behavioural disengagement, denial, self-blame, self-
distraction, and venting.  Such coefficients are often expected with small scales 
and have been common in coping research (de Ridder, 1997; Field, 2013; 
Folkman & Moskowitz, 2004) but the findings suggest potentially limited 
applicability of the above items to HSCT.  However, previous research in HSCT 
using a priori coping categories (emotion-focussed, problem-focussed, and 
avoidance coping) that contain more items also reported very modest reliability 
coefficients (Schoulte et al., 2011), which suggests a broader problem with 
coping assessment in HSCT.  It follows that improving reliability of 
measurement, for example by deriving higher-order coping categories in a 
bottom up manner (e.g., factor analysis with a sufficiently large sample) that 
reflect the context of HSCT, may be helpful in improving the reliability of 
assessment (de Ridder, 1997) and, therefore, analysis in a full trial. 
The BRS was adapted from a trait measure (B. W. Smith et al., 2008) to 
assess the degree of adaptation to HSCT over one week.  It showed 
comparable reliability to the original version (B. W. Smith et al., 2008) except at 
time point 2 where internal consistency appeared modest.  Measurement at this 
time point was on or soon after Day 0 (the beginning of the acute phase of 
HSCT) and some participants found the questions about bouncing back from 
the transplant process ambiguous in this context.  The ambiguity may have 
resulted in mixed ratings and, therefore, the lower internal consistency of the 
scale at that time point.  Consequently, it may be beneficial to clarify the 
transplant process as including the preparatory pretransplant period and to 
refine the wording of the items so that it captures participants’ experience over 
the preceding week better.  For example, “so far, I have been bouncing back 
quickly since this hard time began” could be adapted as “I have been bouncing 
back quickly from this hard time over the past week.” 
 
In sum, findings indicate considerable barriers to conducting an RCT 
during the acute phase of the procedure, to the extent that such an approach 
may not be suitable to evaluate preparatory group interventions in HSCT.  
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However, results also suggest feasibility in some procedures (e.g., data 
collection).  Measures appear mostly suitable but some adjustments may be 
required for the full trial.  There are some limitations to the reliability of coping 
appraisal items in the Brief IPQ, coping subscales of the Brief COPE, and the 
anxiety subscale of the DASS-21.  The DASS-21 anxiety subscale could be 
omitted from the full trial whilst refining some items and deriving higher order 
coping categories may be helpful. 
 
3.5.2  Psychological processes  
The present findings suggest that diverse negative perceptions of HSCT 
and apparent ineffectiveness of coping may explain distress during the acute 
phase of the procedure.  Whilst these may reflect wider processes and causal 
pathways are yet to be firmly established, they highlight the potentially unique 
contribution of HSCT perceptions and coping to the development and 
maintenance of distress in this population, with implications for further 
development of the intervention. 
 
3.5.2.1  Perceptions of HSCT 
Patients reporting more emotional distress appeared to perceive HSCT 
as a prolonged and poorly understood process with severe physical, social, and 
emotional impact on their lives, many side effects, and a cause for concern.  
Overall perceptions of HSCT became more negative as the procedure 
progressed (reflecting the increase in distress) but the change in individual 
subscales did not reach significance.  The diversity of relevant perceptions and 
the findings of an overall rather than subscale increase over time suggest that 
the negative HSCT perceptions and their effect on distress may be cumulative. 
The intensity and complications of HSCT and the disruption they cause 
to patients’ lives appears to reflect the complex pattern of negative perceptions.  
Admission to hospital for HSCT and isolation to prevent infections result in loss 
in many life domains such as social contact, employment (most participants 
function well physically and are often employed prior to transplantation), and 
leisure (Antin & Raley, 2013; Copelan, 2006).  The consequences of the 
physical complications of the procedure (e.g., pain, fatigue) are diverse 
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including physical suffering and disability, inability for self-care and engaging 
with valued-activities, sexual dysfunction, relationship conflict, and so forth, 
particularly in the earlier stages of the procedure (Jim et al., 2014; Mosher et al., 
2009).  Furthermore, these sequelae are often unexpected as patients differ in 
their reactions to HSCT and the course of recovery whilst pretransplant 
information frequently fails to prepare patients adequately (Anderson et al., 
2007; Copelan, 2006; Jim et al., 2014; Larsen et al., 2004; Lee et al., 2005; 
Mosher et al., 2009; Prieto, Atala, Blanch, Carreras, Rovira, Cirera, & Gastó, 
2005; Xuereb & Dunlop, 2003).  Focus on the breadth of complications, their 
impact, and lack of suitable preparation are likely to contribute to negative 
perceptions of the procedure in terms of consequences, defining symptoms, 
length and degree of recovery, and comprehensibility (e.g, Jim et al., 2014). 
All subscales of the Brief IPQ (except coping appraisals) were highly 
correlated with depression, less so with anxiety, and fewer subscales were 
associated with stress.  Initially, negative perceptions may reflect a sense of 
threat to wellbeing as the severe negative sequelae of HSCT emerge resulting 
in the fearful anxiety response observed in the present study (see Rachman, 
2013 for discussion on perceptions and appraisals associated with anxiety).  
This appeared relatively short-lived, which may explain the smaller associations 
between perceptions and anxiety.  Compounded and persistent losses and 
suffering over time is likely to result in increasing hopelessness and the 
depression that was observed both in the present project and other studies in 
HSCT (Fife et al., 2000; Hjermstad et al., 1999; Lee et al., 2005; Prieto, Atala, 
Blanch, Carreras, Rovira, Cirera, & Gastó, 2005).  The pervasiveness of 
negative perceptions associated with depression in the present study are 
consistent with literature suggesting a ubiquitous pattern of negative beliefs 
underpinning this emotional response (Blackburn, James, & Flitcroft, 2006).  
Finally, perceiving negative consequences (including emotional ones), cause for 
concern, and a lengthy recovery appear to characterise stress.  This suggests a 
sense of sustained challenge during HSCT and supports the conceptualisation 
of the DASS-21 stress subscale as tension and worry in the context of ongoing 
demands, as opposed to the fearful anxiety response measured by the anxiety 
subscale (Lovibond, 1998). 
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Notwithstanding the issues with coping appraisals, the present findings 
highlight the relevance of negative HSCT perceptions in explaining distress but 
these could reflect a broader appraisal style.  For example, perceiving the 
procedure more negatively may reflect a broader cognitive bias or schema 
about the world, self, and others based on early experiences (Beck & Haigh, 
2014; Padesky, 1994).  Negative perceptions may also reflect insecure 
attachment models that render the person more susceptible to environmental 
stressors and loss, with limited skills to cope and regulate emotions (Brethreton 
& Munholland, 2008; Dykas & Cassidy, 2011).  A dominant professional 
discourse about HSCT emphasising challenges over resilience and hope once 
the procedure is underway (Copelan, 2006; Xuereb & Dunlop, 2003) may also 
influence patients’ focus on negative outcomes and difficulties.  Attending to 
negative HSCT perceptions in psychological intervention may be useful in 
alleviating distress but the above considerations suggest potential benefits in 
targeting broader appraisal styles and mechanisms in order to be more 
effective. 
In spite of the overall robust findings regarding HSCT perceptions, there 
is a need for cautious interpretation regarding their mediating role in maintaining 
distress.  As discussed in the extended background (Section 4.3.3), the self-
regulatory model assumes primacy of cognition over emotion (Leventhal et al., 
1997; Leventhal et al., 1984; Ogden, 2012; Sharpe & Curran, 2006) but 
contemporary theoretical literature suggests they are likely to influence each 
other (Barnard, Duke, Byrne, & Davidson, 2007; Duncan & Barrett, 2007; 
Gazzaniga, 1998; Ochsner & Gross, 2005; Phelps & LeDoux, 2005; Salzman & 
Fusi, 2010; Storbeck & Clore, 2007).  The extent and precise mechanism of the 
relationship between perceptions and distress in HSCT remains unclear in light 
of the correlational nature of the present study. 
 
3.5.2.2  Coping 
The present findings provided some support for the role of unhelpful 
coping in underpinning distress, as predicted by the self-regulatory model 
though some patterns deviated from what was expected.  Avoidance-based and 
what are broadly considered unhelpful coping styles such as self-distraction, 
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denial, disengagement, venting, and self-blame (Carver et al., 1993; Stanton, 
Danoff-Burg, & Huggins, 2002; Taylor & Stanton, 2007), were associated with 
higher distress in the present study, with similar reports in other literature 
including HSCT (Folkman & Moskowitz, 2004; Mytko et al., 1996; Ogden, 2012; 
Schoulte et al., 2011; Taylor & Stanton, 2007).  In contrast, approach-based 
coping, such as planning and seeking instrumental and emotional support, are 
generally considered helpful styles (Folkman & Moskowitz, 2004; Taylor & 
Stanton, 2007) but the opposite appeared to occur in the present study. 
Avoidance-based coping styles can be helpful with transient stressors 
and the short-term because they can divert attention from distress and its 
causes until both diminish naturally (Folkman & Moskowitz, 2004; Ogden, 2012; 
Taylor & Stanton, 2007).  The acute phase of HSCT is relatively short-term, 
hospitalisation has a relatively clear end at first, and patients may be 
unprepared to cope with complications initially (Anderson et al., 2007; Copelan, 
2006; Jim et al., 2014; Xuereb & Dunlop, 2003).  Consequently, patients may 
rely heavily on avoidance-based coping mechanisms at first but, as 
complications mount rather than diminish, may also persist with using such 
mechanisms (Mah et al., 2008) which could become counterproductive as they 
fail (by definition) to address the situation. 
In contrast, approach-based coping, such as planning and seeking 
instrumental and emotional support, purports to resolve the problem and has 
generally been found to predict lower distress (Folkman & Moskowitz, 2004; 
Taylor & Stanton, 2007).  However, such coping in HSCT and other cancer 
populations with acute or long-term difficulties has not been consistently 
beneficial (Carver et al., 1993; Mytko et al., 1996; Schoulte et al., 2011).  In the 
present study, planning and seeking instrumental and emotional support were 
associated with more distress during HSCT.  This suggests a possible 
interaction with the circumstances of the procedure, as detailed below. 
The effectiveness of approach-based coping (in the solution-focused 
sense) often depends on the availability and appropriateness of social and 
practical resources (Ogden, 2012; Taylor & Stanton, 2007).  HSCT can be very 
challenging, particularly in the first few weeks, with complications and 
consequences (e.g., side effects, fatigue, social isolation) that cannot be 
controlled easily and whose impact often worsens in spite of a range of possible 
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solutions available to patients (e.g., medication, access to activities such as 
physiotherapy, etc.; Antin & Raley, 2013; Copelan, 2006; Jacobsen et al., 
2014).  Furthermore, hospitalisation and physical disability often means that 
HSCT patients lack social support during the procedure and often the support 
they receive is poor match for their needs (Antin & Raley, 2013; Copelan, 2006; 
Schulz-Kindermann et al., 2002; Wells et al., 2009).  Consequently, attempts to 
resolve difficulties during acute HSCT via seeking support may be rendered 
counterproductive.  Planning without sufficient information (as reported by 
patients; Jim et al., 2014) is also unlikely to be effective.  Persisting with the use 
ineffective coping strategies (approach- or avoidance-based) may lead to more 
cognitive focus on the challenges surrounding HSCT, prevent the exploration of 
alternative coping strategies, exacerbate negative perceptions of the procedure, 
and – ultimately – psychological distress (Cheng, Lau, & Chan, 2014; Harris, 
2009; Hulbert-Williams, Storey, & Wilson, 2015). 
The present findings highlight the ineffectiveness of the coping strategies 
in the Brief COPE but other strategies may be more effective.  For example, 
coping via cognitive acceptanceV of and engagement with the distressing 
experience (as in Mindfulness or Acceptance and Commitment Therapy) has 
been found to reduce distress in clinical populations suffering from lack of 
control, prolonged struggle, and a disabling impact on patients’ lives (e.g., 
chronic pain, and other long-term physical conditions; Carlson, Speca, Patel, & 
Goodey, 2004; Hulbert-Williams et al., 2015; Ott, Norris, & Bauer-Wu, 2006).  It 
has also shown promise in HSCT (Bauer-Wu et al., 2008; Horton-Deutsch et al., 
2007).  Such a strategy is different from the approach-based coping styles of 
the present study in being less dependent on the social context and not seeking 
to resolve the challenging situation patients are in.  Instead, it is thought to 
operate via allowing patients to act more in line with what they consider 
important in their life rather than focusing on struggling to resolve a challenging 
situation ineffectively (Hulbert-Williams et al., 2015). 
 
                                            
V Acceptance in the Brief COPE was not related to distress but the style is 
conceptualised as resignation and opposite to denial rather than psychologically 
engaging with the distressing experience (Carver, 1997; Hulbert-Williams et al., 2015). 
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Overall, the present findings highlight the role of negative HSCT 
perceptions and use of some coping strategies in the development and 
maintenance of distress during the acute phase of the procedure.  These 
findings are also in line with research from a range of other clinical populations 
where the self-regulatory model has been applied successfully, such as heart 
failure, epilepsy, and Huntington’s disease (Arran, Craufurd, & Simpson, 2013; 
Bridges & Smith, in press; Hagger & Orbell, 2003; Knibb & Horton, 2008; 
Morgan, Villiers-Tuthill, Barker, & McGee, 2014; Rizou, De Gucht, Papavasiliou, 
& Maes, 2015).  Psychological interventions within HSCT relative to other health 
populations have been unforthcoming (Baliousis et al., in press; Newell et al., 
2002; Nicassio, Meyerowitz, & Kerns, 2004; O'Halloran & Altmaier, 1995; 
Rueda, Sola, Pascual, & Subirana Casacuberta, 2011; Semple et al., 2013), 
perhaps due to an over-focus on the physiological rather than psychological 
predictors of distress.  The present findings provide a promising step towards a 
more nuanced psychological understanding of distress in HSCT that supports 
the rationale for the present intervention and could help guide further 
development of psychological interventions for this population. 
 
3.5.3  Distress and adaptation to HSCT 
The self-regulatory model is concerned with adaptation to illness of which 
psychological distress is one of several possible outcomes (Hagger & Orbell, 
2003; Leventhal et al., 1997; Leventhal et al., 1984; Ogden, 2012; Sharpe & 
Curran, 2006).  As the present project used the model for the first time to 
understand distress in HSCT, some evidence that distress reflected adaptation 
in this population as conceptualised by the self-regulatory model was important 
in supporting such an application of the model. 
The concept of adaption to health-related difficulties as measured by the 
BRS and assumed by the self-regulatory model is multifaceted.  The aspects of 
the concept are diverse, for example psychological distress, depression, 
anxiety, stress, a sense of purpose in life, social functioning, role functioning 
(ability to fulfil one’s role), and so forth (Hagger & Orbell, 2003; Sharpe & 
Curran, 2006; B. W. Smith et al., 2008; B. W. Smith et al., 2013; B. W. Smith et 
al., 2010; Windle et al., 2011).  Relevant variables are highly correlated with 
adaptation as measured by the BRS (B. W. Smith et al., 2008; B. W. Smith et 
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al., 2013; B. W. Smith et al., 2010), as expected by variables that reflect 
aspects of the same construct (Field, 2013).  Such correlations between 
adaptation to HSCT and distress were replicated in the present project and 
suggest that distress is likely to reflect adjustment to the procedure.  This 
supports the secondary hypothesis of the project about the close relationship 
between distress and adaptation and the application of the model to understand 
distress in HSCT. 
The correlations with depression and stress suggest the greatest overlap 
with the concept of adaptation in HSCT.  This indicates that experiencing 
depression and stress during the procedure may reflect limited ability to adapt 
to its circumstances, consistent with the observations of ineffective coping in 
this context.  In contrast, the modest correlation with DASS-21 anxiety suggests 
less overlap with adaptation.  This finding may reflect the nature of the concept 
of DASS-21 anxiety, that is, a fearful response to a threat (Lovibond, 1998; S. 
H. Lovibond & P. F. Lovibond, 1995) likely to precede (or even trigger) the 
process of adaptation (Rachman, 2013) rather than represent a facet of it.  It 
follows that the anxiety subscale of the DASS-21 may be less relevant to the 
self-regulatory model.  This conclusion is also consistent with the smaller 
correlations between DASS-21 anxiety and HSCT perceptions and coping and 
further justifies the rationale for the exclusion of this anxiety subscale from a full 
trial.  However, the smaller correlation between anxiety and adaptation may 
also reflect the possible confounding by physical symptomatology in the former.   
 
3.5.4  Strengths and limitations 
There is a lack of suitably evaluated psychological interventions aiming 
at preparing patients for distress during acute HSCT (Baliousis et al., in press).  
This project makes an empirical contribution to the field through the novel 
application of the self-regulatory model to acute HSCT.  It also extends the 
current literature on distress in the procedure, which is largely focused on 
medical and demographic factors (Ahles, Tope, Furstenberg, Hann, & Mills, 
1996; Fife et al., 2000; Meyers et al., 1994; Prieto, Atala, Blanch, Carreras, 
Rovira, Cirera, & Gastó, 2005; Schulz-Kindermann et al., 2002; Tecchio et al., 
2013).  The project also highlights some of the barriers regarding the feasibility 
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of evaluating and delivering psychological interventions for this population, and 
help to inform future research and intervention in this area.  In addition, the 
study provides preliminary psychometric data relating to two new adaptations of 
the Brief IPQ and BRS scales for HSCT populations. 
 
3.5.4.1  Strengths 
Key strengths of this research included: multisite involvement; a 
prospective design; examination of efficacy as well as process; detailed 
examination of feasibility issues; inclusion of key RCT features; attempts to 
control for sampling bias alongside broad inclusion of HSCT patients; and the 
method of analysis.  Further detail regarding these strengths is provided below.  
 
3.5.4.1.1  Multisite involvement and longitudinal design 
HSCT is a standardised procedure (Antin & Raley, 2013) but there can 
be variations in care across sites, as in the present project, potentially 
contributing to variability in findings between studies.  For example, ambulatory 
care in one site resulted in somewhat later admission compared to the other site 
and may have attenuated the impact of isolation, delayed the emergence of 
anxiety, and so forth.  Significant variability between sites was not detected in 
the present study (no significant differences between them in terms of distress) 
but power for those analyses was limited and findings are potentially more 
representative of the wider population by using more than one site. 
A key advantage of the longitudinal design was evidence for reliable 
change in distress during HSCT.  This may permit a causal link to be inferred 
(though not established as manipulation was not possible due to the nature of 
the transplantation procedure).  The longitudinal association between HSCT 
perceptions, coping, distress, and resilience also strengthens support for the 
underlying theory across the acute phase. 
 
3.5.4.1.2  Process 
Diverse factors may contribute to outcome in psychotherapy research, 
such as those present across modalities (e.g., therapeutic alliance), those 
specific to theory (e.g., cognitive change in CBT), or those that provide a 
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context for therapy (e.g., structure and coherence; Wampold, 2001).  It is, 
therefore, important that intervention research examines process as well as 
outcome to inform further development but this is missing from the HSCT 
literature (Baliousis et al., in press).  The present study provided the first 
attempt to evaluate a psychological intervention in HSCT whilst incorporating 
some evidence for the specific theoretical factors that were assumed to be 
operating, namely HSCT perceptions and coping.  This information can help 
generate targeted recommendations for developing the intervention further in 
terms of both content and delivery.  For example, the findings on HSCT 
perceptions indicated specific targets for intervention whilst the findings on 
coping can guide on what styles to promote, what styles to minimise, and on 
extending the social context of patients to improve the effectiveness of coping 
styles. 
 
3.5.4.1.3  Feasibility focus 
Clinical trials are often faced with considerable feasibility issues but there 
is little understanding regarding specific barriers to and strategies for their 
successful completion (Bower et al., 2014; M. Campbell, Snowdon, Francis, 
Elbourne, & McDonald, 2007; Howard et al., 2009).  This can be compounded 
in HSCT as the challenges facing patients together with the physical burden of 
the procedure and illness can pose considerable barriers to uptake and 
retention (Baliousis et al., in press; Bauer-Wu et al., 2008; Mosher et al., 2010).  
Feasibility studies in HSCT focus primarily on efficacy (Bauer-Wu et al., 2008; 
Bevans et al., 2010; Horton-Deutsch et al., 2007; Lee et al., 2005; Lounsberry 
et al., 2010; Trask et al., 2003) thus failing to document feasibility issues to 
evaluating intervention using RCT designs. 
In contrast, the present study placed a detailed focus on feasibility issues 
during the acute phase of HSCT.  The many barriers that were identified are 
likely to enhance research and further development of interventions in the field.  
They are also able to facilitate better decision-making regarding the overall 
feasibility of the research and possible threats to validity that have been missed 
from the literature to date. 
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A particular aspect of RCTs that has been neglected in HSCT feasibility 
trials concerns the aspect of randomised control (Bauer-Wu et al., 2008; 
Bevans et al., 2010; Horton-Deutsch et al., 2007; Lounsberry et al., 2010).  This 
is in spite of it being considered the method of choice for confounder control 
(McBurney & White, 2007) and its potentially negative impact on recruitment in 
cancer populations (Moyer et al., 2009).  Randomised control within each site 
could be particularly problematic for HSCT studies in light of the present 
findings, where accrual of patients for the intervention was halved due to the 
procedure.  The possibility that participants may be assigned to the control 
group at random and have to go through the research process without any 
tangible benefit when they are already strained may have also impacted 
negatively on uptake to the study.  It follows that results of prior feasibility 
studies of psychological interventions in HSCT may have underestimated 
recruitment and accrual challenges.  The uptake observed in the present project 
is likely to be more representative of the field. 
A further benefit of incorporating randomised control in the present study 
was to assess its potential in producing groups that are comparable on usual 
confounders such as age, diagnosis, performance status, and so forth 
(Andersson et al., 2009; Andersson et al., 2011; Barata et al., 2014; Braamse et 
al., 2014; Hefner et al., 2014; Mosher et al., 2009; Prieto et al., 1996; Tecchio et 
al., 2013).  Consequently, there was no need to include additional variables in 
the statistical models thereby limiting loss of power in the study and improving 
the accuracy of sample size estimates.  Furthermore, by assessing the 
feasibility of allocation concealment and blinding, which are also neglected in 
full and feasibility trials in HSCT (Baliousis et al., in press; Bauer-Wu et al., 
2008; Bevans et al., 2010; Horton-Deutsch et al., 2007; Lounsberry et al., 
2010), the study provides further evidence regarding the applicability of 
randomised control designs for evaluating psychological interventions in HSCT. 
 
3.5.4.1.4  Sampling bias 
Sampling bias can limit a study’s internal and external validity (McBurney 
& White, 2007).  This can become particularly problematic in HSCT in light of 
the many recruitment challenges and attrition that were observed in the study 
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and reluctance to engage with mental health services in this population (Mosher 
et al., 2010).  In addition, stringent inclusion criteria can render samples 
unrepresentative of naturalistic settings in psychotherapy research (Kazdin, 
2008).  Consequently, setting broad inclusion criteria and approaching patients 
consecutively as they entered the service are likely to have made the present 
sample more representative of the HSCT patient population.  Alongside 
recording reasons for nonconsent, these methods also permitted a detailed 
examination of sampling bias.  The evaluation of external validity was enhanced 
further by recording reasons for nonattendance and comparing attendees 
versus nonattendees from those participants randomised to the intervention. 
 
3.5.4.1.5  Analysis 
Use of MLM and robust statistics offered several advantages.  The study 
involved data collection from a highly burdened population resulting in missing 
data and unequal intervals between time points.  In addition, the comparison 
between group attendees and nonattendees was highly unbalanced.  These 
would have been problematic with traditional ANOVA which requires balanced 
designs and complete datasets resulting in considerable loss of participants 
following listwise deletion (Field, 2013).  Indeed, prior research in the field has 
suffered considerably from such loss of outcome data (Baliousis et al., in press), 
a problem also prominent in trials generally (Gravel, Opatrny, & Shapiro, 2007; 
Hollis & Campbell, 1999).  However, MLM in the present project provided partial 
control for these issues by permitting the inclusion of all available data thereby 
enhancing statistical validity.  MLM also enabled control for significant variance 
in intercepts and slopes across participants.  This provided a more valid 
representation of the observed effects in light of such heterogeneity in the 
population.  Additionally, using bias-corrected (bootstrap and robust) tests 
allowed for more accurate estimations of effects and sample calculations for a 
fully-powered efficacy study.  Overall, robust analyses suggested more accurate 
results and better maintenance of nominal Type I error rates notwithstanding 
assumption violations.  This reflected a consistent strength of the present 
project relative to other studies in HSCT and psychotherapy more generally 
(Baliousis et al., in press; Erceg-Hurn & Mirosevich, 2008; Wilcox, 2012). 
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3.5.4.2  Limitations 
In spite of several methodological strengths, the study also contained a 
number of limitations that potentially impact on the validity of the research.  Four 
types of threats to research validity are discussed: internal, external, construct, 
and statistical (McBurney & White, 2007). 
 
3.5.4.2.1  Threats to internal validity 
Internal validity refers to the extent to which a study provides credible 
evidence for the effects under scrutiny (particularly in relation to causality in 
experiments) whilst minimising the plausibility of alternative explanations (D. T. 
Campbell, Stanley, & Gage, 1963; McBurney & White, 2007).  Notwithstanding 
a number of steps to control for confounding variables in the present study it 
was not possible to rule out alternative explanations and several threats to the 
internal validity of the research remained.  In fact, the feasibility component 
provided evidence for a range of additional confounders.  Threats to internal 
validity included limitations to the manipulation, ambiguous temporal 
precedence, factors outside the study, a limited scope of psychological 
processes, effects of the method of collecting data, and attrition.  Further detail 
regarding these limitations is provided below. 
 
3.5.4.2.1.1  Manipulation and temporal precedence 
Manipulation of attendance to intervention aimed to establish a causal 
link between the intervention and its assumed mechanisms of change but this 
was not feasible.  Consequently, the design of the study became exclusively 
correlational.  Whilst the longitudinal component evinced the often close 
relationship of distress with HSCT progression, HSCT perceptions, and coping, 
it was not possible to establish which preceded which.  In the case of HSCT 
perceptions and coping, this means that a causal link with distress, as 
suggested by the self-regulatory model, could only be inferred and the opposite 
pattern remained plausible (as discussed in Section 8.2.1). 
 
 Page 172 of 263 
3.5.4.2.1.2  Confounding variables and control 
Apart from inability to establish direct causal links between the different 
variables, an additional caveat with correlational evidence involves the 
potentially causal contribution of factors not measured in the study (McBurney & 
White, 2007).  Distress may be associated with progression through HSCT but 
the procedure is diverse and multifaceted (Copelan, 2006).  Consequently, 
many factors may have changed how the procedure was perceived, coping, and 
distress such as tests following transplantation, uncertainty regarding going 
home, staff availability, physical needs, and so forth (Antin & Raley, 2013; 
Copelan, 2006).  A range of other psychological processes may have also 
mediated the relationship between the distress, perceptions of HSCT, and 
coping, as discussed earlier (e.g., discourses, attachments, etc.).  This limits 
conclusions regarding the nature of the relationship between distress and the 
psychological variables examined in the study. 
The range of potentially confounding processes also highlights a 
limitation in TAU as control condition.  TAU was not standardised and consisted 
of ad hoc informational and supportive input from clinical staff.  This input may 
have overlapped with the intervention, as patients who did not attend the 
intervention were able to seek support should they wished, but the extent to 
which this occurred was unclear.  This support could include information and 
advice on coping similar to what was addressed during the intervention, albeit 
with less shared exploration with peers (due to isolation and lack of facilitated 
contact). 
Furthermore, most participants were aware of the nature of the 
intervention and, therefore, did not remain blind regarding which groups they 
had been allocated to.  This awareness may have influenced their expectations 
of experiencing distress and, therefore, their responses to the questionnaires.  It 
may have also caused participants to compensate for not receiving the 
intervention by seeking alternative support, as observed often in cancer 
populations (Moyer et al., 2009).  Cancer patients who receive interventions 
have also been found to seek additional assistance (Moyer et al., 2009), which 
may have introduced further bias in the findings.  These possibilities highlight 
patient agency as an important contributor to intervention outcome (Carey & 
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Stiles, in press; M. J. Lambert, 2013).  However, patient agency may be difficult 
to assess due to the uniqueness and diversity of participants’ personalities 
(Carey & Stiles, in press).  Consequently, this factor may be difficult to control in 
clinical trials whilst its inadvertent interaction with randomisation when 
participants cannot be blind to the allocation (such as in psychological 
interventions) may compromise internal validity. 
A further limitation of TAU was that it was not equivalent to the 
intervention in terms of attention to participants.  For example, attending the 
intervention group was likely to have strengthened the alliance between patients 
and the staff team conferring additional benefits to addressing HSCT 
perceptions and coping.  Control for such common (e.g., therapeutic alliance) or 
contextual factors (e.g., coherence; M. J. Lambert, 2013; Wampold, 2001) were 
not adequately controlled for in the study with effects in favour of the 
intervention due to reasons other than the assumed mechanism of change. 
Overall, these considerations highlight limitations to the control strategy, 
the scope of processes that were examined, and the quantitative approach that 
measures relationships between variables to evince effects more generally.  
These limitations also characterise the wider HSCT research and the 
randomised clinical trial (RCT) paradigm more generally (Baliousis et al., in 
press; Carey & Stiles, in press; Kazdin, 2008), with several implications for 
improvement, as discussed in Section 8.6.   
 
3.5.4.2.1.3  Study and instrumentation effects 
The influence of the questionnaire interviews on participants and floor 
effects in the instruments posed additional threats to internal validity.  As two 
participants indicated, the process of going through questionnaires prompted 
them to reflect on their experience and emotional reactions.  It is, therefore, 
possible that participants’ reports of distress, resilience, HSCT perceptions, and 
coping across time points may have been influenced by drawing attention to 
these experiences.  Regarding floor effects, most DASS-21 scores were below 
clinical cut-offs; consequently, notwithstanding previous validation of the 
instrument, loss of sensitivity was possible, making intervention effects difficult 
to detect. 
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Additional limitations relating to the procedure included data collected 
retrospectively and social desirability.  Recall of events can be inaccurate 
(Coughlin, 1990; Kruijshaar et al., 2005; Raphael, 1987) and biased by a range 
of factors such as emotional states, expectations, accessibility, and so forth 
(Eysenck & Keane, 2015; Schwarz, Kahneman, & Xu, 2009).  Recall of coping 
appears especially affected by these issues (Schwartz, Neale, Marco, Shiffman, 
& Stone, 1999).  Participants reported on their distress, resilience, HSCT 
perceptions, and coping based on their recall over the preceding week; 
therefore, their responses may have been biased by such factors.  Furthermore, 
many questions were related to personal experiences and some questions 
requested feedback on the performance of clinical staff (e.g., distress, coping 
styles such as “I’ve been expressing my negative feelings”, the treatment 
control item from the Brief IPQ “How much do you think the care you receive 
can help you through the transplant process?”).  Participants may not have 
wished to disclose personal struggles to a stranger (outcome assessor) over the 
telephone or voice criticism towards clinical staff, resulting in socially desirable 
responding (Carnrike, 1997; Krumpal, 2013) and, therefore, additional bias. 
 
3.5.4.2.1.4  Attrition 
Baseline stress appeared to predict subsequent missing data.  Whilst this 
does not mean that missing data resulted from higher stress at the time they 
were due, it highlights the possibility that this may have been the case.  If so, 
any effects and relationships implicating stress may have been inaccurate, 
which threatens the internal validity of relevant findings.  Furthermore, whilst no 
other relationships between missing data and outcome variables reached 
significance, the samples were small so that bias in the findings was difficult to 
assess fully and replication remains necessary.  Attrition may also threaten 
external validity, as discussed below. 
 
3.5.4.2.2  Threats to external validity 
Threats to the external validity of the findings arose primarily due to 
sample characteristics, sampling bias, and the limited number of sites involved.  
Participants were entirely White-British, mostly males, older individuals, 
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married, with a diagnosis of multiple myeloma, and autologous transplants.  
Other subgroups were underrepresented so that results may not generalise to 
them and differences may have been missed in light of their small size.  As 
distress, health concerns, and coping may manifest differently across cultures 
(Alonso et al., 1998; Ballenger et al., 2001; Minsky et al., 2003; Piccinelli & 
Simon, 1997), results may also not generalise to individuals of non-White-British 
background.  Furthermore, reasons for not consenting to the study were noted 
but were not comprehensive and the characteristics of patients who did not 
consent were not recorded.  Consequently, some of these patients may have 
been from distinct populations who were not represented in the study.  Finally, 
results may also not generalise to individuals with higher stress or poorer 
physical functioning (performance status) as missing data may have been due 
to these factors. 
In addition to sampling issues, the study was undertaken in the British 
NHS under times of unprecedented financial pressure affecting frontline 
services (Appleby, Galea, & Murray, 2014), which may have influenced care 
provision at the participating sites and, therefore, patients’ distress and coping 
resources.  Consequently, it is unclear whether findings would generalise to 
other countries, healthcare systems, and times.  Such reasons may also 
contribute to the variability in distress trajectories reported across studies of 
distress in HSCT (Fife et al., 2000; Lee et al., 2005; Prieto, Atala, Blanch, 
Carreras, Rovira, Cirera, & Gastó, 2005; Schulz-Kindermann et al., 2002). 
 
3.5.4.2.3  Threats to construct validity 
These involve threats to validity due to limitations of the ability of 
instruments to measure the constructs they were intended for (McBurney & 
White, 2007).  A range of measures were employed in the present project for 
measuring variables in connection with the hypotheses.  All have received 
reasonable levels of validation across different populations but their application 
in the emerging field of HSCT has been minimal.  Furthermore, items were 
open to interpretation by participants, which is inherent in such use of 
questionnaires despite standardisation (McBurney & White, 2007).  In addition, 
some physiological items on the DASS-21 relating to anxiety appear 
 Page 176 of 263 
confounded with physical side-effects of HSCT.  These items were removed but 
it is possible that the rest of the subscale may partly reflect physical functioning 
as well as anxiety in HSCT, unlike the populations in which the subscale was 
originally validated.  Furthermore, the Brief IPQ and BRS are novel adaptations.  
In light of the lack of fit of the care control items with the rest of the Brief IPQ, it 
is possible that the constructs measured by these items is different compared to 
the original versions.  Finally, the list of coping styles in the Brief COPE is not 
exhaustive and a bottom-up exploration in order to identify higher-order coping 
constructs in this population was not possible in the present study.  It follows 
that many aspects of the construct validity of the instruments used in the study 
remains uncertain. 
 
3.5.4.2.4  Threats to statistical validity 
A range of statistical analyses were conducted and concerns with 
reliability of measurement, sample size, power, parametric assumptions, and 
some shortcomings of MLM threatened the validity of findings.  A major 
limitation was the relatively low (and at times very low) internal consistency of 
some scales, for example, anxiety at later time points, resilience on the day of 
the transplant, and several coping styles.  It is possible that this increased 
measurement error and resulted in wider confidence intervals thereby 
underestimating effects and inflating Type II error (Field, 2013; McBurney & 
White, 2007).  The relatively small number of participants (Level 2 units in MLM) 
may have also inflated Type II error and biased parameter estimates, 
particularly in analyses relating to participant characteristics (Field, 2013; 
Snijders & Bosker, 2012). 
There were parametric assumption violations in the data with those of 
normality particularly widespread.  Whilst bootstrapping, nonparametric, and 
robust tests may have partly mitigated violations and biases due to the small 
sample size, the effectiveness of bootstrapping for MLM in particular is less 
clear.  Indeed, it has shown promise in providing unbiased estimates for fixed 
effects when samples are large but may be less effective in doing so for random 
effects or small samples (J. R. Carpenter, Goldstein, & Rasbash, 2003; Maas & 
Hox, 2004; Seco, García, García, & Rojas, 2013; Snijders & Bosker, 2012).  In 
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addition, ANOVA tests are exact whilst those in MLM are approximate (Snijders 
& Bosker, 2012) yielding results that may be less accurate.  This may have 
been more prominent for the few models that did not converge when random 
effects were examined, since it was not possible to obtain parameter estimates 
adjusted for variability across participants.  Finally, the process of examining 
assumption violations in MLM is not as rigorous as for classic statistics and it is 
not always clear whether clustering (repeated measurements by each 
participant) is fully controlled for (Field, 2013; Snijders & Bosker, 2012).   
A final note concerning Type I error is necessary.  Measurement error, 
loss of power, conservative and robust analyses, and evaluating overall model 
improvements in MLM prior to examining specific effects (fixed and random 
parameters) may have partly mitigated probability of Type I error.  Nevertheless, 
the number of tests that were conducted was large and it is possible to have 
identified effects where none were present.  Consequently, replication of the 
current findings remains necessary. 
 
3.5.4.3  Summary 
The study demonstrated several methodological strengths that support 
the validity of findings including two-site involvement, examination of 
psychological processes, detail of feasibility variables, assessment of sampling 
bias, and robust analyses.  However, the study also contains a number of 
limitations.  Inability to establish causality, the number of possible uncontrolled 
confounders and covariates, procedural effects (e.g., going through the 
questionnaires influencing participants’ responses), limitations to the 
instruments, and attrition may limit the internal validity of the research.  In 
addition, sample and site characteristics together with a demanding NHS 
context may restrict external validity whilst lack of clarity regarding the validity of 
the assessments and a nonexhaustive coping list indicate limitations to 
construct validity.  Finally, limited reliability of some measurements, small 
sample sizes, lack of power, assumptions violations, and lack of clarity 
regarding the ability of MLM to control for these threaten statistical validity.  
Consequently, caution remains essential when considering the present findings.  
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Notwithstanding these issues, the findings have several clinical and research 
implications, discussed below. 
 
3.5.5  Clinical implications 
The findings indicate limitations to the feasibility in delivering the 
intervention (though confounded with limited feasibility of conducting the trial 
itself) but provided some support for its purpose.  This support is reflected in the 
complex emotional needs that emerged during HSCT and the role of HSCT 
perceptions and coping in underpinning distress.  In light of the barriers to 
uptake and attendance, it appears that a preparatory intervention could be 
better integrated with current care provision alongside some outreach. 
A range of methods could be employed to address negative perceptions 
of HSCT.  The intervention has drawn primarily on psychoeducation and 
exploration but the findings on the range of specific negative perceptions of 
HSCT underpinning distress suggest that teaching patients to identify and 
challenge these might be of benefit.  Such applications of the self-regulatory 
model extending beyond psychoeducation but remaining brief and targeted to 
specific perceptions have shown promise in alleviating distress and improving 
coping (Broadbent et al., 2009; K. M. Keogh et al., 2011). 
The intervention also purported to facilitate more helpful coping by 
increasing approach-based and decreasing avoidance-based coping.  The latter 
is supported by the findings.  In contrast, aspects of the intervention relating to 
approach-based coping may need to be developed further in light of the 
ineffectiveness of planning and support seeking.  Enhancing social resources 
may be a way of improving the effectiveness of these styles, as discussed in 
Section 8.2.2.  A viable way of doing so could be via peer mentoring, as initial 
literature on its usefulness has highlighted that HSCT patients view it as a 
valued resource and it can help them plan for the procedure better (Rini et al., 
2007).  It can also help attenuate fears in relation to HSCT (Rini et al., 2007), 
thus addressing some of the negative perceptions of the procedure.  Allowing 
peer mentors to contribute to the intervention and enabling patient contact with 
this resource throughout the acute phase of HSCT could be options for 
augmenting the intervention helpfully.   
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Promoting cognitive acceptance of and engagement with the distressing 
experience (Hulbert-Williams et al., 2015) could provide a helpful alternative, 
emotion-focussed strategy when resources are lacking.  Such methods have 
often involved mindfulness in HSCT (Bauer-Wu et al., 2008; Horton-Deutsch et 
al., 2007).  As this literature is uncontrolled, the advantages of mindfulness in 
HSCT have not been established, but well-documented benefits in other clinical 
populations (Carlson et al., 2004; Hulbert-Williams et al., 2015; Ott et al., 2006) 
suggest that such methods may be valuable approach-based additions to 
coping with HSCT.  The intervention could introduce the practice of mindfulness 
as an alternative coping mechanism when resources are limited as well as 
facilitating other types of approach-based coping when resources are available. 
In sum, both the feasibility and theoretical findings of the present project 
provided indications for the development of the intervention.  A preparation 
group that is well-integrated with clinical care, aims to offer psychoeducation 
relating to HSCT perceptions and coping, widens the coping styles of patients to 
include mindfulness-based methods, and facilitates peer support may be 
particularly helpful. 
 
3.5.6  Research implications 
Findings on the feasibility issues and the role of negative HSCT 
perceptions and unhelpful coping in underpinning distress together with 
weaknesses in the study have several implications for further research.  These 
implications include adjustments to the design and procedure to improve 
feasibility and areas of further investigation in relation to HSCT perceptions, 
coping, mechanisms of change in the intervention, and physical outcomes.  
Further detail regarding these implications is provided below. 
 
3.5.6.1  Design and procedure 
An alternative design could circumvent some of the feasibility issues 
whilst enhancing the control condition and addressing sampling and attrition 
issues may mitigate some threats to internal validity.  A cluster randomised 
design with crossover (D. Wang & Bakhai, 2006) could help address some 
barriers to conducting the trial posed by randomised control and the recruitment 
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procedure at each site.  With this method, each site (cluster) would be randomly 
allocated to intervention or control.  Consequently, prospective participants 
could be provided with information about the study and be invited to the group 
upon referral to the service (at sites allocated to the intervention), thus reducing 
the length of the recruitment and allocation process.  All consenting patients 
would also be able to participate in the intervention at the relevant sites.  The 
resulting higher accrual rates could allow groups to take place more frequently, 
prior to patients’ transplantation dates.  However, cluster randomisation could 
introduce a higher risk of outcome assessor bias, since deblinding regarding 
one participant could result in deblinding regarding all other participants at the 
same site.   
A disadvantage of a cluster randomised design is that potential 
differences between clusters (sites) could unbalance the samples (D. Wang & 
Bakhai, 2006).  Differences between sites may not be significant (as in the 
present findings) but this may not be replicated if additional sites are used and if 
power increases with larger samples.  Potential confounding could be controlled 
by reversing the condition allocated to each site once a crossover point is 
reached, for example, when 50% of the target sample has been recruited (D. 
Wang & Bakhai, 2006).  The problems with outcome assessor bias in the event 
of deblinding could be further mitigated if the outcome assessor is also blind of 
the crossover point.  Introducing more than one crossover point (e.g., when 
25% of the target sample has been recruited), may mitigate this risk further but 
doing so could burden the staff teams administratively (e.g., change the 
scheduling of the group) thereby increasing the likelihood or procedural error. 
Three other adjustments could enhance the control condition and 
improve control for sampling and attrition bias to address threats to internal 
validity.  The control condition could be more structured than TAU in the present 
study, to match the intervention both in form and staff attention to participants.  
The amended control condition could include a preparatory group meeting with 
focus on communicating empathy and building alliance with staff (common 
factors; Wampold, 2001) without the assumed active ingredients of the 
intervention, that is, challenging negative HSCT perceptions and facilitating 
helpful coping.  However, maintaining these boundaries may be challenging as 
patients may ask for further information or advice during the meeting and it may 
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be unethical (or infeasible) for staff to deny such requests.  Furthermore, inviting 
the heavily burdened HSCT patients to participate in a group which does not 
aim to offer direct benefits may not be easily justifiable ethically. 
The final two adjustments may help address sampling and attrition bias: 
(a) examining differences between patients who declined to participate versus 
those who consented; and (b) facilitating direct rather than telephone contact 
with the outcome assessor.  Cancer patients often experience difficulty with 
participating in research due to the many complications of their illness and 
treatment (Moyer et al., 2009) and this may be more prominent during acute 
HSCT due to the intensity of the procedure (Antoni et al., 2001; Copelan, 2006).  
Identifying characteristics of patients who decline to participate may help assess 
the representativeness and accuracy of findings.  Developing rapport with 
participants and supporting them with completing the questionnaires via direct 
contact may reduce attrition and stress (particularly due to the added burden of 
the research procedure) with similar benefits, though it may also increase the 
likelihood of deblinding the outcome assessor. 
 
3.5.6.2  HSCT perceptions and coping 
Future research should elucidate the role of HSCT perceptions and 
coping in underpinning distress further.  The present findings highlight a range 
of negative HSCT perceptions that appear to underpin distress.  However, 
HSCT is complex and has many complications (Antoni et al., 2001; Copelan, 
2006) but the relevant questions of the Brief IPQ were broad and, therefore, it 
was not possible to examine how these complications interacted with 
perceptions (e.g., what consequences patients perceive on their lives) in detail.  
Such an investigation could provide further evidence for the applicability of the 
self-regulatory model and could help accelerate the process of identifying and 
addressing specific negative perceptions in intervention.  The task is likely to 
benefit by qualitative inquiry which is able to provide a more nuanced level of 
detail than the Brief IPQ. 
Further validation of the novel Brief IPQ for HSCT is needed to verify 
findings and particularly clarify the relationship between coping appraisals and 
distress.  The lack of relationship may be accurate but the role of coping 
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appraisals in underpinning distress in HSCT may also be complex and not 
captured in the present study or the null result may be due to limitations of the 
Brief IPQ.  Further validation of the coping appraisal items could involve 
examining convergent validity, for example, by correlating these items with 
measures of self-efficacy (Hagger & Orbell, 2003). 
Further research on coping in HSCT is needed to explore higher-order 
categories, reasons for the ineffectiveness of planning and support seeking, and 
the usefulness of mindfulness-based coping.  As the outcomes and groupings 
of coping styles differ across populations, exploring higher-order categories in a 
bottom-up manner is considered essential (Folkman & Moskowitz, 2004; 
Ogden, 2012; Taylor & Stanton, 2007).  Doing so in HSCT may allow a better 
understanding of the general types of coping patients use and their outcomes, 
mitigate limitations to the reliability of measurement (since larger scales are 
likely to be more reliable; Field, 2013), and conserve statistical power (by 
conducting fewer tests; Field, 2013).  Examining the resources available to 
patients and their interaction with coping styles may help elucidate reasons for 
the ineffectiveness of planning and support seeking and help develop 
alternative ways of supporting patients to cope.  As the present findings in 
conjunction with prior literature (Bauer-Wu et al., 2008; Horton-Deutsch et al., 
2007; Schoulte et al., 2011) indicate that mindfulness-based coping may be 
more helpful to HSCT patients relative to other strategies, incorporating this 
strategy in future investigations appears necessary in the process of exploring 
how to improve coping in this population.   
 
3.5.6.3  Mechanism of change 
Common therapeutic factors (e.g., therapeutic alliance) have been found 
to contribute to intervention outcome in various populations including HSCT 
(Applebaum et al., 2012; M. J. Lambert, 2013).  It follows that future 
investigations into the effectiveness of the intervention may benefit by 
examining the contribution of common factors to outcome alongside the effects 
of addressing negative HSCT perceptions and unhelpful coping.  Such 
comprehensive process examinations remain largely absent from the HSCT 
literature (Baliousis et al., in press) but could strengthen conclusions regarding 
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the mechanism of change and inform further development of interventions.  
However, in light of the feasibility findings, any added burden on participants 
may compromise uptake and retention. 
 
3.5.6.4  Physical outcomes 
There is a need to improve physical outcomes in HSCT (Anderson et al., 
2007; Antoni et al., 2001; Bhatia et al., 2007; Copelan, 2006; Mosher et al., 
2009).  Distress can predict physical burden and mortality following the 
procedure (Prieto et al., 2002; Pulgar, Garrido, Alcala, & Reyes del Paso, 2012; 
Schulz-Kindermann et al., 2002) whilst negative perceptions and unhelpful 
coping may predict physical status and behaviours promoting recovery (e.g., 
medication adherence) in various clinical populations (Cherrington, Moser, 
Lennie, & Kennedy, 2004; Hagger & Orbell, 2003; Zoeckler, Kenn, Kuehl, 
Stenzel, & Rief, 2014; Zyrianova, Kelly, Sheehan, McCarthy, & Dinan, 2011).  It 
follows that the present intervention for distress may be helpful in in improving 
physical outcomes also.  Such an effect was not assessed in the present study 
but could be examined in future research to ascertain the extent to which the 
intervention can meet the broader needs of HSCT patients and help maximise 
the benefits of the intervention.   
 
In sum, future research could address feasibility issues and threats to 
validity by adopting a cluster randomised design with crossover, enhancing the 
control condition, and other adjustments.  Further research on theoretical 
aspects could explore the relationship between the circumstances of HSCT and 
patients’ perceptions of the procedure, the role of coping appraisals in 
underpinning distress, the validity of the Brief IPQ, the nature of coping in HSCT 
and reasons for ineffectiveness, and mechanisms of change.  Focus on 
physical outcomes may be helpful towards meeting the broader needs of 
patients.  Overall, replication and further exploration in different patient 
subgroups, other cultures, and settings remains necessary. 
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3.5.7  Conclusions 
The present study examined the feasibility of delivering and evaluating a 
group-based psychological intervention to alleviate distress during acute HSCT.  
The study also assessed the applicability of the self-regulatory model in this 
population.  The findings highlight considerable feasibility issues with delivering 
the intervention and conducting the research.  These issues suggest a need to 
integrate the intervention better within routine care and adopt an alternative 
design such as cluster randomisation with crossover.  Control for sampling and 
attrition bias could also improve.  Other aspects of the research procedure and 
most assessments appear feasible and appropriate for a full trial. 
The findings support the self-regulatory model as a basis for the 
intervention.  HSCT perceptions and coping appear to underpin distress as a 
facet of adjustment to the procedure.  A range of negative perceptions of HSCT 
(e.g., consequences, length, etc.) and several coping styles including those 
considered helpful in other populations seem to predict more distress.  The 
intervention could aim to address specific negative perceptions, reduce 
avoidance-based coping, extend access to resources and information for 
effective use of approach-based coping, and promote mindfulness-based 
coping.  Overall, replication in other samples and settings remains necessary. 
 
3.5.8  Reflections 
The three years of training in clinical psychology have provided a unique 
opportunity to develop professionally and personally.  The research component 
has been a major contributor to this.  I believe that applying psychological 
theory and research methods as part of the present study has been 
instrumental in furthering my insights into the processes of research and service 
development in clinical psychology.  This section discusses some of these 
reflections. 
 
3.5.8.1  Research process 
New insights involved the process of formulating research questions, 
recognising ethical implications of the power imbalance between professional 
and participant (especially for those who are also patients), and reappraising 
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the methodological approach to the present project and its epistemological 
assumptions. 
 
3.5.8.1.1  Formulating research questions 
At the beginning of the doctoral programme, I noticed that I experienced 
difficulty developing a research question, finalising the psychological 
intervention, and identifying a theoretical background to inform its development.  
Consequently, I drew extensively on supervisors’ experience and guidance.  
This was in contrast to methodological aspects where I found myself better able 
to generate and reflect on ideas.  At first, the difficulty with the conceptual 
aspect of the research had alarmed me as I believed at the time that I lacked an 
essential skill in clinical psychology and in being able to engage in research. 
As the project progressed, I developed detailed familiarity with the 
population and its difficulties via reflecting on the literature, conversations with 
colleagues and participants, and analysing the data.  This resulted in a keen 
interest in making a difference as a clinical psychologist in HSCT, which 
resulted in identifying numerous questions about how this might be achieved.  
For example, I became curious about how patients experience distress, why 
might their coping be helpful or otherwise, whether empathy and unconditional 
positive regard during their times of vulnerability might also play a role in 
alleviating distress, whether distress predicts physical recovery and mortality in 
the longer-term, and so forth. 
All of these questions could be translated into research.  Coming to this 
realisation, highlighted the importance of developing a nuanced clinical 
understanding of the population and the research area for guiding 
investigations.  This experience also delineated the distinctions between the 
procedure and substance of research in clinical psychology, where the former 
involves its mechanics and can be learnt whilst the latter reflects an authentic 
interest in investigation towards a clinical end. 
 
3.5.8.1.2  Power imbalance and research ethics 
An ethical dilemma emerged early during the project and provided a 
useful opportunity to explore relevant processes, personal assumptions, and 
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develop more person-centred participant engagement skills.  As I called 
participants to complete the questionnaires during the acute phase of HSCT, 
several were unable to respond to the initial attempts or repeatedly requested 
that we reschedule.  At first, my interpretation was that I was harassing them 
when they wished to withdraw and that they were reluctant to say so due to the 
power differential between practitioner and patient.  I saw continuing the 
attempts to contact participants under these circumstances as against my 
ethical principles of professional benevolence and avoiding harm and, 
ultimately, as oppressive.  These beliefs cause me anxiety and led me to avoid 
making further telephone calls after initial unsuccessful attempts. 
This solution highlighted a barrier to conducting research both in the 
present and future projects and indicated a need to explore the issue in 
supervision.  My supervisors, who were experienced in conducting clinical trials, 
highlighted that continuing the attempts to call participants in a collaborative 
manner until participants express a wish to withdraw reflects standard practice.  
Following this conversation, I experimented by adopting such an approach 
whilst communicating the right to withdraw to participants empathically in 
conversations or via messages as appropriate.  Doing so appeared to address 
partly the power differential and allow some participants to withdraw consent 
gratefully.  It also allowed the project to continue without unnecessary loss of 
data. 
This experience also enabled me to review my assumptions regarding 
how participants viewed the research procedure.  When asked about their 
feedback regarding telephone calls and potential intrusiveness, no participant 
described the procedure in such terms.  There may have been some influence 
of social desirability but the feedback appeared genuine as participants 
volunteered comments on my flexibility as interviewer and on feeling no 
pressure to respond. For example, participants expressed appreciation for 
being allowed to determine the timing of subsequent calls or withdraw from the 
study and for my willingness to work around their schedules.  This feedback 
disconfirmed my initial beliefs that participants were becoming frustrated and 
oppressed by participating in the research.  Such beliefs are now less likely to 
pose a barrier to conducting future research with highly distressed participants. 
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3.5.8.1.3  Methodological and epistemological considerations 
The quantitative methodology in the present project reflected my 
familiarity with and value of this approach upon beginning the doctoral training.  
This quantitative orientation was embedded within the medical context of my 
previous research work within psychiatry.  However, my perspective began to 
shift as barriers to conducting an RCT emerged in the present project and as 
my familiarity with the topic and alternative research methods (e.g., qualitative, 
single case) increased during training.  I also became more person-centred and 
appreciative of multiple perspectives in clinical practice, which allowed me to 
note that the present research data is unable to capture the nuance of 
participants’ experiences.  As a result, I concluded that many of my research 
questions in relation to psychological distress in HSCT (such as those 
described in the reflections earlier) might be answered less easily via 
quantitative methods and I have become more reserved towards the realist 
perspective that often underpins such methods (Carey & Stiles, in press; 
Deacon, 2013; Donmoyer, 2012; Gottdiener, 2011).  In contrast, I have valued 
increasingly the contribution of alternative approaches that enable more 
incisive, interpretative, qualitative exploration fit for revealing the nuance of 
psychological experience, even when evaluating and developing psychological 
interventions. 
 
3.5.8.2  Service development and clinical psychology 
Having begun a Doctorate in Clinical Psychology upon submitting a PhD 
thesis, my ambitions regarding a three-year research project extended beyond 
a feasibility study.  However, I decided to focus on the present project (a 
feasibility study) in recognition that I had little idea about the process of 
developing interventions and probably underestimated the importance of 
exploring feasibility issues in conducting relevant research. 
Indeed, feasibility issues were abounding in the present project, which, in 
turn, allowed me to recognise the ubiquity of unintended consequences when 
implementing plans.  This insight coincided with my nascent interest in 
organisational theory and particularly Complexity theory (Cilliers, 1998) in the 
context of service development in clinical psychology.  Complexity theory 
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highlights the limitations of traditional conceptualisations of service development 
as a planned, top-down process determined by the persons who appear to 
engineer it (Weick & Quinn, 1999), in this case myself and the clinical 
psychologists involved in the project.  Instead, it suggests that the process of 
development emerges from unique and iterative contributions by a range of 
agents (including its assumed engineers) and factors involved, as appeared to 
occur in the present study. 
Using this perspective to make sense of my research experience 
enabled me to appreciate the range of possible factors that influenced the 
implementation of the present project.  To name but a few, colleagues were 
unable to recruit participants as planned due to resource cuts, there were 
delays with starting recruitment, transplants were cancelled unpredictably, I was 
willing to contact participants outside standard working hours so that I could 
complete my doctoral training, and so forth.  In my eyes, unintended 
consequences became an inherent part of service development and now I 
consider feasibility studies a necessity in exploring the nature and impact of 
such unexpected outcomes.  Overall, I learnt to view the role of clinical 
psychology as key in coordinating the process of change with the core skills of 
communication, assessment, meaning-making (formulation), intervention, 
reflection, and scientist-practitioner working as vital parts of the work. 
 
3.5.9  Epilogue 
Overall, engaging in doctoral-level research as part of clinical psychology 
training has highlighted the many ways in which such activity is important to the 
role and its added value.  During the training programme, my ultimate research 
aim was to produce findings whose implications would bear direct relevance to 
clinical work.  I believe I have achieved this in light of how my ideas about 
supporting HSCT patients developed and how the practice of my field 
supervisors has changed. 
However, I have also become acutely aware of the barriers to such 
activity in a pressured NHS.  Having completed a PhD with sole focus on 
research just prior to the current training which allocates one day per week to 
research, I realised that time and resource limitations to this type of work can 
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restrict the impact of research considerably.  During the training programme, I 
found myself contributing considerably more time than what was timetabled for 
the research.  In light of the pressures facing services currently, resourcing 
demands are likely to increase further and risk diminishing this part of the role 
as direct clinical work becomes prioritised.  I found this prospect concerning for 
the profession as it appears to strip what I have come to see as an essential 
component of its added value.  If prolonged, this eventuality may alter the 
discourse about what clinical psychologists can contribute to services and pave 
the way for devaluation. 
At the same time, I am unwilling to forego such a rewarding and 
seemingly essential component of the role and have contemplated on different 
ways of working.  Drawing on the ideas of Complexity theory and social 
constructionism, I have wondered whether discursive “interventions” that aim to 
promote questioning in staff teams, foster a reflective process, critique, 
exchange of ideas, and so forth, could highlight the importance of scientific 
investigation and promote greater research engagement within the wider 
system.  In this context, the focus in the work of clinical psychologists could be 
on a conceptual level in a more facilitative than engineering role.  However, in 
light of a changing context of service delivery and the apparent inevitability of 
unintended consequences when implementing plans, it is unclear how such 
“interventions” might play out.  Perhaps this calls for a feasibility study to 
understand the process better. 
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Appendix A 
Guidelines for Referral to Clinical Psychology Service for Patients with 
Haematological Cancer 
 
Referrals can be made from Haematology Consultants, Haematology Specialist 
Registrars (following discussion with Consultant) and Haematology Clinical Nurse 
Specialists.   
 
Patients will normally be offered an appointment at the out-patient area within the 
Haematology Unit.  Patients offered an assessment and up to six appointments, 
depending on their needs.  Each appointment will usually last between 30 - 50 minutes 
and appointments may be offered on a weekly, fortnightly or monthly basis.   
 
Please ensure that the reason for referral is discussed with the patient and that 
consent to the referral is obtained.   
 
Referrals can be made in writing to Dr. [name], Clinical Psychologist, [address].   
 
Alternatively a Clinical Psychology referral form can be completed.   
 
Please highlight any access issues or communication needs so that I can actively 
support patients to engage with the service. 
 
Examples of appropriate referrals 
 
This service is funded to work with people struggling to cope with haematological 
cancer or other issues arising as a result of their disease, where the health 
professionals involved feel unable to provide the level of emotional support needed.  
 
Some examples of the issues I work with are:  
 
1. Patients who have difficulty coping with the stress of their illness or related 
issues 
 
2. Patients who have difficulty coping with feelings of anxiety, panic or depression 
arising from their illness  
 
3. Patients who re-live or remember past traumatic experiences associated with 
their illness 
 
4. Patients who are struggling with body image issues arising from their illness  
 
5. Patients who are struggling to cope psychologically where this impacts on 
treatment concordance  
 
6. Psychological components of pain, fatigue or anticipatory nausea and vomiting 
associated with their illness  
 Page 239 of 263 
 
7. Fear about impending medical procedures where this impacts on treatment  
 
8. Loss and adjustment issues related to having cancer 
 
 
Patients not suitable for a referral to the Haematology Clinical Psychology Service  
 
1. Mental Health Emergency.  A working definition of a mental health emergency is 
when a person’s thoughts and feelings are beyond their control.  This may include:  
 Posing a serious risk to themselves or others  
 Actively suicidal / self harming  
 Psychotic episode 
 
The Psychology Service is not an emergency service and cannot respond to an 
emergency or cancel planned patient appointments to respond to an emergency.  In 
case of emergency, please contact Liaison Psychiatry.   
 
2. Difficulties relating to longstanding severe mental health problems such as 
psychosis, bipolar disorder, severe mood disorders and personality disorders.   
 
3. Active alcohol and drug difficulties or misuse 
 
4. Less severe mental health difficulties that are not related to issues arising from their 
cancer.  However I can undertake an assessment with a view to onward referral to a 
mental health service.  
 
Many of these patients will be linked with mental health teams or psychiatric services, 
therefore speaking directly with the teams involved (with patient consent) may be of 
most benefit.  
 
 
I am available to discuss cases with the team.  Please contact me on [extension] 
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Appendix B 
Pro-forma ID: Date: 
Demographics 
1 Age: _____________  years 
2 Gender: 1-Male 
2-Female 
3 Ethnicity: 1/2-White (British/other) 
3/4-Asian (British/other) 
5/6-Black (British/other) 
7-Mixed 
8-Chinese 
9-Middle Eastern 
10-Other: ____________ 
998-Prefer not to say 
4 Marital status: 0-Divorced or separated 
1-Married/civil partnership/ cohabiting 
2-Single 
3-Widowed 
998-Prefer not to say 
5 Educational background: 0-Mainstream 
1-Further 
2-Higher 
3-Other: _____________ 
Procedural  
1 Disease: ______________________ 
2 Number of recurrences: ______________________ 
3 Type of recurrences: ______________________ 
4 Year of 1st diagnosis: ______________________ 
5 Type of transplant: 0-Autologous 
1-Allogeneic 
6 Conditioning intensity: 0-Reduced intensity conditioning 
1-Myeloablative 
7 Baseline Performance Status? ___ 
8 Length of hospital stay for 
transplantation: 
 
______________________ days 
9 Referral to psychologist during 
transplantation: 
0-No 
1-Yes 
10 Non-concordant events  
 - Leaving isolation room: 0-No 
1-Yes: ________________ days 
 - Intensive care admission: 0-No 
1-Yes: ________________ days 
11 Disease status 0-Complete remission 
1-Partial remission 
2-Stable 
3-Progressive disease 
12 Other: _____________________________ 
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Appendix C 
DAS S 21 ID: Date: 
Please read each statement how much the statement applied to you over the past week.  
There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid 
breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
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Appendix D 
 
Brief Resilience Scale ID: Date: 
The following questions are about how your transplant process have affected you over the 
past week.  Use the following scale and circle one number for each statement to indicate how 
much you disagree or agree with each of the statements. 
The rating scale is as follows: 
1 Strongly Disagree 
2 Disagree 
3 Neutral 
4 Agree 
5 Strongly Agree  
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
So far, I have been bouncing back quickly since this  
hard time began…………………………………. 1 2 3 4 5 
I have had a hard time making it through  
     this stressful event………………………………. 1 2 3 4 5    
It has not been taking me long to recover from this  
     stressful event…………………………….……. 1 2 3 4 5 
It has been hard for me to snap back since  
     this happened………………………....……….. 1 2 3 4 5 
So far, I have come through this difficult time  
     with little trouble..………………………..……. 1 2 3 4 5     
I have been taking a long time to get over  
     this set-back in my life………..…………..……. 1 2 3 4 5  
 
 
 
  
 Page 243 of 263 
Appendix E 
Brief COPE ID: Date: 
These items deal with ways you've been coping with the stress in your life over the past week. There 
are many ways to try to deal with problems. These items ask what you've been doing to cope with 
this one. Obviously, different people deal with things in different ways, but I'm interested in how 
you've tried to deal with it. Each item says something about a particular way of coping. I want to 
know to what extent you've been doing what the item says. How much or how frequently. Don't 
answer on the basis of whether it seems to be working or not-just whether or not you're doing it. 
Use these response choices. Try to rate each item separately in your mind from the others. Make 
your answers as true FOR YOU as you can. 
 
The rating scale is as follows: 
1  I haven't been doing this at all 
2  I've been doing this a little bit 
3  I've been doing this a medium amount 
4  I've been doing this a lot 
 
1 I've been turning to work or other activities to take my mind off things. 1      2      3      4 
2 I've been concentrating my efforts on doing something about the 
situation I'm in. 
1      2      3      4 
3 I've been saying to myself "this isn't real.". 1      2      3      4 
5 I've been getting emotional support from others. 1      2      3      4 
6 I've been giving up trying to deal with it. 1      2      3      4 
7 I've been taking action to try to make the situation better. 1      2      3      4 
8 I've been refusing to believe that it has happened. 1      2      3      4 
9 I've been saying things to let my unpleasant feelings escape. 1      2      3      4 
10 I've been getting help and advice from other people. 1      2      3      4 
12 I've been trying to see it in a different light, to make it seem more 
positive. 
1      2      3      4 
13 I've been criticizing myself. 1      2      3      4 
14 I've been trying to come up with a strategy about what to do. 1      2      3      4 
15 I've been getting comfort and understanding from someone. 1      2      3      4 
16 I've been giving up the attempt to cope. 1      2      3      4 
17 I've been looking for something good in what is happening. 1      2      3      4 
18 I've been making jokes about it. 1      2      3      4 
19 I've been doing something to think about it less, such as watching 
TV, reading, daydreaming, or sleeping. 
1      2      3      4 
20 I've been accepting the reality of the fact that it has happened. 1      2      3      4 
21 I've been expressing my negative feelings. 1      2      3      4 
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23 I've been trying to get advice or help from other people about what to 
do. 
1      2      3      4 
24 I've been learning to live with it. 1      2      3      4 
25 I've been thinking hard about what steps to take. 1      2      3      4 
26 I've been blaming myself for things that happened. 1      2      3      4 
28 I've been making fun of the situation. 1      2      3      4 
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Appendix F 
Brief IPQ ID: Date: 
For the following questions, please indicate the number that best corresponds to your 
views about the process of your transplant over the past week: 
1 How much does the transplant process affect your life? 
       0      1      2      3      4      5      6      7      8      9      10 
 no effect 
at all 
severely 
affects my life 
2 How long do you think the transplant process will continue? 
       0      1      2      3      4      5      6      7      8      9      10 
 a very 
short time 
forever 
 
3 How much control do you feel you have over the transplant process? 
       0      1      2      3      4      5      6      7      8      9      10 
 Absolutely 
no control 
extreme amount 
of control 
4 How much do you think the care you receive can help you through the 
transplant process? 
       0      1      2      3      4      5      6      7      8      9      10 
 not at all extremely 
helpful 
5 How much do you experience symptoms from the transplant process? 
       0      1      2      3      4      5      6      7      8      9      10 
 no symptoms 
at all 
many severe 
symptoms 
6 How concerned are you about the transplant process? 
       0      1      2      3      4      5      6      7      8      9      10 
 not at all 
concerned 
extremely 
concerned 
7 How well do you feel you understand the transplant process? 
       0      1      2      3      4      5      6      7      8      9      10 
 don’t understand 
at all 
understand 
very clearly 
8 How much does the transplant process affect you emotionally?  (e.g., 
does it make you angry, scared, upset or depressed?) 
       0      1      2      3      4      5      6      7      8      9      10 
 not at all 
affected 
emotionally 
extremely 
affected 
emotionally 
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Appendix G 
 
Development and evaluation of a psychological intervention to alleviate 
distress during haematopoietic stem-cell transplantation 
 
An invitation to participate 
 
You are invited to take part in a research study.  The study aims to find out 
whether a new programme of psychological support prior to haematopoietic 
stem-cell transplantation helps people cope better psychologically with the 
treatment. 
 
The study compares the new programme of support with the support currently 
available.  So, if you participate, you may or may not be offered the new 
programme in addition to the support currently available.  The results of this 
study will help clarify whether the new programme provides an added benefit.  
This may enable us to make it routinely accessible to patients like you in the 
future.  Your transplant itself will not be affected in any way by your decision 
whether to participate in this study. 
 
Participation in the study will involve four 15-minute conversations over the 
telephone over a period of approximately six weeks beginning shortly prior to 
your transplantation.  During these interviews, a researcher will ask you a series 
of questions about your experience and how you are coping.  Some participants 
will be asked to attend a meeting of several patients awaiting a transplant at 
[Site] for approximately one hour.  During this meeting a clinical psychologist, 
physiotherapist and bone marrow transplant coordinator will discuss how to 
cope with the transplant.  Some participants may also be invited to take part in a 
longer telephone interview (up to half an hour) asking about your experiences. 
 
For more information about the study and taking part please contact your bone 
marrow transplant coordinator or site clinical psychologist who will be happy to 
provide further details, answer your questions, and enrol you in the study.  Their 
contact details are below: 
 
[Clinical Psychologist and Bone Marrow Transplant Coordinator contact details]  
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Appendix H 
 
Participant Information Sheet 
(Draft Version 1.0: 9th May 2014) 
 
Title of Study: Development and evaluation of a psychological intervention to 
alleviate distress during haematopoietic stem-cell transplantation. 
 
Name of Researcher(s): Dr Michael Baliousis, Dr Michael Rennoldson, & Dr Roshan 
das Nair.  
 
We would like to invite you to take part in our research study.  Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you.  One of our team will go through the information sheet with you and 
answer any questions you have.  Talk to others about the study if you wish.  Ask us 
if there is anything that is not clear. 
 
What is the purpose of the study? 
 
The purpose of the study is to evaluate a new programme of psychological support 
developed to facilitate tolerance of distress in patients undergoing haematological 
stem-cell transplantation. 
 
Why have I been invited? 
 
You are being invited to take part because you will be undergoing haematological 
stem-cell transplantation for a haematological cancer soon.  We are inviting 60 
individuals like you to take part. 
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part.  If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent form.  
If you decide to take part you are still free to withdraw at any time and without giving 
a reason.  This would not affect your legal rights. 
 
What will happen to me if I take part? 
 
Your involvement in the study will begin a short while prior to the transplantation and 
will end approximately four weeks following transplantation.  As part of your 
participation, you will be offered the support already available to all patients during 
transplantation and may or may not be offered the new programme which is being 
evaluated in the study.  However, we will not be able to let you know whether you 
have been offered the new intervention until the end of your participation as this may 
affect your responses in the meantime.  All support and interventions will be delivered 
by the members of your transplant team at the location of your transplantation. 
 
During your participation, you will be contacted four times over the telephone by one 
of the researchers (Michael Baliousis) who will ask you some questions about your 
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feelings, thoughts and actions over the preceding week.  The interviews will take 
place prior to the transplant, on the day of the transplant, two weeks following 
transplantation, and four weeks following transplantation.  Each call will last 
approximately 15 minutes.  While you are an inpatient, the researcher will gain 
permission from a member of staff looking after you on the day of each telephone 
call to ensure that it will not inconvenience you.  Once these interviews have taken 
place, you may be invited to take part in a longer telephone interview (up to half an 
hour) asking about your experiences of the intervention and how you used what you 
learnt. 
 
Expenses and payments 
 
It is not anticipated that you will incur any expenses as a result of participating in the 
study and no travel will be required.  It is not possible to pay participants to 
participate in the study. 
 
What are the possible disadvantages and risks of taking part?  
 
This study involves receiving different types of support in preparation for the 
transplantation procedure.  The types of support available to date have been used 
extensively and have not posed any risks.  The new programme has already been 
piloted with patients like you and no negative effects have been reported.    
 
What are the possible benefits of taking part? 
 
You may or may not be offered the new type of support as a result of taking part in 
the study but, should you receive it, we cannot promise that it will provide you with 
additional benefits to support already on offer.  Indeed, it is the information we will 
get from this study that will show us whether the new programme is helpful to 
patients like you and, if so, it would enable us to make it more widely available to 
patients in the future. 
 
What happens when the research study stops? 
 
You will continue to be seen regularly by you bone marrow transplant team. 
 
What if there is a problem? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers or the clinical psychologist at your clinic who will do their best to answer 
your questions.  The researchers’ and clinical psychologist’s contact details are given 
at the end of this information sheet.  If you remain unhappy and wish to complain 
formally, you can do this by following the local complaints procedure.  The Patient 
Liaison and Advice Service will be able to support you with this.  Their contact details 
are also provided at the end of this document. 
 
Will my taking part in the study be kept confidential? 
 
We will follow ethical and legal practice and all information about you will be handled 
in confidence. 
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If you join the study, some parts of your medical records and the data collected for 
the study will be looked at by authorised persons from the University of Nottingham 
who are organising the research.  They may also be looked at by authorised people 
to check that the study is being carried out correctly.  All will have a duty of 
confidentiality to you as a research participant and we will do our best to meet this 
duty.  
 
All information which is collected about you during the course of the research will be 
kept strictly confidential, stored in a secure and locked office, and on a password 
protected database.  Any information about you which leaves the hospital will have 
your name and address removed (anonymised) and a unique code will be used so 
that you cannot be recognised from it. 
 
Your personal data (address, telephone number) will be kept for 12 months after the 
end of the study so that we are able to contact you about the findings of the study 
(unless you advise us that you do not wish to be contacted) after which they be 
disposed of securely.  All anonymised research data will be kept securely for 7 years 
and then will also be disposed of securely.  During the 7 years, all precautions will be 
taken by all those involved to maintain your confidentiality and only members of the 
research team will have access to your personal data. 
 
What will happen if I don’t want to carry on with the study?  
 
Your participation is voluntary and you are free to withdraw at any time, without 
giving any reason, and without your legal rights being affected.  If you withdraw then 
the information collected so far cannot be erased and this information may still be 
used in the project analysis. 
 
Involvement of the Consultant Haematologist 
 
Should you consent to take part in the study, we will notify your Consultant 
Haematologist of your participation. 
 
What will happen to the results of the research study 
 
The results of the study are likely to be presented in conferences and be submitted 
for publication in scientific journals relevant to clinical psychology and/or the field of 
clinical haematology within two years of its completion.  The study will also be written 
up as part of a Doctorate in Clinical Psychology with the University of Nottingham.  
Any reported results will be aggregate and you will not be identified in any 
publication.    
 
Who is organising and funding the research? 
 
This research is being organised by the University of Nottingham and is being funded 
by the NHS Health Education East Midlands via the Trent Doctoral Programme in 
Clinical Psychology. 
 
Who has reviewed the study? 
  Local letter head to be added 
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All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests.  This study has been reviewed and given 
favourable opinion by East Midlands Research Ethics Committee – Nottingham 1. 
 
Further information and contact details 
 
For further information or complaints please contact the researchers involved in the 
study or the clinical psychologist at your clinic who will do their best to assist you.   
 
[Contact details of Principal Investigator, Research Supervisors, site Clinical 
Psychologist, and Patient Liaison and Advice Service] 
 
  Local letter head to be added 
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Appendix I 
 
CONSENT FORM 
(Final Version 2.0 : 27th September 2014) 
 
Title of Study: Development and evaluation of a psychological 
intervention to alleviate distress during haematopoietic stem-cell 
transplantation 
 
REC ref: 14/EM/1095 
 
Name of Researcher: Michael Baliousis       
 
Name of Participant: 
 
1. I confirm that I have read and understand the information sheet version number 
1.0 dated 4th July 2014 for the above study and have had the opportunity to ask 
questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, and without my medical care or legal rights 
being affected.  I understand that should I withdraw then the information collected 
so far cannot be erased and that this information may still be used in the project 
analysis. 
 
3. I understand that relevant sections of my medical notes and data collected in 
the study may be looked at by authorised individuals from the University of 
Nottingham, the research group and regulatory authorities where it is relevant to 
my taking part in this study.  I give permission for these individuals to have access 
to these records and to collect, store, analyse and publish information obtained 
from my participation in this study.  I understand that my personal details will be 
kept confidential. 
 
5. I understand that some of my conversations as part of the support I receive by 
taking part in the study may be recorded.  The researchers may listen to them for 
quality purposes and to improve the support that is provided.  I understand that my 
personal details will be kept confidential. 
 
6. I agree to my Consultant Haematologist being informed of my participation in 
this study. 
 
7. I agree to take part in the above study. 
 
 
______________________ ______________     ____________________ 
Name of Participant   Date          Signature 
 
________________________ ______________     ____________________ 
 Name of Person taking consent Date          Signature 
 (if different from Principal Investigator) 
 
________________________ ______________     ____________________   
Name of Principal Investigator Date          Signature 
 
3 copies: 1 for participant, 1 for the project notes and 1 for the medical notes 
Please initial 
box 
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Appendix J 
 
R code for robust MANOVA 
 
#To load SPSS files: 
library(foreign) 
#To use melt and cast commands: 
library("reshape") 
#WRS is the package for robust MANOVA: 
library(WRS) 
#Load SPSS file and assign rows (variable “row): 
BaseData<-read.spss("BaseRDistressRandArm.sav",use.value.labels=TRUE, 
to.data.frame=TRUE) 
BaseData$row<-c(1:24,1:21) 
#Restructure data into long format, then rename columns to match variables. 
baseMelt<-melt(BaseData, id = c("RandArm", "row"), measured = 
c("Stressb","Anxietyb","Depressb")) 
names(baseMelt)<-c("RandArm", "row", "Outcome_Measure", "Score") 
#Restructure data into wide format and remove variable "row". 
baseRobust<-cast(baseMelt, row ~ RandArm + Outcome_Measure, value = 
"Score") 
baseRobust$row<-NULL 
#Robust MANOVA function: 
mulrank(2, 3, baseRobust) 
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Research ethics committee approval letters 
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• No significant differences between participants 
randomised to intervention versus control, 
Δχ2(Δdf≤4)≤9.14, Ps>0.05. Similar results for attendees 
versus nonattendees.
• HSCT perceptions & coping predicted distress strongly:
Method
Participants
• Recruited from consecutive referrals over 10 months.
Measures
• DASS-21: Total distress, depression, anxiety, & stress.
• Brief IPQ: Negative perceptions of HSCT –
consequences, duration, identity (HSCT’s label and 
symptoms), understanding, concern, & emotional impact.
• Brief COPE: Helpful (e.g., active coping, seeking support) 
and unhelpful coping styles (e.g., denial, self-blame, etc.).
Background
• The first weeks of haematopoietic stem-cell 
transplantation (HSCT) can be very distressing.1
• Feasibility issues and failure to draw on psychological 
models has hampered development of effective 
interventions.2
• We used the self-regulatory model 3 to develop such an 
intervention:
• Informational and coping components aimed to address 
negative HSCT perceptions and unhelpful coping.  
Objectives
• Assess the feasibility of the intervention and methodology.
• Test the applicability of the self-regulatory model to HSCT.
Intervention for distress during stem-cell transplantation:
Feasibility issues and theoretical underpinnings
Michael Baliousis*, Michael Rennoldson, Dave Dawson, Jayne Mills, & Roshan das Nair
Trent Doctorate in Clinical Psychology
*Email: lwxmb8@nottingham.ac.uk
Results
• Forty-five of 99 approached patients consented: Unable 
to consent prior to transplant (n=18), procedure burden 
(n=18), unwell (n=7), no benefit (n=4), taking part in other 
studies (n=3), distressed (n=1), none given (n=3).
• Five of 21 patients randomised to the intervention 
attended: transplant too early (n=7), other priorities (n=4), 
travel delay (n=2), transplant cancelled (n=2), & 
intervention cancelled (n=1).
• Anxiety peaked at Time 3 but decreased thereafter.
• Depression increased continually.
• Clinical levels of distress in 42% of patients.
Conclusions
• Complex psychological needs during acute HSCT.
• HSCT perceptions and coping underpin distress.
• Considerable barriers to conducting a randomised 
controlled trial and delivering a group intervention.
• Need of alternative research procedure and delivery.
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